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 This dissertation describes the syntheses, molecular structures, and infrared 
spectroelectrochemistry of nitrosyl ruthenium and osmium porphyrins containing 
axially bound alkoxide, thiolate, imidazole, and imidazolate ligands. 
 Chapter 1 introduces the fundamental issues involved in the chemistry of 
Group 8 Fe, Ru, and Os nitrosyl porphyrin complexes with trans and O- and S-bound 
ligands, imidazole, and pyridine and their derivatives.  Additionally, this chapter 
introduces important aspects of the biochemistry of the relevant nitrosyl adducts of 
heme proteins. 
 Chapter 2 describes the syntheses of (OEP)Ru(NO)(XR) (XR = OEt, SEt, S-i-
C5H11, SPh) complexes and the redox behavior of the osmium and ruthenium 
compounds (OEP)M(NO)(OEt) and (OEP)M(NO)(SEt) (M = Os, Ru), as determined 
by cyclic voltammetry and infrared spectroelectrochemistry.  The (OEP)Ru(NO)(XR) 
complexes were prepared in 61 – 85% yields through the formal trans addition of 
RSNO to (OEP)Ru(CO) with loss of CO.  These nitrosyl alkoxide and thiolate 
complexes were characterized by IR and 1H NMR spectroscopy, and by ESI mass 
spectrometry.  Infrared spectroelectrochemical studies revealed that the 
(OEP)Os(NO)(OEt) compound undergoes a single reversible oxidation process in 
dichloromethane.  In contrast, the thiolate compound (OEP)Os(NO)(SEt) undergoes a 
net irreversible oxidation resulting in formal loss of the SEt ligand.  Extended Hückel 
calculations on crystal structures of these two compounds provide insight into the 
nature of their HOMOs. In the case of the alkoxide compound, the HOMO is largely 
 xix 
metalloporphyrin centered.  However, the HOMO of the thiolate compound consists 
of a π bonding interaction between the metal dxz orbital and the px orbital on the 
sulfur, and a π antibonding interaction between the metal d orbital and a π* orbital on 
NO.  The redox behavior of the Ru analogues have been determined, and are 
compared with those of the Os compounds. 
 Chapter 3 describes the syntheses of the neutral and cationic (por)Ru(NO)(RIm) 
(por = TPP, TTP, T(p-OMe)PP), OEP; RIm = imidazolate (Im), imidazole (HIm), 1-
methylimidazole (1-MeIm), 4-methylimidazole (4-MeHIm), 5-methylimidazolate (5-
MeIm), and 5-methylimidazole (5-MeHIm)) compounds.  The neutral imidazolate 
(por)Ru(NO)(RIm) (R = nothing, 4-Me) complexes were prepared from the addition 
of the corresponding RHIm to (por)Ru(NO)(O-i-C5H11).  The cationic imidazole 
[(por)Ru(NO)(RIm)]+ complexes were prepared from the solvent-free addition of 
RHIm (R = nothing, 1-Me, 4-Me) to the precursor [(por)Ru(NO)]+ complex.  Both the 
neutral imidazolate and cationic imidazole complexes were characterized by IR and 
1H NMR spectroscopy, and by FAB or ESI mass spectrometry.  The IR spectra (in 
CH2Cl2) of the neutral imidazolate complexes displayed νNO bands in the 1845 – 1855 
cm-1 range, while the cationic imidazole complexes displayed similar bands in the 
1854 – 1877 cm-1 range.  Bands in these ranges are suggestive of linear NO ligands in 
these types of complexes.  The 1H NMR spectra of the product that resulted from 
addition of 4-methylimidazole to [(OEP)Ru(NO)]+ resulted in two sets of peaks that 
were assigned to the structurally isomeric [(OEP)Ru(NO)(4-MeHIm)]+ and 
[(OEP)Ru(NO)(5-MeHIm)]+ complexes.  Further, we were able to determine that the 
less sterically stable 4-MeHIm containing isomer undergoes a first order dissociation 
 xx 
of the 4-MeHIm ligand from the Ru center with the rate constant (k) of 1.44 x 10-5 s-1 
with a half-life (t1/2) of 4.81 x 104 s.  This was followed by the rebinding of the ligand 
to the metal center to form the [(OEP)Ru(NO)(5-MeHIm)]+ isomer.  The solid-state 
crystal structures of the imidazolate and imidazole adducts of the (OEP)Ru(NO) 
complexes were determined by single-crystal X-ray crystallography. 
 Chapter 4 describes the electrochemistry and infrared spectroelectrochemistry 
of (OEP)Ru(NO)(Im) and [(OEP)Ru(NO)(RIm)]+ (R = H, 1-Me).  Electrochemical 
oxidation of the (OEP)Ru(NO)(Im) complex in CH2Cl2 displayed a partially 
reversible single electron transfer centered on the porphyrin followed by an apparent 
radical hydrogen extraction from the solvent by the nitrogen atom of the imidazolate 
ring to form the cationic [(OEP)Ru(NO)(HIm)]+ derivative.  The 
[(OEP)Ru(NO)(HIm)]+ and [(OEP)Ru(NO)(1-MeIm)]+ complexes, on the other-hand, 
exhibit  porphyrin based reversible single electron transfers upon oxidation.  
However, the reduction of the [(OEP)Ru(NO)(HIm)]+ complex proceeds through a 
partially reversible single electron transfer followed by an apparent H• extraction 
from the nitrogen atom of the imidazole by the solvent system to form the neutral 
(OEP)Ru(NO)(Im) derivative.  The reduction of the 1-MeIm complexes proceeds 
through a partially reversible single electron transfer that was followed by the loss of 
the bond between 1-MeIm ligand the ruthenium center of the porphyrin.  Extended 
Hückel calculations on crystal structures of the (OEP)Ru(NO)(Im) and 
[(OEP)Ru(NO)(HIm)]+ complexes provides insight on their redox properties.  The 
calculated HOMOs for the isoelectronic structures show charge centered on the 
porphyrin, providing supporting evidence for the generation of porphyrin-centered π-
 xxi 
radical cations upon oxidation.  The calculated LUMO of the cationic complex, 
however, suggests that the reduction first occurs on the metal-nitrosyl fragment of the 
[(OEP)Ru(NO)(HIm)]+ complex, increasing the antibonding interaction between the 
metal dxz and π∗ orbital on NO.  Presumably, the resulting unfavorable bent Ru-NO- 
like geometry is relieved by an electronic rearrangement that leads to the extraction of 
H• from the nitrogen of the imidazole by the solvent system. 
 
 1 
Chapter 1.  Introduction 
 
 The chemistry of synthetic nitrosyl metalloporphyrins has generated intense 
interest over the past few decades due largely to the identification of the biological 
signaling molecule, Endothelial Derived Relaxing Factor (EDRF), as nitric oxide 
(NO).  This accompanied the subsequent realization of the wealth of physiological 
and pathological phenomenon that occur as a result of the interaction of NO with 
various heme containing biomolecules such as cytochromes, peroxidases and heme-
thiolate proteins like cytochrome P450 and Nitric Oxide Synthase (NOS).1  Modeling 
the interaction that NO has with reactive heme centers has been accomplished 
primarily using synthetic metalloporphyrins to mimic the porphyrins found naturally 
in heme proteins and reacting them with NO gas or NO donor molecules.   Indeed, 
modeling of the biological nitrosyl heme systems using NO or the related organic 
nitroso compounds (X-N=O) and synthetic metalloporphyrins has been a major focus 
of our research group since 1994.  More recently, in 1999, we expanded our research 
to include studies of the chemistry of NO reactions with biologically derived heme 
proteins. 
 Synthetic metalloporphyrins containing Cr, Mo, Mn, Fe, Ru, Os, and Rh 
metals have been used to mimic the prosthetic iron porphyrin centers of heme 
containing biomolecules containing NO linkages.  Further, the chemistry of ligands 
located trans to the metal nitrosyl fragment has been explored for N-donor (-NR), O-
donor (-OR), S-donor (-SR), C-donor (-CR), and halide (-X) groups.  In addition to 
synthetic, reactivity, and structural studies of nitrosyl metalloporphyrin complexes, 
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the electrochemistry and spectroelectrochemistry of these complexes have been 
examined.  A review of the nitrosyl metalloporphyrin and nitrosyl heme chemistry up 
to 1999 can be found in The Porphyrin Handbook.2  
 NO is not an innocent ligand in either metalloporphyrin complexes or other 
metal nitrosyl complexes.  When bound to metal centers NO can be redox active.  
Indeed, this redox activity makes assignments of formal oxidation states difficult.  
Hence, Enemark and Feltham formulated a notation system based on the electronic 
structures of metal nitrosyl complexes that better describes the trends of these 
complexes.3,4  Accordingly, mononitrosyl complexes are assigned the notation 
{MNO}x, where M is the metal and x is the number of electrons assigned to the 
fragment.  The MNO triatomic group in these complexes is considered as a single 
unit and the NO is viewed as a neutral donor.  Thus, the number of electrons are 
derived from the metal’s group and the electron from the π*-orbital of the NO.  Five- 
and six-coordinate Fe porphyrin complexes display x = 6 or 7 and osmium and 
ruthenium porphyrin (six-coordinate)5 complexes have only been observed for x = 6.  
Structural investigations of {MNO}6 species show that they exhibit near linear to 
linear geometry (167° - 180°) while {MNO}7 complexes display moderately bent M-
NO geometries (137° - 149°).  It should be noted that there has been an increasing 
deviation from the dogma associated with this notation.  Group 8 complexes of Fe 
and Ru containing σ-bound alkyl and aryl groups of {MNO}6 complexes have been 
shown to deviate from the expected MNO geometries.  These complexes, presumably 
due to electronic contributions from the (trans) ligands, lead to structures with 
considerably bent M-NO groups.  For reasons that are unclear, nitrosyl complexes of 
 3 
iron are the only {MNO}7 complexes of all the reported metal porphyrins. More 
recently, a report by our group demonstrated bending of an iron nitrosyl group in a 
{MNO}6 porphyrin complex with a thiolate ligand bound trans to the NO group.6  
The Enemark and Feltham notation will be used throughout this dissertation, 
sometimes in conjunction with the “formal” oxidation state. 
 My research has dealt primarily with the synthetic, molecular, and 
electrochemical studies of the heme model complexes of ruthenium and osmium 
nitrosyl porphyrins containing organic O-, S-, and imidazole based donor ligands.  As 
mentioned, Drs. Cheng and Richter-Addo have written a comprehensive review of the 
binding nitric oxide to metalloporphyrins and heme that includes references to the 
literature up to 1999.2 My intent in this chapter is to provide a brief review of the 
literature up to September 2006 that is most relevant to my research.  Hence, the 
following sections will focus on NO adducts of Fe, Ru, and Os metalloporphyrins that 
contain organic O, S, imidazole-  and pyridine-based donors trans to the nitrosyl 
group.  Further, the reactions of heme systems containing tyrosine, cysteine, and 
histidine bound iron centers by NO will be included in this review.   Additionally, 
Table 1.1 at the end of this report is an update to a similar table previously published2 
by our group and contains a list of the nitrosyl metalloporphyrins and the 
spectroscopy that have been collected on these systems from 1999 to 2006.  Tables 
1.2 and 1.3, also at the end of this chapter, list selected geometric parameters that 
have been obtained from single crystal X-ray studies of Fe, Ru, and Os 
metalloporphyrins discussed in this chapter and the related heme systems, 
respectively.  
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I.  Nitrosyl Heme and Heme Models with organic O- and S-Donors 
A.  Heme Models 
The inherent difficulties that accompany the in vitro studies of proteins 
containing nitrosyl heme groups has led to the wide acceptance of synthetic nitrosyl-
metalloporphyrins as likely structural and in some cases electronic models of the 
biological nitrosyl proteins.  For example, nitrosyl-metalloporphyrins containing 
organic S-donor groups have been prepared as potential models of heme-thiolate 
proteins that are known to interact with NO like NOS and cP450.2  Similarly, 
complexes containing organic O-donor groups have been prepared as potential 
models of nitrosyl-heme proteins containing the iron O-bound amino acid tyrosine 
(Tyr) like catalase (cat).2  
Research on nitrosyl-metalloporphyrins containing organic O- and S-donor 
ligands has revealed striking comparisons in the synthetic, structural and reaction 
chemistry as well as the electrochemistry of these complexes. Additionally, with 
respect to nitrosyl complexes with organic O- and S-donor ligands, the collected 
literature shows that the chemistry and electrochemistry of ruthenium porphyrins is 
closely mirrored by osmium porphyrins.   Hence, the following section will review 
the current literature pertaining to the nitrosyl-metalloporphyrins with organic O- and 
S-donors for the iron containing complexes followed by a section discussing the 
reported research related to the chemistry and electrochemistry of both the ruthenium 




1.  Iron-nitrosyl porphyrins 
{MNO}7. There have been few reports of the preparation of six-coordinate iron 
nitrosyl porphyrin complexes with organic O- and S-donor ligands.7,8  Yoshimura 
demonstrated that organic O- and S-donor groups could be added to the five-
coordinate ferrous (PPDME) Fe(NO) at low temperatures (~77 K) to form Fe-
alcohol, Fe-ether, Fe-thiol, and Fe-thioether adducts.  EPR spectroscopic studies of 
these complexes indicated that the O-bound and the S-bound ligands were weakly 
coordinated, the O-donors more so than the S-donors, to the ferrous metal center of 
the complexes at low temperatures and upon warming to room temperature the 
complexes converted to their five-coordinate (PPDME)Fe(NO) forms.7.  Additionally, 
Yoshimura suggested, based on the EPR data, that the thioether sulfur showed a 
stronger interaction with the iron center of the porphyrin than the thiol. 
{MNO}6.  Recently, a series of formally ferric heme model complexes with 
mutually trans NO and thiolate ligands have been prepared through the addition of 
NO gas to a solution containing the five-coordinate (Por)Fe(III)(SR). 9,10  Nan Xu, in 
our laboratory, prepared X-ray quality crystals of the ferric (Por)Fe(NO)(SR) from 
the addition of NO gas to crystals of the five-coordinate thiolate precursor (Eq. 1.1).6  
 
(por)FeIII(SR) + NO  (por)Fe(NO)(SR)              (1.1) 
 
As seen in figure 1.1, each of these complexes have unusual stabilization of the 
iron(III) bound thiolate ligands.  In the case of the complex prepared by Suzuki et al., 
the thiolate located trans to NO is donated from one of porphyrins meso aryl ligands 
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(Fig. 1.1a) and the nitrosyl adduct of the Fe-SR complex prepared by our group 
shows hydrogen bonding interaction between amide hydrogen and the bound sulfur 
atom of the SR ligand (Fig. 1.1b).9  The IR nitrosyl stretching frequencies for these 
complexes in chlorinated solvents ranged between 1826 and 1891 cm-1. 
 
Figure 1.1:  (a) (T(atpa)pivPP)Fe(NO) (R = NHCOC(CH3)3) and (b) 
(OEP)Fe(NO){S-2,6-(CF3CONH)2C6H3}.  Adapted from references 9 and 6, 
respectively. 
 
 Of the nitrosyl heme thiolate model complexes, the one prepared by Nan Xu is 
the only structurally characterized complex reported to the literature to date (Table 
1.2).  The most interesting feature of the structure is the bent FeIII-NO bond at 
159.6(8)º.  Deviation from the linear M-NO bond angle usually associated with 
{MNO}6 complexes has previously only been observed in model complexes 
containing mutually trans NO and alkyl and aryl groups.11  Similarly bent ferric-
nitrosyl groups have been observed in related cP450 like heme enzymes (vide infra). 
This data suggests that a bent M-NO bond may be common for ferric nitrosyl thiolate 
heme and heme model complexes. 
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The isolation of the cationic ferric alcohol complex [(TPP)Fe(NO)(HO-i-
C5H11)]+ was reported by our group and was prepared through the addition of isoamyl 
nitrite to [(TPP)FeIII(THF)2]+ (Eq. 1.2).12 
 
[(TPP)Fe(THF)2]+ + i-C5H11ONO  [(TPP)Fe(NO)(HO-i-C5H11)]+           (1.2) 
 
Formation of the alcohol complex was likely aided by the presence of advantageous 
protons in the mixture.  Unlike the ferrous alcohol complexes discussed above, the 
ferric complex showed moderate room temperature stability in both condensed phases 
(solution and more so in solid state) and maintained its structural integrity over 
several weeks at -20 °C in solution.  The molecular structure of the 
[(TPP)Fe(NO)(HO-i-C5H11)]ClO4 was obtained and the F-N-O linkage displayed the 
predicted linear bond angle (177.1(7)°). 
 The addition of the analogous RSNO to either the neutral ferric 
(TPP)Fe(THF)2 or cationic analogue of the complex, however, reportedly did not 
produce either the thiolate or thiol complexes.  In the former case, isolation of the 
five-coordinate nitrosyl porphyrin was verified spectroscopically, while the latter case 
resulted in no isolable product. 
2.  Ruthenium- and osmium-nitrosyl porphyrins 
 The lack of easily prepared synthetic nitroso iron porphyrin containing 
organic O- or S-donor containing complexes inspired us to study the related nitrosyl 
metalloporphyin complexes using the Group 8 metals ruthenium and osmium.  
Ruthenium and osmium porphyrins were particularly attractive as potential heme 
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structural model alternatives to the related synthetic iron porphyrins in the formation 
of six-coordinate metal-nitrosyl complexes due to their inclination to form low-spin, 
diamagnetic compounds that generally exhibit moderate to high stability under inert 
atmosphere at room temperature.  Furthermore, recent discoveries that indicate S-
nitroso compounds (RSNO) may play important roles in biological actions of nitric 
oxide have spurred interests in this area of research.13,14 Indeed, Jonghyuk Lee’s (of 
our group) PhD dissertation was based in part on his studies of S-nitroso compounds 
and their interactions with heme models.15 A review by Lee, Chen, West, and Richter-
Addo of the interaction of organic nitroso with metals including Ru and Os porphyrin 
complexes has been published.16  
a.  Syntheses.  Preparation of ruthenium- and osmium-nitrosyl porphyrins 
containing a M-XR (where X = O or S) linkages have been demonstrated to generally 
occur through the trans addition of alkyl nitrites (RONO) or alkyl thionitrites (RSNO) 





Antipas, et al. have also demonstrated in their preparation of the methoxide nitrosyl-
ruthenium porphyrin complex that the alkoxide complexes  can also be prepared from 
bubbling of NO gas into an alcohol solution of the ruthenium-carbonyl porphyrin (Eq. 
1.4).25  Dr. Jonghyuk Lee and Geun-Bae Yi, of our group, showed  
 
(por)Ru(CO) + ROH + NOg  (por)Ru(NO)(OR)             (1.4) 
 
that the thiolate containing complexes could also be prepared through the trans 
addition of ONSCH2CH2SH to (por)M(CO) or from the displacement of the alkoxide 
ligand in a (por)Ru(NO)(OR) complex by a dithiolate (HS(CH2)nSH; n = 2 - 4) at 
room-temperature (Eq. 1.5 and 1.6, where M = Ru, Os and n = 2 - 4).  The osmium 
complexes were reported to show greater stability under ambient conditions.19 
 
(por)M(CO) + ONSCH2CH2SH  (por)M(NO)(SCH2CH2SH)           (1.5) 
(por)M(NO)(OR) + HS(CH2)nSH  (por)M(NO)(S(CH2)nSH) + HOR     (1.6) 
 
During infrared studies of the trans additions of alkyl nitrites and alkyl 
thionitrites to carbonyl porphyrins (Eq. 1.3, above) the putative alkoxide and thiolate 
containing the respective ruthenium- and osmium-carbonyl intermediate complexes 
were detected.12,20 Further kinetic investigations of the trans addition of RSNO to 
ruthenium-carbonyl porphyrin starting materials by our group in conjunction with 
Peter Ford’s research group suggested a mechanism of formation for the 
(por)M(NO)(XR) complexes to involve the attack at the sixth coordination position of 
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the metalloporphyrin by the RXNO molecule through the S or O (X) atom.26 The 
subsequent homolysis of the X-NO bond results in the formation of the intermediate 
complex (por)M(CO)(XR) and the free NO interacts with the metal center on the 
opposite face of the porphyrin, displacing CO to produce the (por)M(NO)(XR) 
complex (Scheme 1.1).  
 
 
Scheme 1.1:  Proposed mechanism for the addition of alkyl nitrites and alkyl 
thionitrites to ruthenium and osmium porphyrin carbonyls (adapted from 12). 
 
 
b.  Spectroscopy.  These complexes, as is the case with many metal-nitrosyl 
complexes, show intense bands in the infrared region that are attributed to a nitrosyl 
stretch.  The infrared nitrosyl stretching frequency of the ruthenium alkoxide 
complexes ranges between 1780 and 1809 cm-1 (KBr) while those of the thiolate 
complexes range between 1773 and 1784 cm-1 (KBr).  Similarly, the osmium alkoxide 
complexes have a νNO (KBr) ranging between 1743 and 1770 cm-1 and the νNO (KBr) 
for the thiolate complexes ranges between 1749 to 1760 cm-1.  These values are 
typical of metal-nitrosyl porphyrin complexes that have been described as containing 
a linear M-NO group. 
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To date, the structural and spectroscopic data reported for the NO adducts of 
alkoxide and thiolate complexes have all indicated binding of the NO ligand to the 
metal center through the nitrogen atom.  However, our lab in conjunction with Philip 
Coppens research group have shown that a number of metal-NO linkage isomers are 
 accessible to (por)Ru(NO)(XR) complexes (where X = O or S).  Infrared 
spectroscopic data indicated that low-temperature irradiation of (OEP)Ru(NO)(O-i-
C5H11) and (OEP)Ru(NO)(SCH2CF3) resulted in two nitrosyl linkage isomers.  These 
isomers were demonstrated to contain an isonitrosyl or O-bound N(O)-Ru linkage 
isomer and a side-on η2-cyclic linkage isomer of the metal-nitrosyl group (Fig. 1.2).27 
The isonitrosyl and side-on linkage isomers are both short lived and upon warming to 
room temperature, reform the nitrosyl isomer.  Similar studies of the five-coordinate 
iron porphyrin analogues were reported to produce results that showed the brief 












The characterization of these metastable isomers may provide insight into nitrosyl’s 
approach to and leaving from iron centers of heme proteins. 
c.  Single crystal X-ray structures.  The X-ray crystal structures have been 
obtained for the alkoxide complexes of (TTP)Ru(NO)(OMe), (OEP)Ru(NO)(O-i-
C5H11) and (T(p-OMe)PP)Ru(NO)(O-i-C5H11) (Ch. 3) 27,29 and exhibit linear to near-
linear Ru-NO linkages (table 1.2).  
Like the alkoxide complexes, only a few X-ray molecular structures of 
ruthenium-NO porphyrin complexes with thiolate groups have also been 
obtained.12,18,21  These complexes ((OEP)Ru(NO)(SC(Me)2CH2NHC(O)Me), 
(OEP)Ru(NO)(NACysMe-S), and (OEP)Ru(NO)(SCH2CH2SH)) were reported to 
have near linear Ru-NO geometries ranging between 170.9(9) – 174.8(6)º (table 1.2). 
d.  Electrochemistry.  In addition to the synthetic, spectroscopic, and solid-
state molecular studies outlined above, we have examined the infrared fiber-optic 
spectroelectrochemistry of the dichloromethane solutions of ruthenium and osmium 
porphyrin complexes with alkoxide or thiolate ligands located trans to the M-NO 
group.23 Currently, this study is the only electrochemical examination of nitrosyl 
metalloporphyrins containing alkoxide or thiolate linkages reported in the literature.  
Results from the IR spectroelectrochemistry of these complexes revealed an 
interesting disparity between the electrochemistry of the alkoxide and thiolate 
nitrosyl-metalloporphyrins.  While the alkoxide complexes undergo an oxidation that 
is characterized by a single reversible electron removed from the porphyrin, the 
thiolate complexes undergo an oxidation that is chemically irreversible and based on 
the metal-nitrosyl axial position of the porphyrin complex resulting in the breaking of 
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the M-SR bond and subsequent formation of the thiol, HSR (Eqs. 1.7 and 1.8).  
Chapter 2 describes the IR spectroelectrochemistry study of both the Ru- and Os-NO 
porphyrin complexes. 
 
 (por)M(NO)(OR)  [(por•)M(NO)(OR)]+ + e-             (1.7) 
 (por)M(NO)(SR)  [(por)M(NO)•]+ + HSR + e-             (1.8) 
 
e. Reactivity.  There have been a number of studies into the reaction chemistry of 
(por)M(NO)(XR) complexes (where M = Ru, Os and X = O, S).  These studies have 
examined the consequences of proton addition to the complexes containing alkoxide 
and thiolate ligands and, in the case of a series of the ruthenium and osmium-nitrosyl 
porphyrin complexes with thiolate-thiol ligands, the coordination chemistry that 
occurs when the terminal –SH reacts with the metal centers of other nitrosyl-
metalloporphyrins.  
Protonation studies of alkoxide metal-nitrosyl porphyrin complexes were reported 
result in the isolation of the analogous alcohol bound complexes.  However, 
protonation of thiolate metal-nitrosyl porphyrin complexes resulted in the cleavage of 
the M-SR bond.  Studies, by our group, of ruthenium and osmium metal-nitrosyl 
porphyrin complexes with amide containing M-thiolate linkage showed that proton 
addition to the complex resulted in a ligand rearrangement and formation of the 




Dr. Lin Cheng of our group obtained spectroscopic results and solid-state 
molecular structures that showed that alcohol complexes of osmium-nitrosyl 
porphyrins could be prepared through the addition of H+ to the related alkoxide 
starting materials (Eq. 1.10).17 
 
(por)Os(NO)(OR) + H+  [(por)Os(NO)(HOR)]+           (1.10) 
 
Subsequently, new alcohol complexes were reported to be prepared when the product 
of Eq. 1.10 was stirred in a solution containing an excess of the alcohol of interest 
(Eq. 1.11) 
 
[(por)Os(NO)(HOR)]+ + R’OH  [(por)Os(NO)(HOR’)]+ + ROH         (1.11) 
 
Additionally, it was found that the electrophilic nature of the [(por)Os(NO)]+ 
fragment allowed for deprotonation of the alcohol complexes with pyridine to form 
the alkoxide analogues (Eq. 1.12). 
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[(por)Os(NO)(HOR)]+ + Py  (por)Os(NO)(OR) + PyH+          (1.12) 
 
Though there is evidence that ruthenium alkoxide complexes can be protonated to 
produce the related [(por)Ru(NO)(HOR)]+ complexes30, the addition of pyridine to the 
alcohol complexes, unlike the osmium analogues, has been reported to result in the 
replacement of the alcohol ligand with a pyridine ligand, forming the 
[(por)Ru(NO)(Py)]+ complex.27  It has been suggested based on this evidence that the 
[(por)Ru(NO)]+ fragment is less electrophilic than the Os analogue, affording for the 
production of the cationic pyridine complex.17 
 As is evident from this report and the references herein, spectroscopic and 
structural studies of alkoxide (por)M(NO)(OR) and thiolate (por)M(NO)(SR) 
complexes (M = Ru, Os) has been extensively examined as potential models of Heme 
systems.  In addition to the potential biomimetic value of these complexes, our group 
has explored the utility of the monometallic thiolate-thiol complexes (vide supra) as 
materials for coordination reactions in the preparation of bimetallic µ-dithiolate 
metalloporphyrin complexes.  There have been numerous reports of the preparation of 
bimetallic metalloporphyrin complexes with bridging sulfido, alkyl, oxo, and other 
related ligands.  However, prior to the studies by our group, reports of µ-dithiolate 
metalloporphyrins were absent from the literature.  Drs. Yi and Lee isolated µ-
dithiolate complexes containing symmetric phenyl-porphyrins (por/por) and 
asymmetric phenyl-porphyrins (por/por’) through the addition of an alkoxide 
(por)M(NO)(OR) to the monometallic thiolate-thiol complex.  An example of this can 
be seen in  equation 1.13.18,19 Preparation of µ-dithiolate complexes with the OEP 
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porphyrin and mixed Ru/Os metals was reported to be achieved from the in situ 
preparation of the putative nitrosyl-metalloporphyrin intermediate complex which, 
when in the presence of a (por)M(CO) complex, lead to the trans addition reaction 




SCH2CH2S) + ROH               (1.13) 
 
 Of these complexes, the tetraryl porphyrin complexes were reported to exhibit 
the greatest stability. 
 
B.  Nitrosyl Heme with –SR and –OR donors 
1. Nitric oxide synthase (NOS) 
 Nitric oxide synthase (NOS) is homodimeric heme enzyme with an active 
center composed of iron bound to the sulfur atom of cysteinate amino acid residue in 
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its resting state.31,32 NOS is involved in the catabolism of L-arginine to L-citrulline and 
NO using NADPH and O2 (Scheme 1.2).33-35   
 
 
Scheme 1.2.  Nitric oxide synthase (NOS) catalyzed production of NO from L-
Arginine (adapted from 2). 
 
 
These monooxygenase reactions have been shown to be dependent on the presence of 
the cofactor 5,6,7,8-tetrahydrobiopterin (H4B).36,37 There exist three known isoforms 
of the enzyme, each encoded by different genes:  (1) an inducible NOS isoform 
(iNOS; Type II), a neuronal type (nNOS, Type I), and an isoform derived from 
endothial vascular cells (eNOS; Type III).38-41 The former of these, nNOS and eNOS 
are constitutive and are regulated by Ca2+/calmodulin, while iNOS is induced by 
bacterial endotoxin and inflammatory cytokines.39,42-45 
 NOS is known to form a iron-NO bond from the interaction of the heme 
center with catalytically NOS-generated NO in all three isoforms.46-55 The 
consequence of NO binding during L-arginine catabolism is to inhibit the enzyme 
towards further catalysis.  This form of negative feedback may serve to protect cells 
from being flooded with NO, which can be cytotoxic to host cells.   Abu-Soud has 
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shown that this “suicide inhibition” of NOS by the binding of NO to the iron center is 
reversible in the presence of oxygen.46,48,50 By coupling the formation of the steady 
state between the Fe-NO NOS and the resting NOS to O2 levels, it is believed that it 
regulates NO production, allowing only the needed amounts of NO to be released 
while excess amounts react with dioxygen to form heavier oxides of NO like NO2. 
Several reviews on the structure, function, and inhibition of NOS have been 
published. 56-59 
 Protein crystal structures of both mammalian and bacterial NOS with iron 
bound NO have been obtained from exogenous addition of NO or NO donors to 
crystals of native NOSs.60,61 A collaboration between Poulos and Masters resulted in 
the determination of the protein crystal structures for ferric-nitrosyl NOS from bovine 
eNOS in the presence and absence of H4B when L-Arg is bound is bound to the active 
site in both structures.60 It was revealed in both structures that the Fe(III)-NO linkage 
was bent at 160º at ~2.00 Å resolution.  Favoring of the bent Fe(III)-NO bent 
geometry in the complexes over the expected linear geometry usually associated 
{MNO}6 porphyrin complexes may be due to stabilization of the bent NO from 
hydrogen bonding between the O(NO) and guanidine group of the L-Arg co-substrate 
in both the H4B and H4B free substrates.  The authors conclude from this data that 
H4B has little effect on the NO geometry as long as L-Arg is present in both enzymes.  
Selected structural geometries for the crystals with H4B (+H4B) and without H4B (-
H4B) are listed in table 1.3. 
 Similarly, Pant and Crane were able to obtain protein crystallographic data for 
the reduced form of Bacillus subtilis NOS with ferrous bound NOS in the presence of 
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L-Arg as well as the reduced form of the structure with the ezymatically catabolised 
NG-hydroxyl-L-arginine (NOHA) in the active site of the enzyme.61  Additionally, 
protein crystallographic geometric data was obtained for two oxidized forms of NOS 
Fe(III)-NO with NOHA in the active site.  Each of these complexes exhibited greater 
than expected bends in the Fe(II)-NO and Fe(III)-NO geometries of the crystal 
structures.  The reduced ferrous-NO—L-Arg and ferrous-NO—NOHA structures 
showed Fe(II)-NO angles of 132º and 126° at 1.9 Å resolution, respectively.  The 
variation in the bond angles for the two complexes was credited to refinement 
problems in the NOHA containing complex.  Despite the differences in the two 
angles, both complexes show a surprising deviation from the expected linearity found 
in other {MNO}6 porphyrin complexes.  The difference in the structures include 
hydrogen-bonding between the nitrogen of the nitrosyl group and the guanidinium 
nitrogen of in the L-Arg complex found in the ferrous-NO—L-Arg structure, while, in 
the ferrous-NO—NOHA the nitrogen of the nitrosyl group forms a tight hydrogen 
bond with the NG of NOHA (2.86 Å vs 2.55 Å). 
 Ferric-NO—NOHA NOS complex was reported to crystallize with two 
molecules per asymmetric symmetry, one exhibiting a moderately bent Fe(III)-NO 
geometry (161°) and another with a severally bent ferric-nitrosy group (101°).  The 
unexpectedly small angle exhibited by the latter Fe-NO group was attributed to 
possible nitrosylation of NOHA molecule in the structure.61 
 More recent work has suggested that the binding of NO to the heme center 
may induce monomerization of the NOS homodimer.  Further, the monomeric form 
of NOS can be converted back into the dimeric form with the addition of arginine and 
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H4B.  Thereby, the initiation of monomerization by binding NO may be another 
regulatory response of the enzyme.62 
2.  Cytochrome P450 
 Cytrochrome P450 (cP450) is a heme enzyme with an iron(III) active site 
covalently linked to the sulfur in cysteine (Cys) in the resting state.  In anaerobes, 
cP450 is primarily responsible for catalyzing the insertion of oxygen into substrates 
(S) (Eq. 1.15). 
 
 S + O2 + 2e-(NADPH) + 2H+  SO + H2O            (1.15) 
 
An excellent review of the reactions catalyzed by cP450 was prepared by Meunier, 
Visser, and Shaik.63 
 Numerous spectroscopic studies have suggested that NO binds to the iron-
heme center of cP50 trans to Cys and is believed to inhibit the function of the 
enzyme.31,64-79  Binding of NO to the ferric P450cam has been predicted to be linear in 
the absence of substrate but otherwise bent when substrate is present.71  Mutation of 
the conserved Glu318 in P450 1A2 to Ala resulted in the reduction of NO ferric 
complex to the ferrous analogue.80  The authors of this study suggest that hydrogen 
bonding interactions between the carboxyl group of Glu318 and NO are crucial for 
stabilization the ferric nitrosyl structure. 
To date, there have not been any reports of single-crystal protein structures of 
the six-coordinate cP450-NO. 
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3.  Fungal nitric oxide reductase 
 Fungal nitric oxide reductase (P450nor) is part of the global denitrification 
cycle and catalyzes the conversion of NO to N2O at the cost of NADH.  Fungal NOR, 
unlike the bacterial analogue (vide infra), is a cytochrome P450-like enzyme that 
binds NO through the ferric center of the heme trans to Cys during catalytic reduction 
of the substrate.81-84  It, however, is unable to catalyze cP450 oxygen insertions into 
substrates.  There have been numerous spectroscopic studies comparing P450nor from 
various sources to cP450.81-85  Spectroscopic and computational evidence has led to 
the suggestion that a nitroxyl species (HNO) is formed from the reduction of NO.85,86  
 Recently, Shiro and co-workers have prepared an X-ray quality crystal of 
Fe(III)-NO fungal NOR from the reaction of crystalline Furasarium oxysporum NOR 
with NO gas under anaerobic conditions.87 The FeIII-NO bond was shown to have a 
bend (161°) and was in agreement with earlier predictions of the bond angle based on 
EXAFS studies.  The ferric-nitrosyl bond angle reported for this heme complex is 
similar to the M-NO bond angle (159.6(8)°) for the related Fe(III)-NO thiolate 
complex [(OEP)Fe(NO)(S-2,6-(CF3CONH)2C6H3}] reported by Nan Xu (vide supra).6 
The authors conclude that the bent Fe(III)-NO is due to trans electronic effects from 
the cysteinate (S-) ligand rather than steric effects from the amino acid residues 
surrounding the active site since it is relatively not crowded.   
4.  Chloroperoxidase 
 Chloroperoxidase is a heme enzyme that contains a five-coordinate iron center 
bound to the sulfur atom of Cys and is responsible for catalyzing the H2O2-dependent 
chlorination of substrates.88  Preparations of NO adducts of chloroperoxidase using 
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exogenous NO sources were done with the intent of using the diatomic molecule as a 
ligand probe of the reactive center of the enzyme.69,89-91  Such probes are often used in 
heme proteins that have traits which make them spectroscopically difficult to 
characterize and/or are difficult to crystallize for single-crystal X-ray studies.92  The 
biological significance of nitrosylated chloroperoxidase is unknown. 
5.  Catalase 
 Catalase is responsible for catalyzing the disproportionation of peroxide to 
water and dioxygen (Eq. 1.16) and the ferric metal center of the heme enzyme 
contains O-bound tyrosine (Tyr) and water.93 
 
 2H2O2  2H2O + O2                          (1.16) 
 
 Several studies have been published that describe the formation of ferrous-NO 
catalase complex upon the exposure of catalase to low concentrations of NO, 
NH2OH, or hydrazine94-100 Further, the reactions of azide with catalase has been 
suggested to result in NO release98,101-103 and may form an NO-catalase complex104.  
Brown has shown that exposure of catalase to physiological levels of NO results in 
the formation of Fe(II)-NO bond and inhibits enzymes catalytic activity.96 The 
nitrosyl-catalase complex is stable in inert atmospheres, however, the five-coordinate 
catalase is reformed when the nitroso catalase is exposed to oxygen.103  
 Recently King, et al. have published a report that details the formation of 
nitrosyl catalase from the reaction of hyroxyurea with catalase in the presence of 
hydrogen peroxide.105 The ferric catalase oxidation of hyroxyurea to form NO 
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catalase is significant due to the recent approval of the use of hydroxyurea as a 
treatment in the reduction of “painful crises” in patients with sickle cell disease.105 
Trials have shown that patients who have been administered hydroxyurea have an 
increase in NO metabolites and, as suggested by Brown, may be due to the catalase-
mediated oxidation of the hydroxyurea medication. 
 
II.  Nitrosyl Heme and Heme Models with Pyridine and Imidazole Based N-Donors 
A.  Heme Models 
1.  Iron-nitrosyl porphyrins 
 Unlike the six-coordinate iron-nitrosyl porphyrin complexes with organic O- 
and S-donor ligands, reports of the similar complexes containing pyridine and 
imidazole based ligands are numerous.106-129 Interest in imidazole and pyridine bound 
metalloporphyrin complexes arises partly from the high percentage of metal bound, 
imidazole containing, histidine (His) residues that are found in biological heme 
proteins.  Of all the Heme proteins, those with N-bound His are most prevalent.  
Further, an abundance of these biological macromolecules are believed to interact 
with NO.  A general review of the published data related to the chemistry of nitrosyl-
iron porphyrins will be presented in this section. 
 a.  Syntheses.  The six-coordinate {MNO}7, formally ferrous,  (por)Fe(NO)(L) 
(L = imidazole- or pyridine-base) are generally prepared through addition of NO or 
N-base to the corresponding five-coordinate precursor (Eqs. 1.17 and 1.18).  
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(por)Fe(NO) + N-base  (por)Fe(NO)(N-base)           (1.17)
 (por)Fe(N-base) + NO  (por)Fe(NO)(N-base)           (1.18) 
 
Scheidt and co-workers have also prepared similar complexes of {MNO}6 
(ferric) [(OEP)Fe(NO)(N-base)]+ bubbling NO gas through a solution containing 
[(OEP)Fe(OClO3)] and the N-base (Eq. 1.19).126 Preparation of the {MNO}6 
complexes required special preparation techniques that involve precise addition of the 
neutral N-donor ligand due to the highly labile MNO fragment.  Addition of too much 
ligand quickly results in the denitrosylation of the complex resulting in the formation 
the bis-Nligand complexes.  This is in contrast to the formation of the analogues 
{MNO}7 complexes, which generally require and excess of ligand to form the six-
coordinate nitrosyl complexes.  Clearly, the binding affinities of the ligands are very 
different in neutral and cationic complexes (vide infra).  
 
[(OEP)Fe(OClO3)] + N-base + NO  [(por)Fe(NO)(N-base)]ClO4         (1.19) 
 
b.  Spectroscopy.  An arsenal of spectroscopic techniques (IR, resonance 
Raman (RR), UV/Vis, electron paramagnetic resonance (EPR), and magnetic circular 
dichroism (MCD)) have been used to better understand the ligand binding in the 
nitrosyl adducts of the iron porphyrin complexes [(por)Fe(NO)(L)] (L = imidazole-, 
pyridine-based ligands)  of both the {MNO}6 and {MNO}7.  Universally, the data 
indicate that binding of imidazole- and pyridine-based ligands to the metal centers of 
these complexes is weak; the more acidic pyridine-based ligands have weaker bonds 
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than the imidazole-based ligands and the cationic (“ferrous”) {MNO}6 
[(por)Fe(NO)(N(L))]+ have much weaker Fe-N(L) bonds than the analogues neutral 
ferric complexes.   The difference in NO binding for the {MNO}7 and {MNO}6 
complexes is reflected in the respective nitrosyl stretching frequencies.   
{MNO}7.  Kon109 and Wayland111, independently using EPR studies suggest 
that the unpaired electron from NO is significantly delocalized away from the NO 
into the dz2 orbital of the Fe.  According to Scheidt, this leads to an antibonding 
orbital combination upon addition of a neutral N-based ligand and contributes to low 
binding constants of the trans ligand that are estimated between 0.1 and 10.130  
Further, this explains the weakening of the Fe-N(MeIm) bond in (TPP)Fe(NO)(1-
MeIm) (2.180(4) Å) when compared to the six-coordinate bis-1-MeIm analogue (2.00 
Å).130 131 132  Recently, Lehnert and coworkers reported, based on NMR and 
computational data, that upon binding the neutral imidazole base the FeII-NO bond is 
weakened.127 
 Interestingly, the activation of soluble guanylate cyclase (sGC) by NO shows 
a similar trans effect on iron bound histidine.  Once NO binds to the five-coordinate 
heme center, the Fe-His bond breaks, activating sGC to catalyze the cyclization of 5’-
triphospate (GTP) to guanosine 3’,5’-cyclic monophosphate (cGMP).  cGMP has 
been shown to be the biomolecule that is responsible for physiological events like 
vasodilation. 
{MNO}6.  As mentioned above, formation of the Fe(III)-NO complexes is 
more dependent on precise additions of the neutral N-donor ligand than the analogous 
Fe(II)-NO complexes.  This suggests that the stability of the [(por)Fe(NO)(N(L))]+ is 
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low in comparison to the similar neutral analogues.  This assumption agrees with the 
results obtained from laser photolysis studies by Ford and coworkers on water soluble 
hexacoordinate {MNO}7 and {MNO}6 nitrosyl heme proteins where the NO binding 
constants were reported to be ca. 1011 and 103 – 105, respectively.133,134 This is, to a 
degree, a reflection of the high (koff) unit in the ferric system.130 
 c.  Single crystal X-ray structures.  Single crystal X-ray data have been 
obtained for the six-coordinate nitrosyl adduct of ferrous {MNO}7 and ferric {MNO}6 
metalloporphyrins containing imidazole and pyridine derived metal linkages.  
However, due to exceptionally weak coordination of the neutral bases to the formally 
ferric metal center, few of these structures are of the {MNO}6 type (table 1.2).  An 
excellent review by Wyllie and Scheidt of the molecular structures of iron-nitrosyl 
porphyrin complexes and other nitrosyl metalloporphyrin complexes has been 
published.130  
{MNO}7.  As is evident from table 1.2, the X-ray derived geometric 
parameters of a few ferrous porphyrin complexes containing mutually trans nitrosyl 
and imidazole/pyridine derived ligands have been reported.  These complexes contain 
the bent M-NO groups (131.8(12) – 143.7(6) º).  In line with the apparent weak 
binding of the neutral donor ligand to the metal trans of NO, there is no significant 
deviation from the geometry of the Fe-NO group in the five-coordinate nitrosyl 
complex upon binding of the neutral N-donor ligand.130 Additionally, comparison of 
the six-coordinate bis-MeIm complex to the related (por)Fe(NO)(MeIm) reveals a 
lengthening of the Fe(II)-N(Im) bond in the NO complex (2.014(5) vs. 2.180(4) Å, 
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respectively)131,132,135  This relatively long Fe(II)-N(Im) bond is due to weak 
coordination of the ligand to the Fe-NO group in the complex. 
{MNO}6.  As mentioned above, the labile nature of the Fe(III)-NO fragment in 
the [(por)Fe(NO)(N-donor)]+ complexes leads to easy, rapid denitrosylation.  In fact, 
the few {MNO}6 crystal structures reported by Scheidt for these complexes were 
solved only after specialized equipment was constructed for the growth of X-ray 
quality crystals.126  These complexes displayed nearly linear Fe-NO geometries 
(~177º). 
d.  Electrochemistry.  Choi and Ryan have reported the cyclic voltammograms 
of (por)Fe(NO)(Py) complexes (por = TPP, PPDME; Py = pyridine-based ligand).123  
Not surprisingly, considering the weak interaction between neutral N-donor ligands 
and the ferric centers of the metal-nitrosyl complexes reported above, the reversible 
one-electron reduction of these complexes were reported to result in the loss of the 
pyridine-substituted bases (Eq. 1.20; site of reduction is not specified). 
 
(por)Fe(NO)(L) + e-   (por)Fe(NO)•- + L           (1.20) 
 
There have been no other reports of electrochemical studies of {MNO}7 or 
{MNO}6 iron porphyrin complexes with imidazole- or pyridine-based ligands. 
2.  Ruthenium- and osmium-nitrosyl porphyrins 
 There have been only a few reports of the preparation of ruthenium-nitrosyl 
complexes with either metal bound imidazole- or pyridine-based ligands, and of these 
reports only one contains full synthetic and spectral data for the complexes.  There 
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have been no reports of the preparation of osmium-nitrosyl porphyrin complexes with 
either imidazole- or pyridine-based ligands.  
In the interest of expanding knowledge of Group 8 metalloporphyrin nitroso 
complexes with imidazole- and pyridine-based ligands, we have studied the synthesis, 
X-ray crystal structures, and electrochemistry of the ruthenium analogues of these 
complexes.  This data will be presented and discussed in Chapter 3 and 4 of this 
thesis. 
a.  Syntheses 
 Bohle was able to obtain the TTP derivative of (por)Ru(NO)(Im) through the 
solvent free reaction of the nitrosyl porphyrin alkoxide precursor complex with 
imidazole (Eq. 1.21) 
 (TTP)Ru(NO)(OR) + HIm  (TTP)Ru(NO)(Im) + HOR          (1.21) 
The preparation of a pyridine containing ruthenium nitrosyl porphyrin complex has 
been reported, however, neither the details of the synthesis or spectroscopic 
elucidation were provided. 
3.  Myoglobin 
 Myoglobin (Mb) is a monomeric heme protein that, in its resting state, is 
composed of a pentacoordinate prosthetic group with an iron porphyrin attached 
through the nitrogen atom of His.  The primary function of Mb is generally regarded 
as a dioxygen storage protein in muscles.   
NO adducts of myoglobin are perhaps the most studied of the heme proteins 
containing iron-NO groups since the wild-type (wt) protein is known to interact with 
NO through the iron heme center and mutated versions of the protein are used to 
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model the reactions of other, less understood heme enzyme interactions with 
NO.106,107,136-164  Indeed, Dan Copeland of our group recently completed his thesis 
entitled “Structural Studies of the Interactions of Nitric Oxide and Nitric Oxide 
Containing Molecules with Heme Proteins.”  Reviews of the NO adducts of Mb have 
been published.2,165  For brevity and in keeping with the scope of this work, only a 
general review of the interactions of NO with Mb will be presented.  More specific 
details can be obtained from the sources listed here. 
 Recent studies have brought the role of Mb as a dioxygen storage protein as 
its primary function into question.  Research by Flögel et al. suggests that 
oxymyoglobin (MbIIO2) may act as a molecular scavenger of NO in the presence of 
elevated NO synthase activity, protecting the inhibition of cytochromes by NO 
binding.166 Further, it was postulated that oxymyoglobin reacts with NO, forming an 
MbFe(II)NO intermediate that reacts with dioxygen forming metMb and releasing 
NO3-. 
 This, however, is not the first report of NO binding to the iron in Mb(II).  It 
has been known for over 100 years that the coloration in cured meat is due to the 
formation of pentacoordinate Mb(II)NO.2,141,161 The addition of nitrite to uncooked 
meat reacts to form N2O3 that, when reduced, forms the NO that binds to the iron 
center of Mb.  This process is commonly believed to be aided by bacterical or 
enzymatic actions as well as chemical curing agents like sodium chloride.  It has been 
proposed that the addition of nitrite to meat results in the oxidation of  Mb(II)O2 
forming Mb(III)NO.  Reduction in the meat matrix powered by NADH results in the 
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formation of the penatcoordinate Mb(II)NO that is associated with the blood red color 
of cured meat.167 
 The binding of NO to Mb(II) has been extensively studied.  It has been 
suggested that there is a charge transfer from Fe(II) to NO when bound in Mb that 
results in NO being nitroxyl (NO-) in character.  The single crystal protein X-ray 
structures of sperm whale MbNO (swMbNO)168 and horse heart MbNO 
(hhMbNO)169,170 have been reported and selected geometric data for these complexes 
can be found in table 1.3.  The former sperm whale structure exhibited a Fe(II)-NO 
bond angle of 112°.  The Fe-NO angle is more acute than what is generally associated 
with {MNO}7 complexes but agrees with M-NO angles derived previously from EPR 
data (108º-110º).162,163 The authors of this work attributed this to electrostatic 
interactions between the ligand and a distal His residue in the swMbNO.  Three 
different crystal structures of hhMbNO were prepared; two of the structures were 
prepared from the addition of nitrite/dithionitrite to a hhMb crystal while a third 
complex was prepared from the addition of NO gas to crystalline hhMb.   The Fe-NO 
geometry for the structures prepared from the nitrite/dithionitrite soak were 
essentially the same (147° and 144°), while, surprisingly, the Fe-NO bond angle in 
the structure that was prepared from the addition of NO gas showed a Fe-NO bond 
angle of 120°.  Copeland and coworkers explain the discrepancy in these geometries 
as occurring from constraints placed on the formation of the different hhMbNO 
structures from the “pre-formed distal pocket” of the protein.  Presumably the 
reactions occur through different pathways, which result in formation of 
intermediates whose structures are dependent on stabilization by the distal pocket.  
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The end result reflects the minimized structures afforded by the distal pocket 
interactions.  
 In addition to the Mb(II) nitrosyl complexes, there have been reports of 
nitrosyl adducts of the oxidized ferric Mb.140,142,144,147,150,152,155 The binding affinity of 
NO for Mb(III) have been shown to be significantly lower than for Mb(II).140 The 
bond angle of the FeIII-NO group is predicted to be near linear via EPR studies and is 
similar to the angle predicted for other {MNO}6 heme model complexes.146 The 
biological importance of the in vivo binding of NO to Mb(III) has been questioned.167 
 There have been reports that also describe the weakening of the ferrous-
nitrogen bond in the trans His of MbFe(II) upon binding NO.164 The bond between 
the proximal base and the Fe(II) center of Mb is further weakened in low pH 
solutions of MbFe(II)NO complexes.139,148,154,157 
 In addition to studies of the binding of NO in wild type (wt) Mb, there have 
also been studies of the binding of NO to the ferrous centers of Mb that have had 
amino acid residues changed through mutation.142,153 Similarly, metal-substitution 
MbNO has been studied.136-138,155,156 While this research supplies important 
information about mechanistic and stabilization aspects of the addition and formation 
of NO adducts of Mb, it lies outside the scope of this work and will not be further 
reviewed here. 
4.  Cytochrome c Oxidase  
Cytochrome c oxidase (CcO) reduces molecular oxygen to water through a 
series of electron transfers which in-turn provides energy to pump protons across the 
mitochondrial membrane in eukaryotic cells.171-173 CcO is composed of two hemes, 
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heme a and a3, a dimeric copper center, CuA, and a mononuclear CuB.174,175   
Reduction of dioxygen occurs at the heme-copper binuclear center, where heme a3 
and CuB are in close proximity (Fig. 1.3).   The structural features of various CcO 
enzymes have been extensively explored.  The heme a3 contains an Fe center axially 
linked with a His, whereas the CuB site is linked to three His residues, one of which is 
covalently bound to a tyrosine (Tyr) residue.  
 
                                    
Figure 1.3:  Binuclear center in CcO. 
 
Evidence has shown that NO reversibly binds to the iron center of CcO 
competitively with oxygen.176-199 It is believed that the binding of NO to the heme 
center plays a role in oxygen sensing and the cell’s response to hypoxia.200 
Additionally, interaction of a NO molecule with the CuB site reversibly induces 
limited inhibition of the dioxygen reduction.179,180,188-190,192-195,197-199,201    
A series of studies comparing the reactions of NO with oxidized and reduced 
forms of CcO in both the presence and absence of azide have resulted in 
spectroscopic evidence that suggests highly conditional forms of NO binding to the 
iron center and the CuB binuclear site of the protein.176,178-180 In the case of the 
oxidized complex (a3+, CuB2+) in the absence of azide NO reversibly binds to the CuB.  
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Interestingly, in the presence of azide, NO reacts with the oxidized CcO to form a 
bridged isonitrosyl structure (a32+-NO-CuB2+) that was reported to be stable.180 When 
NO was introduced to reduced forms of CcO (a3+, CuB+), a3+-NO and CuB+-NO where 
observed. 178 
5.  Soluble Guanylyl Cyclase 
 Soluble guanylyl cyclase (sGC) is a heterodimeric heme enzyme consisting of 
a pentacoordinate high-spin ferrous metal center bound to histidine and a 
hexacoordinate low-spin iron heme center (likely consisting of His ligands bound in a 
trans fashion across the face of the porphyrin) in the resting state.202,203  sGC is 
activated by NO binding to the iron heme center which in-turn catalyzes the 
cyclization of guanosine 5’-triphosphate (GTP) to guanosine 3’,5’-cyclic 
monophosphate (cGMP).  cGMP is the biological molecule that initiates a series of 
physiological events like vasodilation. 
 The NO adducts of ferrous sGC have been studied204-217 and it is generally 
accepted that upon binding NO to the ferrous heme center the proximal His is 
liberated leaving the pentacoordinate (por)Fe(NO) heme complex206,207,209-212,214,217. 
Indeed, Burstyn et al. concluded from studies on sGC proteins that had been 
reconstituted with (PPIX)MnII and (PPIX)CoII that the loss of the metal-His bond 
upon binding NO is required to activate sGCs enzymatic activity.206 Further, Marletta 
and co-workers have shown from their studies of the loss of the ferrous-His bond 
upon the binding of NO to sGC that a conformational change in the proximal pocket 
of the enzyme occurs and have speculated that this may have important implications 
to the mechanism of sGC activation by NO. 210   
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6. Nitrite Reductase 
 Nitrite reductase (NiR) enzymes are another important member of the 
denitrification cycle and are responsible for the reduction of nitrite (NO2-) to NO.  
There are two major classes of NiR enzymes.  The first is the heme containing 
cytochrome cd1 NiR and the second is the non-heme copper nitrite reductase.2   
The cyt cd1 NiR, as the name implies, is composed of a heme c and heme d1 in 
each subunit of the enzyme. Both hemes have iron centers bound to His. Heme d1 has 
been shown to bind NO2- whereas heme c has been proposed to the location of the 
initial electron donation and provides the needed reductive energy through a series of 
steps to heme d1 for reduction of the bound NO2- to NO.218-224 Heme d1 has been 
shown crystollographically (from Thiosphaera pantotropha (NiR-Pd)) to have two 
histidine residues (His345 and His388) and a tyrosine residue (Tyr25) in the distal 
pocket.225,226 The His residues are believed to be involved in the reduction NO2- to NO 
while the Tyr residue is believed to be involved in the removal of NO from the Fe(III) 
heme d1 center.   Reviews of the proposed mechanism of reduction of nitrite to NO 
have been published.222,227 
 The single crystal protein structures for the NO adduct of cyt cd1 NiRs have 
been reported from Thiosphaera pantotropha225 (NiR-Tp) as well as Pseudomonas 
aeruginosa228 (NiR-Pa).  Both structures contain a bent Fe(III)-NO angles (131º and 
135º, respectively).   The bending of these {MNO}7 complexes is proposed to arise 
due to interactions between the oxygen atom of NO and His in the distal pocket of the 
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enzyme.  The NO adducts of cyt cd1 NiR are believed to form just prior to the release 
of the ligand from the metal center during the catalytic path of reduction of nitrite. 
7.  Bacterial Nitric Oxide Reductase 
 Like the fungal nitric oxide reductase discussed above, bacterial nitric oxide 
reductase (NOR) catalyzes the reduction of NO to N2O.  There have been a number of 
reports describing the composition of the enzyme as cytochrome bc complex, 
however, more recent data suggests that the enzyme may be composed of two heme b 
centers and a heme c center (denoted as cytochrome cbb).177,229-231   
The current belief is that the catalytic site of the enzyme is composed of a 
five-coordinate low-spin heme b bound to a His through the ferric iron and a non-
heme iron(II) located next to the heme center in the distal pocket.  EPR studies by 
Saraste and coworkers suggest that both the heme and non-heme iron(II) active 
centers each bind an NO during the catalytic reduction to N2O.232 
8.  Other Heme-proteins 
 There have been reports of the interaction of NO with the iron centers of a 
number of other heme proteins.  The binding and activation of NO to these heme 




Table 1.1:  Fe, Ru, and Os nitrosyl-porphyrins with organic S-, O-donors and imidazole- and pyridine-based axial ligands reported 
from 1999-2006. 
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(OEP)Fe(NO){S-2,6-(CF3CONH)2C6H3} 6 1850 
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Table 1.2:  X-Ray geometric parameters from Group 8 synthetic nitrosyl porphyrins with organic S- and O-donors and imidazole- and 
pyridine-based axial ligands reported from 1999 - 2006. 
 {M(NO)}n M-NNO (Å) N-O (Å) ∠MNO (º) M-Xlig (Å) ∠MXY (º) ref 
Iron        
[(TPP)Fe(NO)(HO-i-C5H11)]ClO4a 6 1.776(5) 0.925(6) 177.1(7) 2.063(3) 
127.8(6), 
131.8(6) 12 
[(OEP)Fe(NO){S-2,6-(CF3CONH)2C6H3}] 6 1.671(9) 1.187(9) 159.6(8) 2.356(3) 110.6(3) 6 
[(OEP)Fe(NO)(1-MeIm)]ClO4 6 1.6465(17) 1.135(2) 177.28(17) 1.9889(16) 
128.09(13), 
125.74(13) 126 











(TPP)Fe(NO)(1-MeIm)•CHCl3b 7 1.743(4) 1.121(8) 142.1(6) 2.180(4) 
126.6(4)j, 
130.4(4)j 131,132 





(TPP)Fe(NO)(4-MePip)b 7 1.7210(10) 1.141(13) 138.5(11) 2.328(10) 112.5(5), 113.1(6) 234 
(TPP)Fe(NO)(4-MePip)•CHCl3 7 1.740(7) 1.112(9) 143.7(6) 2.463(7) 
113.6(8), 
113.3(9) 234 
(TPP)Fe(NO)(4-MePip)•CHCl3k 7 1.7517(19) 1.171(2) 138.04(17) 2.2851(19) 
115.10(13)j, 
113.65(13)j 233 
(TPP)Fe(NO)(4-NMe2Py)b 7 1.7577(13) 1.1700(13) 139.79(12) 2.2783(13) 
123.77(11)j, 
118.91(11)j 233 
(TpivPP)Fe(NO)(NO)(Py)•C6H5Cl 7 1.742(5) 1.194(9) 133.4(5) 2.260(5) 
121.0(3), 
121.0(3) 233 
Ruthenium        
(TTP)Ru(NO)(OMe)a, c 6 1.84(4)  180.0 1.80(5)  29 
[(OEP)Ru(NO){O=C(Me)NHCH2C(Me)2SH}]BF4 6 1.708(6) 1.141(7) 177.8(5) 2.049(4) 143.8(5) 21 
(OEP)Ru(NO)(SC(Me)2CHNHC(O)Me) 6 1.769(3) 1.114(4) 172.8(3) 2.390(1) 121.74(13) 21 
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 {M(NO)}n M-NNO (Å) N-O (Å) ∠MNO (º) M-Xlig (Å) ∠MXY (º) ref 
(OEP)Ru(NO)(S-NACysMe) 6 1.790(5) 1.123(8) 174.8(6) 2.362(2) 107.1(3) 12,20 











164(3) 27  
(OEP)Ru(NO)(Im)•HIm•CH2Cl2 6 1.748(3) 1.148(4) 174.9(3) 2.063(3) 
127.9(2), 
128.0(2) Ch. 3 
(OEP)Ru(NO)(5-MeIm)•4-MeHIm 6 1.740(4) 1.145(5) 171.2(4) 2.059(4) 128.1(4), 127.9(3) Ch. 3 
[(OEP)Ru(NO)(HIm)]SbF6d 6 1.695(9) 1.131(12) 175.3(7) 2.069(8) 
128.9(6), 
128.2(8) Ch. 3 
[(OEP)Ru(NO)(4-MeHIm)]SbF6/ 
[(OEP)Ru(NO)(5-MeHIm)]SbF6e 
6 1.7305(17) 1.144(2) 176.94(18) 2.1036(17) 122.49(16), 130.93(13) Ch. 3 
Osmium        
(OEP)Os(NO)(O-n-Bu)c 6 1.833(8) 1.173(11) 172.8(8) 1.877(7) 130.8(9) 22 
(OEP)Os(NO)(OEt)c 6 1.81(2) 1.33(2) 156.1(17) 1.89(2) 123.7(15) 17 
(OEP)Os(NO)(OEt)c, f 6 1.880(7) 1.165(9) 172.4(10) 1.849(7) 128.0(8) 23 
[(OEP)Os(NO)(HOEt)]BF4•HOEt 6 1.720(4) 1.167(5) 178.5(3) 2.062(3) 130.5(4) 17 
[(OEP)Os(NO)(HOiPr)]BF4•iPrOHg 6 1.709(4) 1.186(5) 176.6(3) 2.075(3) 129.1(6) 17 
[(OEP)Os(NO)(HOhexyl)]BF4 6 1.740(6) 1.159(9) 174.4(6) 2.097(5) 127.3(4) 17 
[(OEP)Os(NO)(HOhexyl)]BF4h 6 1.728(7) 1.174(9) 176.8(7) 2.073(5) 126.3(5) 17 
(OEP)Os(NO)(SEt)•CH2Cl2c 6 1.994(10) 1.136(11) 172.7(8) 2.227(2) 112.8(4) 23 
(OEP)Os(NO)(SC(Me)2CH2NC(O)Me 6 1.781(5) 1.126(6) 176.8(5) 2.415(2) 121.8(2) 19 
(TTP)Os(NO)(S-i-C5H11)a 6 2.041(7) 1.086(10) 170.0(9) 2.209(3) 111.8(5) 12 
 
aDisorder in ligand trans NO.  bTwo positions of NO ligand observed.  cDisorder of the axial ligands across the face of the porphyrin required by an inversion center.  dCrystal was 
reported to be weakly diffracting.  eIsomeric disorder.  fSecond molecule from different crystallization.  gMixture of EtOH and iPrOH structures observed in the crystal.  hSecond 
crystal.  iConflicting values were provided for the ∠MNO angle in the publication (138º) and in the author’s supplementary material (131.8(12)º).  jData taken from author’s 





Table 1.3:  Selected geometric parameters for nitrosyl Heme biomolecules. 
Nitrosyl heme proteins res (Å) pdb O.S. Fe-NNO (Å) N-O (Å) ∠FeNO (º) Fe-Lax (Å) ∠FeXC (º) ref 
Cys-ligated          
prokaryotic NOS from 
Bacillus subtilis          
    with L-Arg cofactor  1.9 1FC1 II 1.68 1.15a 132 2.31a 107a 61 
    with NOHA 
cofactor 1.9 2FBZ II 1.86 1.16
a 126 2.45a 104a 61 
    with NOHA 
cofactor 2.2 2FC2 III 1.69 1.14
a 161 2.44a 111a 61 
    with NOHA 
cofactor 2.2 2FC2 III 2.29 1.13
a 103 2.56a 106a 61 
eukaryotic eNOS           
    with L-Arg cofactor 2.0 1FOP II 1.79 1.14 160 2.26 110a 60 
    1.79 1.15 160 2.27 116a 60 
    with L-Arg + H4B 
cofactors 2.3 1FOO II 1.79 1.15 160 2.26 112
a 60 
 2.3 1FOO II 1.79 1.13 160 2.27 111a 60 
Fungal NOR           
    WT 1.7 1CL6 III 1.63 1.16 161 2.31 115a 87 
    S286V mutant 1.7 1CMN III 1.62 1.13 162 2.37 115a 87 
    S286T mutant 1.7 1CMJ III 1.65 1.13 165 2.33 112a 87 
His-ligated          
sw Mb 1.7  II 1.89 1.15 112 2.18 121
a, b, 130a, 
c 168 
L29F/D122 sw Mb 1.9  II 1.86a 1.14a 127a 2.31a 125
a, b, 123a, 
c 168 
hh Mb 1.30 2FRJ II 1.87 1.20 144 2.08 126
a, b, 126a, 
c 170 
hh Mb 1.30 2FRK II 2.13 1.17 120 2.15 127
a, b, 125a, 
c 170 
NP1 from Rhodnius 
prolixus 2.3 4NP1 II 2.06
 a 1.34 a 119.5 a 2.10 a 123
a, b, 131a, 
c 235 
   III 2.02a 1.32a 146a 2.0a 118
a, b, 135a, 
c  
NP2 1.45 1T68  1.93a 1.38a 134a 2.10a 124





Nitrosyl heme proteins res (Å) pdb O.S. Fe-NNO (Å) N-O (Å) ∠FeNO (º) Fe-Lax (Å) ∠FeXC (º) ref 
NP4 from Rhodnius 
proxilus          
    WT (pH 7.4) 1.08 1X8N II 1.74(2) 1.20(2) 143.8(1.6) 2.06(1) 127
a, b, 126a, 
c 237 
    WT (pH 5.6) 1.01 1X8O III 1.69(1) 1.09(1) 159.1(1.1) 1.994(7) 126
a, b, 127a, 
c 237 
D129A/L130A mutant 1.0 1SXX III 1.60(2) 1.35a 155(2) 2.05a 126
a, b, 125a, 
c 238 
    T121V mutant 1.0 1SY1 III 1.62(2) 1.29a 158(2) 2.03a 125
a, b, 126a, 
c 238 
    D30N mutant 1.0 1SY3 II 1.78(2) 1.38a 132(2) 2.06a 126
a, b, 125a, 
c 238 
    D30A mutant 1.05 1SXW II 1.71(3) 1.35a 139(2) 2.09a 125
a, b, 126a, 
c 238 
HO from Neisseriae 
meningitides 1.75 1P3U II 1.58
 a 1.17 a 147 a 2.13 a 128
a, b, 123a, 
c 239 
HO-1 from rat 1.7 1J02 II 2.10 a 1.14 a 125 a 2.17 a 128
a, b, 122a, 
c 240 
Human HO-1          
    WT 1.55 1OZW II 1.64 a 1.14 a 138 a 2.12 a 123
a, b, 126a, 
c 241 
    D140A mutant 2.59 1OZL II 1.49 a 1.16 a 148 a 2.12 a 127
a, b, 123a, 
c 241 
    Verdoheme 2.10 1TWR  1.83 a 1.15 a 150.9 a 2.54 a 89a, b, 155a, c 242 
    1.98 a 1.16 a 150.4 a 2.36 a 100
a, b, 145a, 
c  
Lupin legHb 1.8 1GDL II 1.97 a 1.35 a 145 a 2.19 a 118





2.5 1DP8 II 1.76 a 1.14 a 154 a 2.10 a 124
a, b, 127a, 
c 244 
cyt c′ from Alcaligenes 
xylosoxidans 1.35 1E85 II 2.03
 a 1.16 a 125 a 5-coor  245 
    1.92 a 1.16 a 132 a    
cyt cd1 NiR from 
Paracoccus pantotropha 1.8 1AOM II 2.0 1.37
 a 128 a 1.99 a 116
a, b, 138a, 
c 225 
cyt cd1 from 
Pseudomonas 2.65 1NNO II 1.80 1.15 
140 a 
 2.04 a 





Nitrosyl heme proteins res (Å) pdb O.S. Fe-NNO (Å) N-O (Å) ∠FeNO (º) Fe-Lax (Å) ∠FeXC (º) ref 
aeruginosa 
cyt c peroxidase from 
yeast 1.85   1.82  125, 135 2.04  246 
cyt c from Rhodobacter 
sphaeroides 2.20 1DW2 II 1.76
 a 1.43 a 112 a 2.23 a 123
a, b, 130a, 
c 247 
    1.83 a 1.37 a 112 a 2.16 a 126
a, b, 125a, 
c 247 
Horse Hb 2.8   1.74 1.11 ~145   248 
Hb (βcysSNOH)  1BUW        
α heme 1.8  II 1.75 1.13 131 2.28 125
a, b, 125a, 
c 249 
β heme 1.8  II 1.74 1.11 123 2.28 127
a, b, 124a, 
c 249 
T-state human Hb  1RPS        
   α heme 2.15  II 1.72 1.13 138 5-coor  250 
    β heme 2.15  II 1.75 1.15 128 2.25 123
a, b, 129a, 
c 250 
T-state human Hb 
(βcysSOH)  1RQ4        
    α heme 2.11   1.72a 1.15a 138  5-coor  250 
    β heme 2.11   1.75 1.15 128 2.19 121
a, b, 130a, 
c 250 
T-state human Hb 
βW37E mutant  1RQA        
    α heme 2.11   1.71 1.16 135 2.24 116
a, b, 135a, 
c 250 
    β heme 2.11   1.76 1.18 126 2.19 120
a, b, 130a, 
c 250 










CcO cytochrome c oxidase 
CD circular dichroism 
cGMP guanosine 3′,5′-cyclic monophosphate 
Cp2Fe0/+ Ferrocene/ferrocenium couple 
cyt cytochrome 
ENDOR electron-nuclear double resonance 
eNOS endothelial nitric oxide synthase 
EPR electron paramagnetic resonance 
EXAFS extended X-ray absorption fine structure 
FTIR Fourier transform IR 
H4B 5,6,7,8-tetrahydrobiopterin 
Hb hemoglobin 
hh horse heart 
HRP Horseradish peroxidase 
Im imidazolate 




MCD magnetic circular dichroism 
NACysMe N-acetyl-L-cysteinate methyl ester 
NADPH reduced nicotinamide adenine denuleotide 
NiR nitrite reductace 
nNOS neuronal nitric oxide reductase 
NO nitric oxide 
NOHA N-hydroxyarginine 
NOR nitric oxide reductase 
NOS nitric oxide synthase 
NOS nitric oxide synthase 
NP nitrophorin 
OEP dianion of 2,3,7,8,12,13,17,18-octaethylporphyrin 
Por dianion of porphyrin 
pdb Protein data base 
Pip piperidine 





RR resonance Raman 
sGC soluble guanylyl cyclase 
sw sperm whale 
T(p-OMe)PP dianion of meso-tetrakis(p-methoxy-
phenyl)porphyrin 
TMP dianion of meso-tetrakis(2,4,6-
trimethylphenyl)porphyrin 
To-F2PP  Dianoin of tetrakis(o-diflurophenyl)porphyrin 
TpivPP dianion of meso-α,α,α,α-tetrakis-(o-
pivalamidophenyl)porphyrin 





TPP dianion of tetraphenylporphyrin 
TTP dianion of tetratolylporphyrin 
UV ultra violet 
Vis visible 
WT wild type 
XAFS X-ray absorption fine structure 
XANES X-ray absorption near-edge spectroscopy 
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Chapter 2.  Synthesis and fiber-optic infrared reflectance 
spectroelectrochemical studies of osmium and ruthenium 




 Nitric oxide (NO) is known to interact with metals.  Several review articles1 
and a book2 have been published containing details of the preparation, 
characterization, and reaction chemistry of metal-NO compounds.  NO is important in 
bioinorganic chemistry; it reacts with many heme-containing biomolecules3,4 and iron 
sulfur clusters5 to result in the formation of Fe-NO bonds.  Related reactions with the 
cobalt-containing vitamin B12 have also been studied.6,7 We are interested in the 
reactions of NO with group 8 synthetic metalloporphyrins as models for the 
interactions of NO with heme.  Buchler and Smith were the first to report the 
syntheses of the osmium nitrosyl porphyrins (OEP)Os(NO)X (X = OMe, F).8 Other 
neutral (por)Os(NO)X compounds (X = halide,9 alkoxide,10,11 thiolate,11,12 ONO,13 
OClO3,14 O2PF2,11 alkyl/aryl9) have since been described, including the µ-oxo dimer 
[(OEP)Os(NO)]2(µ-O).9 Several related ruthenium compounds (por)Ru(NO)X (X = 
halide, O-donor, S-donor, N-donor, C-donor) have also been reported.14-31  
                                                
∗ This Chapter was taken in part from “Fiber-optic infrared reflectance 
spectroelectrochemical studies of osmium and ruthenium nitrosyl porphyrins 
containing alkoxide and thiolate ligands.” Carter, S.M.; Lee, J.; Hixson, C.A.; Powell, 
D.R.; Wheeler, R.A.; Shaw, M.J.; Richter-Addo, G.B. Dalton Trans. 2006, 10, 1338-





 As part of our studies on the class of Os and Ru nitrosyl porphyrins containing 
alkoxide and thiolate trans ligands, we investigated the redox behavior of a 
representative set of these species.  Infrared spectroelectrochemistry32 is a very useful 
tool for identifying the products resulting from electron removal or addition in metal 
nitrosyl and carbonyl compounds.  We recently developed a relatively simple 
apparatus for infrared spectroelectrochemistry based on fiber-optic infrared 
reflectance spectroscopy,33 and we have also extended this methodology to low-
temperature work with manganese nitrosyl porphyrins.34 
In this chapter, we report the preparation of the (OEP)Ru(NO)(XEt) (X = O, 
S) and (OEP)Ru(NO)(SR) (R = i-C5H11, Ph) complexes.  Additionally, we report on 
the comparative electrochemistry and infrared spectroelectrochemistry of the set of 
(OEP)M(NO)(OEt) and (OEP)M(NO)(SEt) compounds, where M = Os and Ru.  Prior 
to the publication of this work35, only a few other studies of the electrochemistry of 
ruthenium nitrosyl porphyrins had been reported,15,26,28,36 including the infrared 
spectroelectrochemistry of (TPP)Ru(NO)(ONO).26 
 
Experimental Section  
All reactions were performed under an atmosphere of prepurified nitrogen 
using standard Schlenk techniques and/or in an Innovative Technology Labmaster 
100 Dry Box unless stated otherwise.  Dichloromethane and hexane were distilled 
from CaH2 under nitrogen just prior to use.   
Chemicals.  Ethyl nitrite (10-20 wt.% in ethanol), t-butyl nitrite (95%), 
ethanethiol (97%), 3-methyl-1-butanethiol (isoamylthiol) (97%), thiophenol (97%), 
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methanol (anhydrous, 99.8%) were purchased from Aldrich Chemical Company and 
used as received.  NBu4PF6 (98%; Aldrich Chemical Company) was recrystallized 
from hot ethanol.  (OEP)Ru(CO)(MeOH) was purchased from Midcentury 
Chemicals.  Chloroform-d (99.8 %) was obtained from Cambridge Isotope 
Laboratories, subjected to three freeze-pump-thaw cycles, and stored over Linde 4 Å 
molecular sieves.  Ferrocene (Cp2Fe; Cp = η5-cyclopentadienyl anion) was sublimed 
prior to use. 
Instrumentation.  Electrochemical measurements were recorded using a BAS 
CV50W instrument (Bioanalytical Systems, West Lafayette, IN, USA).  For all 
electrochemical experiments, a 3.0 mm diameter Pt disk electrode was used as the 
working electrode, a silver wire coated with silver chloride acted as the reference 
electrode, and a platinum wire served as the auxiliary electrode.  All experiments 
were performed at room temperature unless otherwise noted, and were performed 
under an atmosphere of pre-purified nitrogen in a 0.1 M NBu4PF6 solution of the 
analyte (1.0 mM) in CH2Cl2.  Ferrocene served as an internal standard, and potentials 
are referenced to the Cp2Fe0/+ couple set at 0.00 V (+0.44 V vs. Ag/AgCl).37 Typical 
solvent system windows with our configuration were +1.2 to +1.5 V for the oxidation 
limit, and  –1.8 to –2.1 V for the reduction limit (vs. the Cp2Fe0/+ couple). 
Infrared spectroscopic measurements for the synthetic work were performed 
using a BioRad FT-155 FT-IR spectrometer.  For the spectroelectrochemical 
experiments, the infrared spectroscopic measurements were performed using a Bruker 
Vector 22 FTIR spectrometer equipped with a mid-IR fiber-optic dip probe and liquid 
nitrogen cooled MCT detector (Remspec Corporation, Sturbridge, MA, USA) as 
 
 69 
described previously.33 The same electrode configuration was used for both cyclic 
voltammetry and infrared spectroelectrochemical experiments.  The fiber-optic 
infrared reflectance spectroelectrochemical experiments were performed in a 
specially designed cell and in a manner that was previously reported.33 For the low-
temperature work we jacketed the cell with a dry ice/acetone bath as described in our 
complementary studies on manganese nitrosyl porphyrins.34  
NMR measurements were performed on a Varian 300 MHz instrument, and 
the signals referenced to that of CDCl3 (at 7.24 ppm).  All couplings are in Hz.  
Electrospray-ionization mass spectra were obtained on a Micromass Q-TOF 
spectrometer. 
Preparation of (OEP)Ru(NO)(OEt).  To a stirred pink solution of 
(OEP)Ru(CO)(MeOH) (20 mg, 0.029 mmol) in CH2Cl2 (15 mL) was added ethyl 
nitrite (0.55 mL, ~6 mmol).  The resulting mixture was refluxed for 45 min resulting 
in a change of color to dark red.  An IR spectrum of the solution showed the 
disappearance of the νCO of the starting material at 1921 cm-1 and the appearance of a 
new band at 1801 cm-1 assigned to νNO.  The solution was taken to dryness in vacuo.  
The residue was redissolved in CH2Cl2 (5 mL), and hexane was added (2 mL).  The 
resulting solution was subjected to slow solvent evaporation at room temperature to 
yield microcrystals of the product (12 mg, 0.018 mmol, 61% isolated yield).   IR 
(KBr, cm-1): νNO = 1791. 1H-NMR (CDCl3 ppm):  10.29 (s, 4H, meso-H of OEP); 
4.15 (q, 16H of OEP, J =  8 Hz), 1.98 (t, 24H of OEP, J = 7 Hz), –2.78 (q, 2H of OEt, 




Preparation of (OEP)Ru(NO)(SEt).  To a stirred CH2Cl2 solution (15 mL) 
of (OEP)Ru(CO)(MeOH) (20 mg, 0.029 mmol) was added a previously prepared red 
mixture of ethanethiol and t-BuONO (1:1 v/v, 0.20 mL; in 4 mL of CH2Cl2; 10 min 
mixing time).  The mixture was stirred for 10 min, during which time it turned from 
pink to dark red.  The solvent was removed in vacuo, and the product isolated as for 
the ethoxide derivative (20 mg, 0.028 mmol, 97% isolated yield).   IR (CH2Cl2, cm-
1): νNO = 1788.  IR (KBr, cm-1): νNO = 1773.  1H NMR(CDCl3, ppm):  10.26 (s, 4H, 
meso-H of OEP), 4.14 (m, 16H of OEP, J = 8 Hz), 1.99 (t, 28H of OEP, J = 8 Hz), –
1.84 (t, 3H of SEt, J = 8 Hz), –3.09 (q, 2H of SEt, J = 8 Hz).  ESI-MS (m/z):  664.3 
[(OEP)Ru(NO)]+ (87%). 
Preparation of (OEP)Ru(NO)(S-i-C5H11).  (OEP)Ru(NO)(S-i-C5H11) was 
prepared in a manner similar to what was described for the preparation of 
(OEP)Ru(NO)(SEt) except isoamylthiol was used in place of ethanethiol and vacuum 
was applied while heating at 85° C for 4.15 hr in order to remove excess isoamyl 
thiol, which under standard conditions, boils at ~118 ºC (18 mg, 0.024 mmol, 81% 
isolated yield).  IR (CH2Cl2, cm-1):  νNO = 1786.  IR (KBr, cm-1): νNO = 1775.  1H-
NMR (CDCl3, ppm):  10.27 (s, 4H, meso-H of OEP), 4.15 (m, J = 4, 16H of OEP), 
2.00 (t, J = 8, 28H of OEP), -0.32 (d, J = 5, 6H of S-i-C5H11), -0.39 (m, J = 7, 1H of 
S-i-C5H11), -1.88 (q, J = 6, 2H of S-i-C5H11), -3.18 (t, J = 8, 2H of S-i-C5H11).  ESI-
MS (m/z):  664.3 [(OEP)Ru(NO)]+ (100%). 
Preparation of (OEP)Ru(NO)(SPh).  (OEP)Ru(NO)(SPh) was prepared in a 
manner similar to that described above except thiophenol was mixed with t-BuONO 
to make the putative thionitrite and the excess thiol precursor was removed by 
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washing three times with MeOH (anhydrous, 15 mL total), followed by drying under 
vacuum (19 mg, 0.025 mmol, 85% isolated yield).   IR (CH2Cl2, cm-1):  νNO = 1793.  
IR (KBr, cm-1):  νNO = 1783.  1H-NMR (CDCl3, ppm):  10.15 (s, 4H, meso-H of 
OEP), 6.28 (t, J = 8, 1H of SC6H5), 5.85 (t, J = 8, 2H of SC6H5), 4.11(q, J = 8, 16H of 
OEP), 2.87 (d, J = 8, 2H of SC6H5), 1.96 (t, J = 8, 24H of OEP).  ESI-MS (m/z):  
664.3 [(OEP)Ru(NO)]+ (70%).  
Preparation of (OEP)Os(NO)(OEt).  The (OEP)Os(NO)(OEt) was prepared 
as previously described.10 A suitable crystal of (OEP)Os(NO)(OEt) was grown from a 
CH2Cl2/hexane mixture by slow evaporation of the solvent under inert atmosphere.†  
The molecular structure is displayed in Fig. 2.1a. 
Preparation of (OEP)Os(NO)(SEt).  The (OEP)Os(NO)(SEt) complex was 
prepared as previously described.12 A suitable crystal of 
(OEP)Os(NO)(SEt).0.5(CH2Cl2) was grown from a CH2Cl2/hexane mixture by slow 
evaporation of the solvent under inert atmosphere.†  The molecular structure is 
displayed in Fig. 2.1b. 
Extended Hückel Calculations.‡   Extended Hückel calculations, as 
implemented in the YAeHMOP suite of programs,38 were performed on the six-
coordinate osmium nitrosyl complexes (OEP)Os(NO)(OEt) and (OEP)Os(NO)(SEt) 
using geometries obtained from the crystal structures included in this work.  
Calculations on the five-coordinate complex [(OEP)Os(NO)]+ were also performed 
                                                
 
† Jonghyuk Lee, of our group, obtained the (OEP)Os(NO)(OEt) and 
(OEP)Os(NO)(SEt) crystals.  Structural data will be included in this report to aid in 
the discussion. 
‡ Extended Hückel calculations were performed in collaboration with Dr. Ralph 
Wheeler and C. Adam Hixson of this Department. 
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using a geometry derived from the crystal structure of (OEP)Os(NO)(SEt) by 
removing the thiolate ligand.  Initial images of the molecular orbitals were produced 
using the viewkel application distributed in the YAeHMOP suite.38  Adobe 
Photoshop® was used to add color to the figures. 
 
Results and Discussion 
Synthesis and Structural Characterization.  The osmium compounds used 
in this study have been reported previously,10,12 and the ruthenium compounds were 
synthesized using procedures similar to those used for the osmium compounds.   
Thus, the nitrosyl ethoxide compound (OEP)Ru(NO)(OEt) was prepared in 61% 
isolated yield from the reaction of ethyl nitrite with the ruthenium carbonyl precursor 
as shown in Eq. 2.1. 
 
(OEP)Ru(CO)(MeOH)  +  EtONO    (OEP)Ru(NO)(OEt) +  CO  +  MeOH      (2.1) 
 
The thiolate analogue (OEP)Ru(NO)(SEt) was prepared in 97% isolated yield 
in an analogous manner using in situ generated EtSNO.  Similarly, the 
isoamylthiolate complex (OEP)Ru(NO)(S-i-C5H11) and the phenolthiolate analogue 
(OEP)Ru(NO)(SC6H5) were prepared in 81 and 85% isolated yields, respectively.  All 
the compounds (OEP)M(NO)(XR) (M = Os, Ru; X = O, S; R = Et, i-C5H11, or Ph) 
contain mutually trans nitrosyl and XR groups and exhibit similar spectroscopic 
features for their (OEP)M(NO) units; they are diamagnetic with strong NO stretches 
in the infrared spectra.   
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Tables 2.1 and 2.2 list the infrared nitrosyl stretching frequencies of selected 
osmium and ruthenium porphyrin complexes containing alkoxide and thiolate 
linkages and linear metal nitrosyl groups.  As is evident from the data listed in the 
tables, the complexes reported here exhibit nitrosyl stretching frequencies 
characteristic of synthetic metalloporphyrin compounds with linear metal-nitrosyl 
linkages.3 The thiolate substituted (OEP)Ru(NO)(SR) complexes prepared by us, for 
example, exhibit νNOs of 1773 cm-1 (SEt), 1775 cm-1 (S-i-C5H11), and 1783 cm-1 
(SPh).  The (OEP)Ru(NO)(SPh) has the highest reported νNO stretch of the ruthenium 
complexes reported here and is among the highest reported for similar ruthenium 
porphyrin thiolate complexes, suggesting that the phenolthiol ligand is a poor 
contributor of charge to the metal due to the electron withdrawing aromatic group 
contained in the ligand.  The high frequency νNO, thus, results from the decreased 
charge otherwise available to the π-backbonding NO ligand from the metal center.   
It is interesting to note that a similar effect by the phenolthiolate ligand on the 
meso protons of the OEP macrocycle is revealed in the 1H NMR spectra of the 
thiolate and alkoxide complexes.  The meso (porphyrin) proton peaks in the 
(OEP)Ru(NO)(X) complexes containing the trans axial ligands OEt, SEt, S-i-C5H11, 
and SPh resonate at 10.29, 10.26, 10.27, and 10.15 ppm, respectively.  
Similar to the aforementioned ‘trans effect’, the substitution around the 
porphyrin periphery also affects the NO stretching frequency, as is evidenced in 
Tables 2.1 and 2.2.  Of the substituted porphyrins reported for (por)M(NO)(XR) 
complexes (where por = porphyrin; M = Os, Ru; XR = alkoxide or thiolate ligand), 
the ethyl substituted porphyrins tend to have lower nitrosyl stretches in the infrared 
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frequency when compared to their analogous aryl substituted porphyrin complexes.   
The delocalized aryl groups around the porphyrin periphery pull electrons away from 
the metal core of the porphyrin center whereas the ethyl groups are electron donors.  
In the later case, the increased charge is contributed to the metal where it is 
incorporated in the MNO electron donation, strengthening the π bond and leading 
to lower nitrosyl stretching frequencies.  Buchler et al. have reviewed the trans and 
cis effects on metalloporphyrins.39 
The infrared data listed in the two tables indicates that alkoxide and thiolate 
ligands containing hydrocarbon chains tend to donate more charge to the ruthenium 
and osmium metal centers and that the longer, unbranched chains are the best electron 
donors as evidenced by the lower νNOs exhibited by the compounds with hydrocarbon 
chains.  Further, the complexes containing alkoxide and thiolate ligands with 
aromatic groups or electronegative atoms are poor donors of charge to the metal 
centers and, hence, have relatively higher nitrosyl stretching frequencies.  
Surprisingly, these trends are not clearly reflected in the IR data for the thiolate 
containing osmium-nitrosyl porphyrin complexes.  
In this case the aromatic phenolthiolate (-SPh) complex exhibits the lowest IR 
nitrosyl stretching frequency of the complexes listed in Table 2.2 indicating that it 
contributes more charge to the metal center than related complexes with thiolates 
containing hydrocarbon chains.  This data suggests that the electronic interaction 
between the osmium and the axial ligands in the (OEP)Os(NO)(SR) complexes is 
more complex than the model used above to explain the trends. 
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The mass spectra of the (OEP)Ru(NO) alkoxide and thiolate complexes shows 
that the complexes are easily fragmented at the Ru-O or Ru-S portion of the molecule 
resulting in the appearance of the [(OEP)Ru(NO)]+ moiety as a major component in 
the spectrum.  This data indicates that, relative to the Ru-NO bond, the Ru-alkoxide 
and Ru-thiolate bonds are weaker and under the conditions of the mass spectrometry 
experiment are easy to break. 
We have obtained the X-ray crystal structures of (OEP)Os(NO)(OEt) and 
(OEP)Os(NO)(SEt), and their molecular structures are shown in Figure 2.1.  Selected 
bond angles and lengths are listed in Table 2.3.  A full list of the bond lengths and 
bond angles for the molecular structures are included in the Appendix (Tables 2.5 – 
2.9). 
The compounds contain nearly linear OsNO groups, and the axial ligands are 
disordered over the two faces of the porphyrin macrocycle.  In our earlier report on 
the crystal structure of (OEP)Os(NO)(OEt),10 we proposed a bent OsNO geometry for 
the axially-disordered structure based on the refinement statistics for the earlier data.  
However, the spectroscopic and spectroelectrochemical data for this compound are 









Table 2.1.  Infrared nitrosyl stretching frequencies of select ruthenium nitrosyl 






Compound νNO (KBr, cm-1) Reference 
Alkoxide complexes   
(OEP)Ru(NO)(OMe) 1780 40 
(OEP)Ru(NO)(O-i-C5H11) 1788 28 
(OEP)Ru(NO)(OEt) 1791 This work 
(TPP)Ru(NO)(O-i-C5H11) 1800 28 
(T(p-OMe)PP)Ru(NO)(O-i-C5H11) 1801 Chapter 3 
(TTP)Ru(NO)(O-i-C5H11) 1809 16 
Thiolate complexes   
(OEP)Ru(NO)(SEt) 1773 This work 
(OEP)Ru(NO)(S-i-C5H11) 1775 This work 
(OEP)Ru(NO)(SCH2CF3) 1782 18 
(OEP)Ru(NO)(SPh) 1783 This work 
(OEP)Ru(NO)(SC(Me)2CH2NHC(O)Me) 1789 19 
(OEP)Ru(NO)(SC6F4H) 1798 18 
(TTP)Ru(S-p-tolyl) 1784 27 
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Table 2.2.  Infrared nitrosyl stretching frequencies of select osmium nitrosyl 
porphyrins with alkoxide and thiolate ligands. 
 
Compound νNO (KBr, cm-1) Reference 
Alkoxide complexes   
(OEP)Os(NO)(O-n-Bu) 1743 11 
(OEP)Os(NO)(OMe) 1745 41 
(OEP)Os(NO)(O-i-C5H11) 1747 11 
(OEP)Os(NO)(OEt) 1756 10 
(TTP)Os(NO)(O-i-C5H11) 1770 17 
Thiolate complexes   
(OEP)Os(NO)(SPh) 1749 11 
(OEP)Os(NO)(S-i-C5H11) 1751 11 
(OEP)Os(NO)(S-i-Pr) 1751 12 
(OEP)Os(NO)(SEt) 1753 12 
(OEP)Os(NO)(S-t-Bu) 1754 12 
(OEP)Os(NO)(SMe) 1755 12 










Table 2.3.  Selected bond lengths and angles for (OEP)Os(NO)(XEt) (X = O, S). 
 
 (OEP)Os(NO)(OEt) (OEP)Os(NO)(SEt) 
Os-N(NO) (Å) 1.880(7) 1.994(10) 
N-O (Å) 1.165(9) 1.136(11) 
Os-X (Å) 1.849(7) 2.227(2) 
Os-N(por) (Å) 2.059(4), 2.066(4) 2.048(3), 2.054(2) 
Os-N-O (º) 172.4(10) 172.7(8) 
Os-X-C (º) 128.0(8) 112.8(4) 






Figure 2.1.  Molecular structure of (a) (OEP)Os(NO)(OEt), and (b) 
(OEP)Os(NO)(SEt). Hydrogen atoms have been omitted for clarity.   
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Cyclic Voltammetry and Infrared Spectroelectrochemistry.  The redox 
properties of the related four compounds (OEP)M(NO)(XEt) (M = Os, Ru; X = O, S) 
were examined by cyclic voltammetry, and the electrochemical data are summarized 
in Table 2.4.  We will consider the alkoxide and thiolate compounds in turn. 
Alkoxide Compounds.  The single response feature in the cyclic 
voltammogram of (OEP)Os(NO)(OEt) is shown in Figure 2.2.  No other features for 
oxidation or reduction were observed within the solvent limit. 
 
Figure 2.2.  Cyclic voltammogram of (OEP)Os(NO)(OEt) in CH2Cl2 containing 0.1 
M NBu4PF6.  Potentials are referenced to the Cp2Fe0/+ couple at E°’ = 0.00 V.  Scan 










Table 2.4.   Electrochemical data for the (OEP)M(NO)(XEt) (M = Os, Ru; X = O, S) 





Compound E°/1 E°/2 Epa3  E°/ 
(OEP)Os(NO)(OEt) 0.42 (72)     
(OEP)Ru(NO)(OEt) 0.43 (117) 0.67 (93) 1.01  –1.83 (240) 
(OEP)Os(NO)(SEt) 0.42b 0.66 (144) 0.84  –2.02 (129) 
(OEP)Ru(NO)(SEt) 0.37
b
 0.66 (120)   –1.64 (195) 
 
a Potentials are in volts, and are referenced to the ferrocene-ferrocenium couple set at 
0.00 V.  Conditions:  1 mM analyte, 200 mV/s, 0.1 M NBu4PF6.  The numbers are in 
brackets represent the ΔE values (in mV) for the redox couples. 
b These peaks are irreversible. 
 
 The compound (OEP)Os(NO)(OEt) exhibits a single well-defined reversible 
oxidation at +0.42 V versus the ferrocene-ferricenium couple.  The ΔEp for this redox 
couple is 72 mV and its value is independent of scan rate over the 50 to 500 mV/s 
range.  The cathodic to anodic peak current ratio (ipc/ipa) is 0.9 at 200 mV/s, and 
approaches unity at higher scan rates, suggesting that the oxidation is chemically 
reversible.  The plot of ipa vs (scan rate)1/2 is linear and indicative of a diffusion-
controlled reversible one-electron transfer process (Eq. 2.2; site of oxidation not 
specified).  
 




 The cyclic voltammogram of the Ru analogue (OEP)Ru(NO)(OEt) is shown 
in Figure 2.3.  The redox behavior is characterized by three oxidations and one 
reduction.  When the potential scan is reversed just after the first oxidation, a coupled 
reduction becomes clearly evident, suggesting reversibility for this first oxidation as 
shown in Figure 3b (E°’ = +0.43 V; ipc/ipa  = 0.9; ΔE = 117 mV).  When the potential 
scan (oxidation) is continued until the solvent limit, two other oxidations are 
observed; a reversible couple at +0.67 V and an irreversible peak at +1.01 V.  Follow-
up electrochemical processes at –1.00 and –1.50 V as a result of these latter 
oxidations are observed (Figure 2.3a).  Since we were primarily interested in detailing 
the first oxidation (and first reduction) of the ruthenium compounds, the other 
oxidation processes were not investigated further. 
 An irreversible reduction peak at Epc = –1.90 V is observed at 50 mV/s, and 
reversibility for this reduction process (E°’ = –1.83 V) first becomes apparent at scan 
rates close to 200 mV/sec (Figure 2.3a).  Even at 1.0 V/s, ipa/ipc for this redox couple 
was 0.6, indicative of considerable reactivity of the reduction product; consistent with 
this conclusion is the appearance of a daughter peak at –1.32 V.   Based on infrared 
spectroscopic evidence (vide infra), we believe that the lack of complete reversibility 




Figure 2.3.  Cyclic voltammograms of (OEP)Ru(NO)(OEt) in CH2Cl2 containing 0.1 
M NBu4PF6.  Potentials are referenced to the Cp2Fe0/+ couple at E°’ = 0.00 V.  Scan 
rate of 200 mV/s.  (a) Complete cyclic voltammogram.  (b) Cyclic voltammogram 
showing only the first oxidation.  
 
The IR difference spectrum which shows product formation after the 
oxidation of (OEP)Os(NO)(OEt) is presented in Figure 2.4.  The electrogenerated 
product of the oxidation has a νNO band at 1789 cm-1, which is shifted by +30 cm-1 
from that of the starting compound.  Such a relatively small shift in νNO is attributed 
to an oxidation site that is somewhat remote from the OsNO fragment.  Indeed, 
evidence for a porphyrin-centered oxidation is provided by the appearance in the 
spectrum of a new band at 1530 cm-1 due to an OEP-containing π-radical cation.  
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Diagnostic bands at 1520-1570 cm-1 have been reported for OEP-containing π-radical 
cations and have been proposed to arise from a combination of carbon-carbon and 
carbon-nitrogen stretches in the macrocycle.42 Thus, the oxidation process may best 
be represented by Eq. 2.3 (i.e., a slight modification of Eq. 2.2), where the 
electrooxidation occurs at the porphyrin ring.  
 
(OEP)Os(NO)(OEt)        [(OEP.)Os(NO)(OEt)]+  +  e-                       (2.3) 
 
As noted earlier, no reduction process was observed by cyclic voltammetry for 
(OEP)Os(NO)(OEt) within the solvent limit. 
 
Figure 2.4.  Difference FTIR spectrum showing the formation of product from the 
first oxidation of (OEP)Os(NO)(OEt) in CH2Cl2 containing 0.1 M NBu4PF6, with the 




 The IR spectroelectrochemistry result obtained during the first oxidation of 
the related (OEP)Ru(NO)(OEt) compound is similar to that of the Os analogue (i.e., 
Eq. 2.4).  Thus, a new νNO band at 1855 cm-1 (ΔνNO = +50 cm-1) is observed to form 
when the potential is held at +0.58V,  positive of the E°’ for the first oxidation 
(Figure 2.5).  In addition, a small band at 1530 cm-1 is also evident in the IR 
difference spectrum 
 
(OEP)Ru(NO)(OEt)      [(OEP.)Ru(NO)(OEt)]+  +  e-                                  (2.4) 
 
indicative of a porphyrin-based first oxidation.  Such porphyrin-based first oxidations 
have been observed and proposed for other six-coordinate (por)Ru(NO)-containing 
compounds.15,26,28,36   Holding the electrode potential at values higher than that 
sufficient for the second oxidation of (OEP)Ru(NO)(OEt) led to ill-defined product 
υNO bands in the 1857-1900 cm-1 region, indicative of multiple new RuNO oxidation 





Figure 2.5.  Difference FTIR spectrum showing formation of product from the first 
oxidation of (OEP)Ru(NO)(OEt) in CH2Cl2 containing 0.1 M NBu4PF6, with the 
potential held at +0.58 V vs. the Cp2Fe0/+ couple. 
 
 
 The reduction behavior for (OEP)Ru(NO)(OEt) was also examined by IR 
spectroelectrochemistry.  As noted earlier in Figure 2.3a, this complex displays a 
somewhat reversible reduction process at higher scan speeds.  As seen in Figure 2.6, 
the spectroelectrochemical reduction of (OEP)Ru(NO)(OEt) results in loss of νNO at 
1803 cm-1 due to the consumption of the (OEP)Ru(NO)(OEt) compound at the 
electrode surface without formation of a new RuNO-containing species, suggesting 
rapid loss of the NO ligand after reduction (Eqs 2.5 and 2.6). 
 
(OEP)Ru(NO)(OEt)  +  e-      [(OEP)Ru(NO)(OEt)]-             (2.5) 







Figure 2.6.  Difference FTIR spectrum showing the consumption of 
(OEP)Ru(NO)(OEt) during its reduction in CH2Cl2 containing 0.1 M NBu4PF6, with 
the potential held at –2.00 V vs. the Cp2Fe0/+ couple. 
 
Figure 2.7.  Cyclic voltammogram of (OEP)Os(NO)(SEt) in CH2Cl2 containing 0.1 
M NBu4PF6.  Potentials are referenced to the Cp2Fe0/+ couple at E°’ = 0.00 V.  Scan 





 Thiolate Complexes.  The response features of the cyclic voltammogram of 
(OEP)Os(NO)(SEt) are shown in Figure 2.7.  The first oxidation occurs at Epa1 = 
+0.42 V,  
 
and is irreversible up to 500 mV/s.  The |Ep-Ep/2| value of 83 mV (at 200 mV/s) 
suggests a reversible oxidation followed by a rapid chemical reaction.  A second 
oxidation process is evident which is partially reversible (E°’2 at +0.66 V; ΔE = 144 
mV) with an associated cathodic peak at +0.44 V.  A third oxidation at Epc3 = +0.84 
V is also observed, which we assign to the oxidation of ethanethiol generated in 
solution (vide infra).   In addition, a reduction peak is observed at –2.02 V, which is 
partially reversible at scan speeds >100 mV/sec.  This peak becomes more reversible 
at higher scan speeds.  This reduction peak is close to the solvent limit, hence we are 
uncertain if the apparent increased peak height is due to a two-electron reduction 
process or interference from the electrolyzed solvent system. 





Figure 2.8.  Cyclic voltammogram of (OEP)Ru(NO)(SEt) in CH2Cl2 containing 0.1 
M NBu4PF6.  Potentials are referenced to the Cp2Fe0/+ couple at E°’ = 0.00 V. Scan 
rate of 200 mV/s. 
 
The first oxidation of (OEP)Ru(NO)(SEt) occurs at +0.37 V, and is irreversible with 
an |Ep-Ep/2| value of 79 mV at 200 mV/s.  This is indicative of a reversible electron 
transfer followed by a fast chemical reaction; two daughter peaks at –0.91 and –1.45 
V are also observed after the first oxidation.   
  Interestingly, the second oxidation of (OEP)Ru(NO)(SEt) is reversible 
(Figure 2.8), and occurs at E°’ = +0.66 V.  Unlike the case for Os, there is only a 
small daughter peak at +0.45 V associated with this redox couple.  This daughter peak 
is virtually absent in the low-temperature (–78 °C) cyclic voltammogram of the 




Figure 2.9.  Low temperature (-78 °C) cyclic voltammogram of (OEP)Ru(NO)(SEt) 
in CH2Cl2 containing 0.1 M NBu4PF6.  Potentials are referenced to the CpFe0/+ couple 
at E°’ = 0.00 V. Scan rate of 200 mV/s. 
 
 
 A single cathodic peak at –1.64 V is observed at room temperature upon 
scanning to negative potentials (Figure 2.8), and this peak has an associated daughter 
peak at –1.37 V.  At a scan rate of 500 mV/s, the ipa/ipc ratio of this couple is 0.8 
indicative of increased reversibility for this process at higher scan rates.   
 The IR difference spectrum demonstrating the formation of the product from 





Figure 2.10.  Difference FTIR spectra showing formation of products during (a) the 
first oxidation of (OEP)Os(NO)(SEt), and (b) the second oxidation of 
(OEP)Os(NO)(SEt).  The potentials were held at +0.50 V and +0.80 V (vs. the 





 As can be seen in the Figure, the νNO of 1759 cm-1 due to the starting 
(OEP)Os(NO)(SEt) is consumed at an applied potential just slightly positive of Epa1, 
and a new product with  νNO at 1830 cm-1 is formed.  This relatively large shift of 
νNO (ΔνNO = 71 cm-1) is indicative of a change in electron density close to the Os-NO 
fragment of the complex.  Based on the electrochemical and IR 
spectroelectrochemical results, the net irreversible first oxidation of 
(OEP)Os(NO)(SEt) can be described as consisting of a reversible oxidation process 
followed by a fast irreversible structural change that does not involve the loss of NO 
from the metal center, but rather involves cleavage of the Os-SEt bond (Eq. 2.7 and 
2.8). 
 
(OEP)Os(NO)(SEt)       [(OEP)Os(NO)(SEt)].+   +  e-                                  (2.7) 
[(OEP)Os(NO)(SEt)].+      [(OEP)Os(NO)]+  +  .SEt                                      (2.8) 
 
 Examination of the second oxidation by spectroelectrochemistry reveals a 
further shift in υNO to 1855 cm-1 and the appearance of a new band at 1530 cm-1 due 
to an OEP-radical cation species.  The relative small shift of υNO (ΔνNO = 25 cm-1) is 
characteristic for a porphyrin-ring centered oxidation for this compound after the first 
oxidation.  The second oxidation can thus be described by Eq. 2.9, which involves the 
formation of the π-radical species in the dicationic product.  In this experiment, the 




 [(OEP)Os(NO)]+     [(OEP.)Os(NO)]2+   +   e-                        (2.9) 
 
was not entirely consumed at the electrode surface as evidenced by presence of the 
peak of the monocation (υNO 1830 cm-1) in the IR spectrum.   
 We assign the third oxidation in Figure 2.7 to the oxidation of EtSH, since a 
cyclic voltammogram of authentic EtSH shows an oxidation at +0.84 V, which is 
coincident with Epa3 in Figure 2.7.  It may then be possible that hydrogen-atom 
abstraction by the .SEt radical produced in Eq. 2.8 occurs in the presence of the 
solvent system.  We do not have experimental evidence to support the formation of 
the disulfide, although it may be present as well.   
The reduction (OEP)Os(NO)(SEt) results in the loss of the NO ligand, as 
demonstrated by the IR difference spectrum shown in Figure 2.11a.  However, when 
the difference spectrum is recorded while the electrode potential is cycled between –
1.8 V and –2.2 V at 400 mV/sec for 1 min (to allow for a build-up, and better 
detection, of this short-lived OsNO-containing species near the electrode surface), a 
new νNO band is observed at 1709 cm-1 (Figure 2.11b).  This relatively small shift of 
νNO (ΔνNO = –50 cm-1) suggests a porphyrin-centered reduction process.  Thus, the 
IR data suggests that the (OEP)Os(NO)(SEt) undergoes a fast electron transfer 
centered on the porphyrin (Eq. 2.10) followed by a structural change that involves 
loss of the NO from the metal center (Eq. 2.11). 
 
(OEP)Os(NO)(SEt)  +  e-      [(OEP)Os(NO)(SEt)]-                     (2.10) 





Figure 2.11.  Difference FTIR spectra showing the consumption (OEP)Os(NO)(SEt) 
during its reduction (a) without buildup of product, and (b) with buildup of product 
on the electrode surface.  The potential was held at –2.10 V vs. the Cp2Fe0/+ couple.  
The build-up of the reduction product was achieved by cycling the potential between 











Figure 2.12.  Difference FTIR spectra showing formation of products during (a) the 





The IR difference spectrum which reveals the consumption of the 
(OEP)Ru(NO)(SEt) complex upon oxidation is shown in Figure 2.12a.  The band 
geometry for the new product suggests that perhaps more than one cationic species 
are produced in the timescale of our experiment.  Upon the second oxidation (Figure 
10b), however, the product peak sharpens considerably, consistent with the presence 
of a single nitrosyl-containing dicationic species with νNO = 1875 cm-1.  Similar to 
that seen in the Os analogue, a new band at 1532 cm-1 is also evident in the difference 
spectrum after the second oxidation, which suggests that a π-radical cation is 
produced during the second oxidation.   The spectroelectrochemical results upon 
reduction of (OEP)Ru(NO)(SEt) show consumption of the complex, and will not be 
discussed further.  
Extended Hückel Calculations.   We were interested in the electronic 
structures of the osmium alkoxide and thiolate complexes, since both 
(OEP)Os(NO)(OEt)  and (OEP)Os(NO)(SEt) display an identical νNO value of 1759 
cm-1 in CH2Cl2.  In contrast, the (OEP)Ru(NO)(OEt) (νNO = 1801 cm-1) and the 
(OEP)Ru(NO)(SEt) (νNO = 1788 cm-1) compounds display νNOs that are consistent 
with the increased electron density of the thiolate complex. 
The highest occupied molecular orbitals (HOMOs) of (OEP)Os(NO)(OEt), 
(OEP)Os(NO)(SEt), and [(OEP)Os(NO)]+ are displayed in Figure 2.13.  The HOMO 
of (OEP)Os(NO)(OEt) is largely centered on the (OEP)Os fragment as shown in 
Figure 2.13a, with 70% of its charge in the metal d orbitals, ~25% concentrated on 
the porphyrin ring, and small contributions from the axial ligands.  The infrared 
spectroelectrochemical results for the oxidation of (OEP)Os(NO)(OEt), described 
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earlier, reveal a net formation of a porphyrin-based π-radical cation as the primary 
observable product.  The axial ligands are not affected much by the oxidation of 
(OEP)Os(NO)(OEt), consistent with the HOMO of (OEP)Os(NO)(OEt) having only 
small axial ligand contributions and significant contributions from the (OEP)Os 
moiety.  The LUMO of (OEP)Os(NO)(OEt) (Figure 2.14a) involves antibonding 
interactions between the metal dxz orbital and both the π* orbital of NO (major) and 
the ethoxy O-atom’s px orbital (minor).  In the electrochemical experiment with 
(OEP)Os(NO)(OEt), however, this LUMO is not accessed since the compound’s 
reduction potential apparently falls outside the solvent limit.  The HOMO of  
(OEP)Os(NO)(SEt) is shown in Figure 2.13b.  It consists of a π bonding interaction 
between the metal dxz orbital and the px orbital on the sulfur (46% of the electron 
density is localized on sulfur, 10% on the metal), and a π antibonding interaction 
between the metal dyz orbital and a π* orbital on NO (25% of the electron density is 
located on the nitrosyl N-atom, 8% on the O-atom). This implies that oxidation of this 
compound should weaken the Os-sulfur bond and strengthen the OsNO link.  Indeed, 






Figure 2.13.  Highest occupied molecular orbitals of (a) (OEP)Os(NO)(OEt), (b) 
(OEP)Os(NO)(SEt), and (c) the model compound [(OEP)Os(NO)]+ as determined by 
extended Hückel calculations.  The eight ethyl groups on the porphyrin ring and all 





Figure 2.14.  Lowest unoccupied molecular orbitals of (a) (OEP)Os(NO)(OEt), and 
(b) (OEP)Os(NO)(SEt) as determined by extended Hückel calculations.  The eight 
ethyl groups on the porphyrin ring and all hydrogen atoms were included in the 




Upon oxidation, both the υNO increase (ΔνNO = 71 cm-1) and Os-SEt bond 
cleavage (Eq. 2.8) occur.  In fact, the result is the generation of [(OEP)Os(NO)]+ as 
shown in Eq. 2.8.  We thus computed the HOMO of the cation [(OEP)Os(NO)]+, 
depicted in Figure 2.13c.  The HOMO is largely centered on the (OEP)Os fragment 
(88% of its electron density on the metal), similar to that described for 
(OEP)Os(NO)(OEt) and shown in Figure 2.13a.  We have shown that the second 
oxidation of (OEP)Os(NO)(SEt) results in the generation of a porphyrin π-radical 
cationic species [(OEP.)Os(NO)]2+ (Eq. 2.9), which is consistent with the calculated 
orbital using similar reasoning to that shown in the (OEP)Os(NO)(OEt) case.   
The LUMO of (OEP)Os(NO)(SEt) (Figure 2.14b) involves antibonding 
interactions between the metal dxz orbital and both the S-atom and a π* orbital on 
NO.  Thus, reduction of the thiolate complex will be expected to result in a 
weakening of the Os-NO bond and an increase in the antibonding character of the N-
O bond, with a weakening of the Os-SEt bond.   Our experimental observation of a 
partially reversible reduction resulting in loss of the NO ligand (Eq. 2.11 and Figure 
2.11) during the reduction of (OEP)Os(NO)(SEt) (ΔυNO = –50 cm-1) is consistent 
with the increased occupation of this LUMO. 
 
Conclusion     
 We have shown that within the class of (OEP)M(NO)(XEt) compounds (M = 
Os, Ru; X = O, S), differences exist in their redox behaviors that can be readily 
explained by extended Hückel calculations.  In the case of (OEP)Os(NO)(OEt), only 
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one electrochemical response was observed in its cyclic voltammogram in CH2Cl2, 
and this was a reversible oxidation centered on the porphyrin ring.  A different redox 
behavior was observed for the thiolate analogue (OEP)Os(NO)(SEt), where the first 
oxidation results in a net removal of the SEt ligand.  The calculations on 
(OEP)Os(NO)(SEt) reveal a HOMO with significant π bonding character between Os 
and S, consistent with loss of SEt in the oxidation process.  Further, the calculated 
LUMO shows an antibonding interaction between the metal and the NO ligand, 
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Chapter 3.  Syntheses, spectroscopy, and solid-state molecular 
structures of ruthenium nitrosyl porphyrin complexes containing 




Nitric oxide (NO) is known to be a biologically important signaling molecule that 
interacts with the iron centers of heme proteins resulting in both pathological and 
physiological consequences.  In many cases, the exact nature of this interaction is not 
well defined and over the past three decades has been the subject of intense 
worldwide study.  While biochemists have scrutinized the overall interaction of NO 
with the prosthetic heme center and the surrounding protein, chemists have taken the 
more fundamental approach of studying the binding of the free radical to the metal 
center using metalloporphyrin models of the reactive heme prosthetic group.  In some 
cases, as with our group, a combination of biomimetic modeling and examination of 
NO binding in natural and mutated heme proteins has been used in conjunction to 
better understand this interaction.  
Of the biologically abundant heme proteins, those with the imidazole containing 
histidine (His) residue bound to the iron center of the porphyrin prosthetic group are 
most prevalent.   In enzymatic heme proteins, the cytochrome and peroxidase classes 
of enzymes are the largest groups containing iron bound histidine.  Cytochromes are 
membrane bound proteins that facilitate electron transfers in and out of the membrane 
and catalyze various redox reactions while peroxidases catalyze the oxidation of 
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substrates using peroxide as an electron acceptor.  In both cases, NO is believed to 
interact with the heme iron centers under physiological conditions.1-7 
 Recently, the importance of the protonation state of histidine in heme proteins 
has been questioned.8 It has been suggested that the protonation state of the imidazole 
containing proximal His residue in heme proteins may influence the binding of both 
the substrate and the proximal His to the iron center of the heme pocket.  
Additionally, strong hydrogen bonding between the N-H segment of His with other 
amino acid residues in proteins essentially causes the His residue to have more of a 
deprotonated like charge and may effect the reactivity of some heme proteins.   The 
known crystal structures of many of the peroxidases, for example, show putative 
hydrogen bonding between the proximal His and a conserved asparagine (Asn) 
residue (Fig. 3.1).  These studies suggests that not only is the question of if the 
imidazole group of the His contains a protonated nitrogen is important, but also that 
the strength of the N-H bond may be significant in the reactive properties of heme 
containing peroxidases and some cytochromes. 
 
 
Figure 3.1:  Hydrogen bonding between a heme bound histidine and an asparagine 
amino acid residue inside the proximal pocket of a heme enzyme. 
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Despite the abundance of heme proteins with iron histidine bonds and their 
known interactions with nitric oxide, there have been few modeling studies involving 
a metalloporphyrin containing both NO and imidazole linkages.9,10 Scheidt and 
coworkers have obtained single crystal molecular structural data for an ferric 
metalloporphyrin containing trans 1-methylimidazole and NO groups, however, 
specially developed synthetic and crystallization techniques were required due to the 
ease in which this complex underwent reductive nitrosylation which results in the loss 
of the NO group from the six-coordinate complex.10 The instability of this complex 
severely limits synthetic and chemical studies.  The few reports of nitrosyl-heme 
model complexes with imidazole linkages in the literature and the previously 
mentioned importance of the protonation state of the imidazole containing histidine 
ligand, interested us in preparing stable Group 8 nitrosyl metalloporphyrin complexes 
containing metal bound imidazole ligands with emphasis on synthetic, reactivity, 
spectroscopic, and structural comparison of imidazolate with cationic imidazole 
complexes. 
Previously, our group has extensively explored the synthesis, solid-state 
molecular structures, and reaction chemistry of Group 8 nitrosyl-metalloporphyrins 
containing alkoxides (-OR) and thiolate (-SR) linkages trans to the NO.11-20 Studies of 
the infrared-spectroelectrochemistry of some of these complexes have been published 
and were presented in Chapter 2.21 In these studies, we have shown that osmium and 
ruthenium porphyrin complexes readily react in the presence of organic nitrite 
(ONOR) and organic thionitrite (ONSR) complexes to form osmium and ruthenium 
porphyrins containing alkoxides and thiolates, respectively, trans to a nitrosyl group.  
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Interestingly, while the alcohol analogues of the alkoxide complexes can be prepared 
without difficulty from protonation of (por)Os(NO)(OR) to give the 
[(por)Os(NO)(HOR)]+ cationic derivatives18, attempts at the preparation of the thiol 
complexes of the nitrosyl-metalloporphyrins have been unsuccessful to date.  This 
difference in reactivity of Group 8 osmium and ruthenium nitrosyl-metalloporphyrins 
towards the formation of alcohol and thiol metal bound complexes is still under 
investigation.  The discrepancies in these Group 8 nitrosyl-metalloporphyrins towards 
the formation of the alcohol vs. thiol complexes has further compelled us into 
examining the chemistry of imidazolate- and imidazole-containing ruthenium low-
spin nitrosyl porphyrins. 
In this chapter, we examine the synthesis, structure and reactivity of neutral 
(por)Ru(NO)(RIm) and the analogues cationic [(por)Ru(NO)(RIm)]+ complexes 
(where por = TPP, TTP, T(p-OMe)PP, and OEP and RIm = imidazolate (Im), 
imidazole (HIm), 1-methylimidzole (1-MeIm), 5-methylimidazolate (5-MeIm) or 4- 




Scheme 3.1.  Imidazolate and imidazole ligands used in this study. 
 
Experimental Section 
All reactions were performed under an atmosphere of prepurfied nitrogen gas 
in standard Schlenk glassware and/or a Labmaster 100 Dry Box.  All samples for 
spectral studies were also prepared under a nitrogen atmosphere.  All solvents were 
distilled from appropriate drying agents under an atmosphere of nitrogen just prior to 
use:  CH2Cl2 (CaH2), hexanes (CaH2). 
The (Por)Ru(CO) compounds were prepared by published procedures (TTP, 
TPP, T(p-OMe)PP).22  (OEP)Ru(CO) and (OEP)Ru(CO)·HOMe were purchased from 
 109 
Mid-Century Chemicals and Aldrich Chemical Company, respectively.  Isoamyl 
nitrite (i-C5H11ONO, 97%), imidazole (HIm, 99+%), 1-methylimidazole (1-MeIm, 
≥99%, purified by redistillation), 4-methylimidazole (4-MeHIm, 98%), and pyridine 
(Py, anhydrous, 99.8%) were purchased from Aldrich Chemical Co. and used as 
received.  Nitrosonium hexafluoroantimonate (99%) and nitrosonium 
tetrafluoroborate (98%) were purchased from Strem Chemicals and Alfa Aesar 
Chemicals, respectively.  Chloroform-d (99.8%, Cambridge Isotope Laboratories) 
was subject to three freeze-pump-thaw cycles and stored over molecular sieve (type 
4A) under nitrogen prior to use.  (OEP)Ru(NO)(O-i-C5H11) and (TPP)Ru(NO)(O-i-
C5H11) where prepared as described in the literature.16   
Infrared spectra were recorded using a Bio-Rad FT-155 FTIR spectrometer.  
Proton NMR spectra were obtained on Varian 400 or 300 MHz spectrometers and the 
signals were referenced to the residual proton signal of CDCl3 (7.24 ppm).  All 
coupling constants are in Hz. FAB mass spectra were obtained on a VG-ZAB-E mass 
spectrometer.   ESI mass spectra were obtained on a TOF-MS-ES mass spectrometer. 
Preparation of (T(p-OMe)PP)Ru(NO)(O-i-C5H11).   (T(p-
OMe)PP)Ru(NO)(O-i-C5H11) was prepared using methods similar to those previously 
reported for the related (TPP)Ru(NO)(O-i-C5H11) complex16 but with slight 
modifications.  A stirred red mixture of (T(p-OMe)PP)Ru(CO) (14.6 mg, 0.0169 
mmol) and isoamyl nitrite (2.5 µL, 0.0169 mmol, 98%) in CH2Cl2 (15 mL) was 
refluxed under N2 for 40 min.  The color changed to a dark red-brown and the IR 
spectrum of an aliquot showed the disappearance of υCO at 1937 cm-1 and the 
appearance of υNO at 1808 cm-1.  The sample was dried in vacuo leaving a purple 
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microcrystalline residue.  The crude yield prior to recrystallization was ca. 90 %. 1H 
NMR, prior to recrystallization, showed that an unidentified (T(p-OMe)PP)Ru 
complex (~10%) remained with the nitrosyl product. Purple crystals suitable for 
single crystal X-ray crystallographic analysis were obtained from the slow 
evaporation under N2 of a CH2Cl2/hexanes (1:1, 6 mL total) mixture of the reaction 
product.  IR (KBr):  υNO = 1801 cm-1.  1H NMR (CDCl3, 7.24 ppm, δ): 8.98 (s, 1.6 H, 
unidentified β-H porphyrin), 8.94 (s, 8 H, β-H of T(p-OMe)PP), 8.15 (m, 8H, J = 2 
Hz, phenyl H of T(p-OMe)PP), 7.29 (d, 8 H, 8H, J = 8 Hz, phenyl H of T(p-
OMe)PP), 4.09 (s, 12 H, H of OMe), 0.054 (s, grease), -0.573 (d, 6 H, J = 7 Hz, H of 
O-i-C5H11), -1.00 (m, 1 H, J = 7 Hz, , H of O-i-C5H11), -2.34 (t, 2 H, J = 8 Hz, , H of 
O-i-C5H11), -2.80 (q, 2 H, J = 8 Hz, , H of O-i-C5H11).  ESI Mass Spec:  864.0 m/z 
(100%, (T(p-OMe)PP)Ru(NO)+), 952.1 m/z (31%, [(T(p-OMe)PP)Ru(NO)(O-i-
C5H11) + H]).  
Preparation of (OEP)Ru(NO)(Im).  This procedure is a slight modification 
of a published procedure for the preparation of the analogous (TTP)Ru(NO)(Im).9  
(OEP)Ru(NO)(O-i-C5H11)16 (0.0505 g, 0.0672 mmol) and excess HIm (0.0241 mg, 
0.354 mmol) were loaded into a Schlenk tube, the bottom three-quarters of which was 
wrapped in aluminum foil.   The stirred solid mixture was heated under nitrogen 
between 85 and 100 °C in an oil bath.   During 2 hr of heating, white, crystalline HIm 
sublimed onto the upper portion of the Schlenk tube that was not wrapped with 
aluminum foil.  The white imidazole crystals were removed from the top of the 
Schlenk tube by carefully syringing hexanes over the crystals while the Schlenk tube 
was inverted.  The crude product contained ca. 3% of the unbound HIm ligand (as 
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evidenced by 1H NMR spectroscopy) and was removed by heating to 90 ºC with 
stirring under vacuum for 1 hr.  Free HIm was once again washed out with hexanes 
from the top of the Schlenk tube.  Recrystallization of the residue from a 1:2 mixture 
of CH2Cl2:hexanes (9 mL total) resulted in the generation of dark red brown 
microcrystals of the (OEP)Ru(NO)(Im) product (0.0439 g, 0.585 mmol, 87% isolated 
yield).   A suitable brownish red crystal of (OEP)Ru(NO)(Im)·Im·0.25 CH2Cl2 was 
grown from the slow evaporation of a CH2Cl2:hexanes mixture of the crude mixture 
containing free imidazole.  IR (CH2Cl2, cm-1): νNO = 1848 cm-1.  IR (KBr, cm-1):  νNO 
= 1828 s; also 2963 s, 2927 s, 2870 m, 1465 m, 1446 m, 1371 w, 1315 w, 1263 w, 
1228 w, 1151 m, 1106 m, 1080 m, 1058 m, 1019 m, 993 m, 961 m, 904 w, 843 w, 
811 w, 742 w, 709 w, 664 w, 621 w, 574 w.  1H NMR (CDCl3, δ):  10.36 ppm (s, 4H, 
meso-H of OEP), 5.27 ppm (s, CH2Cl2), 4.16 ppm (m, 16 H, J = 7, CH2CH3 of OEP), 
1.99 ppm (t, J = 8, 24 H, CH2CH3 of OEP), 0.073 ppm (sharp s, 1H, bound Im), -0.03 
ppm (broad s, 1H, bound Im), -0.52 ppm (broad s, 1H, bound Im).  ESI mass 
spectrum:  m/z 732 (100 %) [(OEP)Ru(NO)(Im) + H]+.  
Preparation of (por)Ru(NO)(Im) (por = TPP and T(p-OMe)PP). † 
(TPP)Ru(NO)(O-i-C5H11)16 (0.091 g, 0.108 mmol) and imidazole (0.04 g, 0.588 
mmol) were loaded into a Schlenk tube and heated with an oil bath at 90-95 °C for 3h 
as described for the OEP analogue.  Excess imidazole was removed under high 
vacuum.   IR (CH2Cl2, cm-1): νNO = 1854 cm-1.  1H-NMR (CDCl3, δ):  8.98 (s, 8H, 
pyr-H of TPP), 8.26 (d, J = 6, 4H, o-H of TPP), 8.13 (d,  J = 7, 4H,  o'-H of TPP), 
7.79 (m, 12H, p, m-H of TPP), 4.36 (s, 1H, imidazole), 0.48 (s, 1H, imidazole), -
                                                
† These complexes were originally prepared by Dr. Li Chen in our group. 
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0.045 (s, 1H, imidazole).  ESI mass spectrum:  m/z 812.1725 (100%) 
[(TPP)Ru(NO)(Im) + H]+. 
The new (T(p-OMe)PP)Ru(NO)(Im) compound was also generated by this 
method quantitatively as judged by 1H NMR spectroscopy. 
(T(p-OMe)PP)Ru(NO)(Im).   IR (CH2Cl2, cm-1): νNO = 1855 cm-1.  IR (KBr, 
cm-1): νNO = 1846 s, also 2834 w , 1605 s, 1574 w, 1526 w, 1511 s, 1493 m, 1462 m, 
1439 m, 1411 w, 1349 m, 1304 m, 1288 m, 1244 s, 1175 s, 1152 w, 1107 m, 1074 m, 
1043 w, 1018 s, 1009 s, 905 w, 885 w, 867 w, 848 w, 811 m, 798 m, 788 m, 713 m, 
664 w, 639 w, 600 w, 556 w, 537w, and 508 w.  1H NMR (CDCl3, δ):  9.02 (s, 8 H, 
pyrrole H), 8.11 (d of doublets, J = 42, 8 H, m-H), 7.30 (t, J = 9, 8 H, o-H), 4.37 (s, 1 
H, Im), 4.10 (s, 12 H, OMe H), 0.49 (s, 1 H, Im), -0.049 (s, 1 H, Im).  ESI mass 
spectrum:  m/z 932 (80 %) [(T(p-OMe)PP)Ru(NO)(Im) + H]+, 864 (100 %) [(T(p-
OMe)PP)Ru(NO) + H]+.  
Preparation of (OEP)Ru(NO)(5-MeIm). (OEP)Ru(NO)(5-MeIm) was 
prepared using methods similar to those described in the preparation of 
(OEP)Ru(NO)(Im) except 4-MeHIm was used in place of HIm and the mixture was 
heated to just above the melting point of 4-MeHIm, between 82 and 100 °C for 2 hr.  
Peaks corresponding to free 4-MeHIm were observed in the 1H NMR spectrum of the 
product mixture and further separation from the product was not attempted.   A dark 
red single crystal of (OEP)Ru(NO)(5-MeIm)·4-MeHIm suitable for X-ray 
crystallographic analysis was grown from the slow evaporation of a 1:1 
CH2Cl2:hexanes mixture containing the product.  IR (CH2Cl2, cm
-1):  νNO = 1845.   
1H NMR (CDCl3, δ):  10.36 ppm (s, 4H, meso-H of OEP), 7.20 ppm (s, free 4-
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MeHIm), 6.54 ppm (s, free 4-MeIm), 5.29 ppm (s, CH2Cl2), 4.17 ppm (m, J = 8 Hz, 
16 H, CH2CH3 of OEP), 2.06 ppm (s, 3H, free 4-MeHIm), 2.01 ppm (t, J = 8, 24 H, 
CH2CH3 of OEP), 0.36 ppm (s, 3H, bound 5-MeIm) 0.08 ppm (sharp s, grease), -0.11 
ppm (s, 1H, bound 5-MeIm), -0.84 ppm (s, 1H, bound 4-MeIm).  ESI mass spectrum:  
m/z 746.4 (100 %) [(OEP)Ru(NO)(5-MeIm) + H]+. 
Preparation of [(por)Ru(NO)(HIm)]+ ([(OEP)Ru(NO)(HIm)]SbF6,  and 
[(TTP)Ru(NO)(HIm)]BF4).  (OEP)Ru(CO)•(MeOH) (12.3 mg, 1.76 x 10
-5 mol) and 
HIm (2.1 mg, 3.09 x 10-5 mol) were stirred together in freshly distilled CH2Cl2 (20 
mL).  NOSbF6 (~10.2 mg, ~3.940 x 10-5 mol) was added to the light red solution, 
resulting immediately in a darkening of the solution.  IR spectroscopic monitoring of 
the reaction solution showed that the νCO at 1936 cm-1 was replaced by a νNO at 1870 
cm-1.  The solvent was removed in vacuo leaving a red-purple crystalline solid.  
Excess HIm was sublimed at the top of the Schlenk tube after heating the tube (the 
bottom ¾ of which was wrapped in aluminum foil) at 100 ºC for 1 hr.  The white 
crystalline solid was removed as described above.  This red-purple solid was washed 
with hexanes (3x10 mL) and redissolved in CH2Cl2.  Microcrystals of the 
[(OEP)Ru(NO)(HIm)]SbF6 product were obtained from slow evaporation of a 1:2 
mixture of CH2Cl2:hexanes (9 mL total) (84% yield, 14.6 mg). A dark red single 
crystal of [(OEP)Ru(NO)(HIm)]SbF6 suitable for X-ray crystallographic analysis was 
grown from the slow evaporation of a 1:1 chlorobenzene:hexanes mixture (8 mL 
total) under nitrogen.  IR (CH2Cl2, cm-1):  νNO = 1870.  IR (KBr, cm-1): 1852.  1H 
NMR (CDCl3, δ):  10.47 ppm (s, 4H, meso-H of OEP), 5.28 ppm (s, CH2Cl2), 4.21 
ppm (m, J = 8, 16 H, Et of OEP), 2.02 ppm (t, J = 8, 24 H, Et of OEP), 0.22 ppm (s, 1 
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H, bound HIm), 0.06 ppm (s, 1 H, bound HIm), -0.63 ppm (s, 1 H, bound HIm).  ESI 
mass spectrum:  m/z 732.3120 (100 %) [(OEP)Ru(NO)(HIm) + H]. 
The new [(TTP)Ru(NO)(HIm)]BF4 compound was generated using this 
method except NOSbF6 was substituted with NOBF4. 1H NMR spectroscopy showed 
quantitative conversion of the reagents to product. 
 [(TTP)Ru(NO)(HIm)]BF4.    IR (CH2Cl2, cm-1): νNO = 1854.  1H NMR 
(CDCl3, δ):  9.13 (s, 8 H, pyrrole H), 8.12 (d , J = 8, 4 H, o-H), 8.08 (d, J = 7, 4 H, o’-
H), 7.61 (t, J  = 7, 8 H, m-H), 4.62 (s, 1 H, Im), 2.72 (s, 12 H, CH3 of TTP), -0.09 (s, 
1H, Im).  ESI mass spectrum:  m/z 868.2338 (100 %) [(TTP)Ru(NO)(HIm) + H]+. 
Preparation of [(OEP)Ru(NO)(Py)]BF4.  Preparation of 
[(OEP)Ru(NO)(Py)]+ was previously reported, however, the synthetic details and 
spectroscopy were not given.17  The [(OEP)Ru(NO)(Py)]BF4 complex was prepared 
in a Schlenk tube by mixing NOBF4 (4.3 mg, 0.037 mmol) with a bright pink solution 
of (OEP)Ru(CO)•(MeOH) (20 mg, 0.029 mmol) in CH2Cl2 (15 mL).  The resulting 
dark red-brown solution was stirred for 15 min.  Pyridine (2.3 µL, 0.029 mmol) was 
syringed into the solution.  The mixture was stirred for 30 min resulting in a deep 
crimson solution.  Removal of solvent under vacuum resulted in red-purple 
microcrystals of the [(OEP)Ru(NO)(Py)]BF4 complex.  IR (CH2Cl2): νNO = 1877 cm-1.  
IR (KBr): νNO = 1859 cm-1.  1H NMR (CDCl3, δ):  10.51 (s, 4 H, meso-H of OEP), 
6.18 (t, J = 8 Hz, 1 H, Py), 4.98 (t, J = 8 Hz, 2 H, Py), 4.22 (m, J = 8 Hz, 16 H, 
CH2CH3 of OEP), 2.01 (t, J = 8 Hz, 32 H, CH2CH3 of OEP), -0.28 (d, J = 5 Hz, 2 H, 
Py).  FAB mass spectrum: m/z 743.32 (100%) [(OEP)Ru(NO)(Py)]+. 
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Preparation of [(OEP)Ru(NO)(1-MeIm)]BF4.  The [(OEP)Ru(NO)(1-
MeIm)]BF4 complex was prepared by the addition of NOBF4 (4.0 mg, 0.034 mmol) to 
a Schlenk tube containing a bright pink (OEP)Ru(CO)(MeOH) (20 mg, 0.029 mmol) 
solution in CH2Cl2 (15 mL).  After an immediate darkening of the solution to red-
brown, the mixture was stirred for 15 min.  Excess 1-MeIm (5.7 µL, 0.072 mmol) 
was syringed into the stirred solution and the reaction proceeded at room temperature 
for 30 min.  The solution was dried in vacuo.  Excess 1-methylimidazole was 
removed from the mixture by heating the Schlenk at ~120 °C for 1 hr followed by 
washing with hexanes as described above, followed by redissolving the microcrystals 
in a 2:1 mixture of CH2Cl2:hexanes (3 mL total) and recrystallizing, resulting in a 
dark red [(OEP)Ru(NO)(1-MeIm)]BF4 complex which contained (as evident by 1H 
NMR spectroscopy) ca. 1% free 1-MeIm.  IR (CH2Cl2): νNO = 1872 cm-1.  1H NMR 
(CDCl3, δ):  10.48 (s, 8 H, meso-H of OEP), 7.58 (s, free 1-MeIm), 7.05 (s, free 1-
MeIm), 6.92 (s, free 1-MeIm), 4.46 (t, J = 2 Hz, 1 H, 1-MeIm), 4.21 (m, J = 8 Hz, 16 
H,  CH2CH3 of OEP), 3.79 (s, free 1-MeIm), 2.01 (t, J = 8 Hz, 32 H, CH2CH3 of 
OEP), 1.81 (s, 3 H, CH3 of 1-MeIm), -0.32 (s, 1 H, 1-MeIm), -0.681 (t, J = 2 Hz, 1 H, 
1-MeIm).  FAB mass spectrum: m/z 746.3 (100%) [(OEP)Ru(NO)(1-MeIm)]+. 
Preparation of [(OEP)Ru(NO)(5-MeHIm)]SbF6/[(OEP)Ru(NO)(4-
MeHIm)]SbF6*.  [(OEP)Ru(NO)(5-MeHIm)]SbF6 was prepared in a manner similar 
to that described above for the imidazole complexes except HIm was substituted with 
4-MeHIm.  Repeated preparations consistently resulted in the observation of a second 
set of 1H NMR peaks, which were assigned to the structural isomer [(OEP)Ru(NO)(4-
                                                
* The mixture containing the ruthenium bound 4-MeHIm and 5-MeHIm isomers is 
represented by the notation 5(4)-MeHIm. 
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MeHIm)]SbF6.  A dark red single crystal of [(OEP)Ru(NO)(5-MeHIm)]SbF6 suitable 
for X-ray crystallographic analysis was grown from the slow evaporation of a 1:1 
CH2Cl2:hexanes mixture containing the dissolved product.  IR (CH2Cl2, cm-1):  νNO = 
1871.  1H-NMR (CDCl3, δ):  10.44 (s, 4H, meso-H of OEP for 5-MeHIm isomer), 
10.40 (s, 1.6H, meso-H of OEP for 4-MeHIm isomer), 7.34 (s, free 4-MeHIm), 6.58 
(s, free 4-MeHIm), 4.19 (m, 8Hz, 23H, CH2CH3 of OEP for 5(4)-MeHIm isomeric 
mixture), 2.09 (s, free 4-MeHIm), 1.99 (m, 8Hz, 36H, CH2CH3 of OEP for 5(4)-
MeHIm isomeric mixture), 0.23 (s, 3H, 5-MeHIm), -0.40 (s, 0.76 H, 4-MeHIm), -
1.01 (s, 1H, 5-MeHIm), -2.63 (s, 1.4H, 4-MeHIm). 
High-Temperature 1H NMR Spectrum of [(OEP)Ru(NO)(5(4)-
MeHIm)]SbF6.  All experiments were performed using a J. Young NMR tube 
containing CDCl3 solution of the [(OEP)Ru(NO)(5-MeHIm)]+/[(OEP)Ru(NO)(4-
MeHIm)]+ isomers sealed under N2. The temperature of the sample in the 1H NMR 
probe was determined to be 58.6 ºC using an ethylene glycol NMR solution and 
standard NMR temperature calibration techniques.  An 1H NMR spectrum obtained 
just after the initial preparation of the 5(4)-MeHIm isomeric mixture revealed distinct 
peaks for the porphyrin meso-Hs of [(OEP)Ru(NO)(5-MeHIm)]SbF6 and 
[(OEP)Ru(NO)(4-MeHIm)]SbF6 at 10.47 and 10.43 ppm with peak integrations of 
2.49 and 2.46 H, respectively.  Similarly, the peaks assigned to CH3 protons of the 
methyl imidazoles for the 5-MeHIm and 4-MeHIm isomers at 0.33 and -2.65 ppm.  
These peaks, the porphyrin meso and methyl imidazole protons, were considered 
spectroscopic handles and were followed throughout the experiment as a means to 
measure the relative ratios of the isomers in solution.  The additional porphyrin and 
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ligand peaks mentioned above were also observed but are not listed here for clarity.  
In addition to the peaks assigned to the isomeric mixture, there was a small, 
unidentified porphyrin meso-H peak at 10.57 ppm (~5%) that remained unaffected 
throughout the kinetics study.  An arrayed 1H NMR experiment at 58.6 °C with a total 
of 30 discrete transient sets, with a 0.5 hr rest time between the sets (15 hr total), was 
acquired for the isomeric mixture. 
 
Results and Discussion 
Synthesis.  Several ruthenium porphyrin complexes containing an imidazole-
derived ligand, [(por)Ru(NO)(RIm)]+, or a imidazolate-derived ligand, 
(por)Ru(NO)(RIm) (where R is vacant, 1-Me, 4-Me, or 5-Me), trans to the nitrosyl 
ligand have been synthesized and characterized.   
The neutral imidazolate derived complexes were prepared from the addition of 
an alkoxide complex (por)Ru(NO)(O-i-C5H11) to RIm.  The alkoxide  served as a 
convenient starting material that deprotonated the imidazole starting material, 
forming the imidazolate product, (por)Ru(NO)(Im), and presumably isoamyl alcohol 




(por)Ru(NO)(O-i-C5H11) + RIm    (por)Ru(NO)(RIm)  +  HO-i-C5H11   (3.1) 
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Syntheses of these compounds were carried out under solvent free conditions similar 
to that reported by Bohle et al., in the preparation of the analogous (TTP)Ru(NO)(Im) 
complex9 and showed quantitative or near quantitative conversion to products.   
 The preparation of the cationic compounds [(por)Ru(NO)(HIm)]+, was 
achieved through the reaction of the in situ generated cationic [(por)Ru(NO)]+ 
complex with pyridine or an imidazole derivative (eq 3.2, where por = TTP or OEP 
and HR = pyridine, imidazole, 5(4)-methylimidazole, or 1-MeIm). 
 
[(por)Ru(NO)]+ + HR   [(por)Ru(NO)(HR)]+                                           (3.2) 
  
The addition of 4-methylimidazole to [(OEP)Ru(NO)]+ resulted in a 3:1 tautomeric 
mixture of the [(OEP)Ru(NO)(5-MeHIm)]+ and [(OEP)Ru(NO)(4-MeHIm)]+, which 
was determined by the 1H NMR spectroscopy and from an X-ray crystal structure 
analysis.  Compounds containing similar mixtures of the 4- and 5-methylimidazole 
structural isomers have been reported non-porphyrin ruthenium compounds.23-25  
Clarke et al. for example, reported that the addition of 4-MeHIm to [H2O(NH3)5Ru]2+ 
resulted in the formation of a [(5-MeHIm)(NH3)5Ru]3+ and its isomeric 4-MeHIm 
analogue in a 20:1 ratio.25  Similar, 1H NMR spectroscopy data showed the formation 
of the [Ru(5-MeHIm)6]2+ complex and the isomeric [Ru(5-MeHIm)5(4-MeHIm)]2+ 
analogue.23  In this case, the authors reported that X-ray crystallographic data showed 
conversion to the sterically less hindered [Ru(5-MeHIm)6]2+ isomer upon 
recrystallization.  However, the rate of isomeric conversion was not reported.  
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Spectroscopy.   
a.  Infrared (IR). All of the NO species display intense nitrosyl bands in their 
infrared spectra.  Table 3.1 lists the nitrosyl stretching frequencies for the imidazole, 
imidazolate, and the pyridine complexes, as well as for the previously reported 
(TTP)Ru(NO)(Im) complex.9  
Table 3.1.  Nitrosyl stretching frequencies of imidazole, imidazolate, and pyridine 
ruthenium-nitrosyl porphyrins.   
 νNO (cm
-1)a Reference 
Neutral Complexes   
(OEP)Ru(NO)(L′)   
L′ = Im 1848 This work 
5-MeIm 1845 This work 




(T(p-OMe)PP)Ru(NO)(Im) 1855 This work 
Cationic complexes   
[(OEP)Ru(NO)(L′)]SbF6   
L′ = HIm 1868 This work 
5(4)-MeHIm 1868 This work 
[(OEP)Ru(NO)(L′)]BF4   
L′ = 1-MeIm 1872 This work 
Py 1877 This work 
[(TTP)Ru(NO)(HIm)]BF4 1854 This Work 
a All νNOs were recorded for complexes in CH2Cl2 unless otherwise noted. 
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Neutral complexes.  The υNOs for the imidazolate complexes ranged between 
1845 and 1855 cm-1, which is typical of ruthenium porphyrins containing linear NO 
linkages.26 The compounds containing the electron donating OEP macrocycle had 
lower υNO (1848 and 1845 cm-1 for the Im and 5-MeIm derivatives, respectively) than 
the complexes with the tetraarylporphyrin macrocycle as a result of the increased 
RuNO backbonding afforded by the increased electron density around the metal 
center.   
Cationic complexes.  The νNOs for the cationic complexes ranged between 
1866 – 1877 cm-1.  Of these complexes, the 1-MeIm and Py analogues exhibit the 
highest νNOs in their infrared spectra.  Presumably the higher nitrosyl stretches in the 
IR spectra reflect poor electron donation of the bases when compared to the HIm and 
5(4)-MeHIm analogues.  
The cationic imidazole complexes ([(TTP)Ru(NO)(HIm)]BF4, 
[(OEP)Ru(NO)(HIm)]SbF6, and the [(OEP)Ru(NO)(5(4)-MeHIm)]SbF6 isomeric 
mixture) exhibit the same characteristic linear νNOs as their neutral analogues, 
however, the nitrosyl stretches  are ~20 cm-1 higher.  This indicates decreased 
RuNO back-bonding in the cationic imidazole complexes and follows the trend 
observed for the υNOs of the group 8 cationic osmium-porphyrin-nitrosyl alcohol and 
neutral alkoxide complexes (ΔνNO = ~70 cm-1) previously reported by us.18   
 b. 1H NMR.  Neutral complexes.  1H NMR spectra of the low-spin 
diamagnetic neutral ruthenium nitrosyl complexes in CDCl3 confirmed the near 
quantitative to quantitative conversion of precursor compounds to the desired 
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product.  The OEP macrocycles and the tetraarylporphyrin macrocycles exhibited the 
expected proton peaks for the macrocycles and imidazolate-derived ligands.  The 
protons of the imidazolate ligands tended to exhibit resonances downfield (~0 ppm) 
due to influence from the aromatic macrocycle.   
Cationic complexes.  Like the neutral analogues, the cationic complexes 
exhibited 1H NMR spectra that were typical of low-spin, diamagnetic ruthenium 
nitrosyl porphyrin complexes.27 Similarly, the proton resonances associated with the 
imidazole and pyridine peaks were located downfield (~0 ppm) in the NMR spectra.  
No peaks were observed for the imidazole (N-H) protons for any of the cationic 
complexes.  The reaction of [(OEP)Ru(NO)]+ with 4-MeHIm that yielded 
[(OEP)Ru(NO)(5-MeHIm)]+, consistently resulted in a second set of 1H NMR peaks.  
This second set of peaks was assigned to the linkage isomer [(OEP)Ru(NO)(4-
MeHIm)]+.  X-Ray crystallographic analysis confirmed presence of the linkage 
isomers of the bound 5-MeHIm to 4-MeHIm complexes in the crystalline state (vide 
infra).  The formation of the isomeric mixture of [(OEP)Ru(NO)(5-MeHIm)]+ and 
[(OEP)Ru(NO)(4-MeHIm)]+ complexes is not surprising, considering that when 4-
methylimidazole is added to solutions it tautomerizes to form  an equilibrium with 5-
methylimidazole (1:2 ratio, respectively) (fig. 3.2).28,29 Hence, the existence of the 
tautomeric ligands in the reaction mixture allows for the formation of the nitrosyl 




Figure 3.2.  Tautomeric mixture of 5- and 4-methylimidazole. 
 
Over time, the peaks assigned to the sterically bulky 4-MeHIm isomer 
decreased in intensity while those peaks assigned to the 5-MeHIm isomer showed 
growth in their intensities, indicating that the 4-MeHIm isomer was converted to the 
less sterically hindered 5-MeHIm isomer, likely through the disassociation of the 4-
MeHIm ligand followed by the binding of 5-MeHIm ligand to the metal center.  To 
measure the rate of conversion of the 4-MeHIm complex to the 5-MeHIm, we 
performed high temperature (58.6 °C) 1H NMR spectroscopy experiments.  As 
outlined in the experimental section of this chapter, at this elevated temperature the 
meso-H of [(OEP)Ru(NO)(5-MeHIm)]SbF6 and [(OEP)Ru(NO)(4-MeHIm)]SbF6 
displayed resonances at 10.47 and 10.43 ppm with relative intensities of 3.60 and 4 H, 
respectively.  Similarly, the peaks assigned to CH3 of the methyl imidazoles for the 5-
MeHIm and 4-MeHIm isomers displayed resonances at 0.33 and -2.65 ppm with 
relative intensities of 3.39 and 3.00 H, respectively.  In addition to the peaks assigned 
to the isomeric mixture, there was a small unidentified meso-H (OEP)Ru peak at 
10.57 ppm (~5%) that remained unaffected throughout the kinetics study.  
Conveniently, the frequencies of the meso-H and the methyl-Hs peaks assigned to the 
4-methylimidazole and 5-methylimidazole complexes remained unaffected 
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throughout the NMR experiment, however, the (porphyrin) meso-peak associated 
with the 4-MeHIm derivative showed significant reduction while the peak associated 
with the 5-MeHIm showed significant enhancement (Fig. 3.3).  The same trend was 
reflected in the peaks associated with the methyl protons of the 5-MeHIm and 4-
MeHIm derivatives. 
The decrease of the peaks associated with the [(OEP)Ru(NO)(4-
MeHIm)]SbF6 isomer exhibited first order kinetics with a rate constant, k = 1.44 x 10-
5 s-1 and a half-life, t1/2 = 4.81 x 104 s (Graph 3.1).  The rate of growth for the peaks 
associated with the 5-MeHIm isomer was more complex and did not fit the criteria for 
zero, first, or second order.  Though the compound was prepared in a different 
solvent, CH2Cl2, than what the 1H NMR experiments were performed in (CDCl3) we 
expect that the result of ligand isomerization to be qualitatively the same. 
 
Figure 3.3.  1H NMR spectra of the meso-H porphyrin peaks assigned to the isomers 
[(OEP)Ru(NO)(5-MeHIm)]SbF6 (10. 47 ppm) and [(OEP)Ru(NO)(4-MeHIm) (10.43 
ppm) in CDCl3 at (a) time = 0 and the integration of the peaks at 10.47 and 10.43 
ppm are 2.49 and 2.46, respectively, and (b) time = 15 hr and the integration of the 
peaks at 10.47 and 10.43 ppm change to 4.00 and 1.18, respectively.  The spectra 
were recorded at 58.6 °C.  
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In order to better understand the nature of the dissociation of the 4-MeHIm 
ligand and subsequent binding of the 5-MeHIm ligand in the isomeric mixture of the 
nitrosyl ruthenium porphyrins,  ~3.5 molar excess of unsubstituted imidazole (HIm) 
was added to the freshly prepared [(OEP)Ru(NO)(5(4)-MeHIm)]+ mixture.  Addition 
of the external imidazole ligand provided us with a more detailed spectroscopic 
glimpse into the plausible pathway by which the 4-MeHIm isomer was converted to 
the 5-MeHIm isomer.  There are two likely ways in which this conversion occurs: (1) 
both the 4-MeHIm and the 5-MeHIm ligands are released from the ruthenium 
forming an equilibrium with the five-coordinate complex (Scheme 3.2a) or (2) the 4-
MeHIm dissociates from the metal center and the 5-MeHIm tautomer binds to the 5-
coordinate nitrosyl ruthenium porphyrin to form the sterically favored product, which 
is stable and does not undergo bond dissociation (Scheme 3.2b).   
 
Graph 3.1.  First order decomposition of the peak at δ 10.43 ppm assigned to the 




In the first scenario, we would expect to observe decreases in the 
concentrations of both the 5-MeHIm and 4-MeHIm isomers since abundant free 
imidazole ligand would have a higher probability of interacting with the five-
coordinate equilibrium product, diminishing both the 5-MeHIm and 4-MeHIm 
complexes and forming the [(OEP)Ru(NO)(HIm)]+ complex.  The second scenario 
would reveal diminishing peaks for the 4-MeHIm isomer with growth of new peaks 
associated with the HIm complex, while the concentration of the 5-MeHIm remained 
unaffected. 
When an excess amount of imidazole (ca. 3.5 molar) was added to a freshly 
prepared mixture of the [(OEP)Ru(NO)(5(4)-MeHIm)]+ isomers in CDCl3, high 
temperature 1H NMR revealed a gradual decrease in the resonance peaks associated 
with the porphyrin meso- and methyl-protons associated with the 4-MeHIm ring 
(10.43 and -2.65 ppm, respectively).  In addition to the disappearance of the peaks 
associated with the 4-MeHIm complex, new resonances were observed for the 
appearance of the [(OEP)Ru(NO)(HIm)]+ complex.  There was no observed change in 
the resonances for the [(OEP)Ru(NO)(5-MeHIm)]+ complex.  The 1H NMR data 
suggests that the 4-MeHIm dissociates from the metal center followed by the binding 
of the tautomeric 5-MeHIm ligand  to form the [(OEP)Ru(NO)(5-MeHIm)]+ 
complex.  The [(OEP)Ru(NO)(5-MeHIm)]+ complex is stable and undergoes no 
ligand dissociation (Scheme 3.2b).  
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Scheme 3.2.  Plausible pathway of ligand dissociation in the [(OEP)Ru(NO)(5(4)-
MeHIm]+ isomeric complexes. (a) The methylimidazole ligands dissociate from the 
ruthenium centers of both isomeric complexes, forming the 5-coordinate nitrosyl 
complex and a tautomeric mixture of ligands, prior to the formation of the 5-MeHIm 
complex.  (b) The 4-MeHIm ligand dissociates from the ruthenium center of the 
[(OEP)Ru(NO)(4-MeHIm)]+ isomer forming the 5-coordinate nitrosyl complex and a 
tautomeric mixture of ligands, prior to the formation of the 5-MeHIm complex.  
 
c.  X-ray crystallography.  Isolated crystalline solids were obtained for the 
imidazole, imidazolate, 5(4)-methylimidazole mixture and 5-methylimidazolate 
complexes containing the (OEP)Ru(NO) fragment.   
The structure for the (T(p-OMe)PP)Ru(NO)(O-i-C5H11) starting complex was 
obtained (Fig 3.3).  The C5H11 portion of the alkoxide ligand showed disorder over 
three positions in the X-ray structure.  The geometric parameters for the related 
(OEP)Ru(NO)(O-i-C5H11) complex was obtained previously in a collaboration with 
the Coppens laboratory.17 Besides these complexes, there have been no reports of 
solid-state molecular structure for any of the metal-nitrosyl porphyrin complexes 
containing isoamyl alkoxide linkages in the literature.11,16,19,20 There has only been one 
other report of a solid state crystal of a metalloporphyrin complex containing 
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mutually trans nitrosyl and methoxy ligands.30 Table 3.2 compares selected solid-
state structural parameters for the related alkoxide complexes whose X-ray structures 
are known.  A complete list of the bond lengths and bond angles obtained from single 
crystal X-ray crystallographic structure reported here can be found in Tables 3.4 
through 3.12 of the Appendix.  However, beyond acknowledging the geometric 
similarities between this complex and the similar (TTP)Ru(NO)(OMe) complexes 
obtained by Bohle, this structure will not be further discussed in the context of the 
imidazolate and imidazole complexes that are the focus of this chapter.   
 











1.780(10) 1.191(14), 1.191(14) 
170.2(11), 











(TTP)Ru(NO)(OMe) 1.84(4) Not reported 180 1.80(5)  30 




Figure 3.4.  Molecular structure of (T(p-OMe)PP)Ru(NO)(O-i-C5H11).  The 




 Figure 3.5.  Solid-state structure of (OEP)Ru(NO)(Im)•HIm.  Hydrogen atoms have 





Figure 3.6.  Molecular structure of (OEP)Ru(NO)(5-MeIm).  Hydrogen atoms have 












Figure 3.7.  Crystal structure of [(OEP)Ru(NO)(HIm)]SbF6.  Hydrogen atoms have 
been omitted for clarity. 
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Figure 3.8.  Crystal structure of the cation of [(OEP)Ru(NO)(5-
MeHIm)]SbF6/[(OEP)Ru(NO)(4-MeHIm)]SbF6.  Hydrogen atoms and the SbF6 anion 
have been omitted for clarity. 
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Table 3.3.  Selected structural data (in Å and °) for ruthenium complexes containing 
imidazolate and imidazole ligands. 
 
Ru-N(O) N-O Ru-N-O Ru-L(ax) ref 
Imidazolate      
[Ru(bpy)2(Im)2][BF4]2    
2.093(6), 
2.096(7) 3 
(OEP)Ru(NO)(Im) 1.748(3) 1.148(4) 174.9(3) 2.063(3) This work 
(OEP)Ru(NO)(5-MeIm) 1.740(4) 1.145(5) 171.2(4) 2.059(4) This work 
Imidazole      
[Ru(2,2’-bipy)2(HIm)2]SO4    
2.096(11), 
2.093(11) 32 
Na[trans-RuCl4(DMSO)(HIm)]    2.081(2) 33 
[P(C6H5)4][RuCl4(5-NO2HIm)2]    2.081(5) 34 
[Ru(bipy)(terpy)(HIm)](PF6)2    2.072(8) 35 
[Ru(bipy)(terpy)(Ph2HIm)](PF6)2    2.124(3) 35 





[Ru(HIm)6]CO3·H2O    2.102(2) 36 





trans-[(HIm)2(NH3)4Ru]Cl3    
2.046(4), 
2.051(4) 37 





   2.049(7) 39 
[RuCl2(DMSO-d6)2HIm2    2.105(4) 40 
(HIm)2[RuHImCl5]    2.044(12) 41 
HIm[trans-RuHIm2Cl4]    2.079(3) 42 
4-MeHIm[trans-Ru(5-
MeHIm)Cl4] 
   2.087(6), 2.088(5) 42 
[(Im)2H][trans-
RuCl4(HIm)(NO)] 
1.740(3) 1.128(4) 177.7(3) 2.091(2) 43 








[(OEP)Ru(NO)(HIm)]SbF6 1.695(9) 1.131(12) 175.3(7) 2.069(8) This work 





Prior to this study, there have only been a few reports containing geometric 
parameters for complexes containing the imidazole or imidazolate Ru-LN linkages 
and none for those containing the porphyrin ON-Ru-LN axial group.6,7,12-24 Selected 
bond lengths and angles for the structures reported here and other related crystalline 
solids containing either a Ru-imidazole or Ru-imidazolate linkage can be found in 
Table 3.3.  Tables listing complete bond distances and angles for all structures 
obtained in this work are provided in the Appendix.   
 Neutral complexes.  The crystal structures for the neutral (OEP)Ru(NO)(Im) 
and (OEP)Ru(NO)(5-MeIm) are shown in Figures 3.5 and 3.6, respectively.  Figure 
3.9 a and b displays the torsional angles between the four nitrogen core of the 
porphyrin and the six-membered ring of the axial ligand for the neutral complexes.  
Also shown in Figure 3.9 are the deviations of the atoms from the 24-atom mean 
plane; positive values, in units of 0.01 Å, are toward the nitrosyl ligand.  
The imidazolate solid-state structures, (OEP)Ru(NO)(Im) and 
(OEP)Ru(NO)(5-MeIm), exhibited nearly linear Ru-N-O groups (174.9(3) and 
171.2(4)º, respectively) with M-N(O) and N-O bond lengths that are comparable to 
solid-state structures that have been reported for other {RuNO}6 complexes (Table 
3.3). 26 The Ru-NIm bond lengths displayed in the crystal structures for the Im and the 
5-MeIm complexes were 2.063(3) and 2.059(4) Å, respectively.  The crystal structure 
of the imidazolate complex exhibited a moderate hydrogen bonding interaction 
between the basal nitrogen of the bound imidazolate and the N-H of an unbound 
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imidazole (N8-H---N7 in Figure 3.5) with a 1.89 Å H-N7 bond length and an angle of 
169.4º between N8-H-N7. 
Both of solid-state structures of the neutral complexes showed moderate 
ruffled distortions of the 24-atom porphyrin planes and the Ru atom in both 
complexes are displaced by ~0.1 Å from the porphyrin cores towards the NO ligands 
(Fig. 3.9). The imidazolate ligands in both of the crystal structures (as can been seen 
in Fig. 3.9) bisect the nitrogen core of the porphyrin at  ~25.5°. 
Cationic complexes.  The solid state crystal structures of the cationic 
imidazole complexes [(OEP)Ru(NO)(HIm)]+ and [(OEP)Ru(NO)(5(4)-MeHIm)]+ are 
shown in Figures 3.7 and 3.8, respectively. Figure 3.9 c and d displays the torsional 
angles between the four nitrogen core of the porphyrin and the six-membered ring of 
the axial ligand for the neutral complexes. An interesting feature of the 5(4)-MeHIm 
crystal structure was the presence of isomeric disorder in the 5-MeHIm ligand in the 
form of ~25% of the methyl groups in the unit cell positioned on C39 of the ring (Fig. 
3.8).  This value agrees well with the 1H NMR data showing a 3:1 ratio of the 5-
MeHIm to 4-MeHIm linkage isomers of [(OEP)Ru(NO)]+, suggesting that the linkage 





Figure 3.9.  Formal diagrams of the porphinato cores of (a) (OEP)Ru(NO)(Im), (b) 
(OEP)Ru(NO)(5-MeIm), (c) [(OEP)Ru(NO)(HIm)]SbF6, and (d) 
[(OEP)Ru(NO)(5(4)-MeHIm)]SbF6 displaying displacements from the 24-atom 
porphinato plane of each unique atom in units of 0.01 Å.  Positive values are towards 
the nitrosyl ligand.  The torsional angles between the nitrogen cores of the porphyrins 
and the six-membered imidazole/imidazolate ring of the axial ligands (i.e., NP-Ru-
NIm-C(37)) are shown. 
 
Similar to the neutral complexes, the solid-state structures of the cationic 
complexes [(OEP)Ru(NO)(HIm)]+ and [(OEP)Ru(NO)(5(4)-MeHIm)]+ display nearly 
linear Ru-N-O groups (175.3(7) and 176.94(18)º, respectively) with little difference 
in the Ru-N(O) and N-O bond lengths reported above for the neutral analogues (Table 
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3.3).  The Ru-NIm bond length in the HIm complex shows no real difference from the 
neutral analogue (2.063(3) vs. 2.069(8) Å, respectively); however, the 5(4)-MeHIm 
structure displays moderate lengthening of Ru-NIm when compared to the neutral 
analogue (2.103(17) vs 2.059(4) Å, respectively). The lengthening of the Ru-NIm 
bond in the cationic complex is likely due to the presence of the 4-MeHIm structural 
linkage isomer in the crystal structure.   The methyl group (denoted C40’ in Fig. 3.8) 
of this isomer is directed toward the OEP macrocycle.  The increased steric stress that 
would otherwise result from this is minimized by the elongation of the Ru-NIm bond 
length.  It is interesting to note that the only other reported six-coordinate linear 
{MNO}6 structural analogue, namely [(OEP)Fe(1-MeIm)(NO)]ClO4, displays axial 
bond geometries similar to the protonated complexes with the exception of a shorter 
M-NIm bond length (Fe-N(O) = 1.6465(17) Å, N-O = 1.135(2), Fe-NIm = 1.9889(16) 
Å).10 
A hydrogen bonding interaction between the hydrogen atom attached to the 
basal nitrogen of the bound imidazole to F(5) of SbF6 (N6-H6a---F(5) in Fig. 3.6) is 
observable in the crystal structure of [(OEP)Ru(NO)(HIm)]SbF6 (H6a-F5 = 2.45 Å 
and ∠N6-H6a-F5 = 123.1º).  This interaction is significantly weaker than the 
hydrogen bonding interaction discussed above in the neutral Im complex. 
The crystal of [(OEP)Ru(NO)(HIm)]+ shows a moderate wave distortion of 
the 24-atom porphyrin plane, while the 5(4)-MeHIm structure displays more of a 
ruffled distortion. Of both the neutral and cationic structures, the 
[(OEP)Ru(NO)(5(4)-MeHIm)]+ complex shows the largest out of plane distortions of 
individual porphyrin core atoms, likely due to steric reasons discussed above (Fig. 
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3.9).  Unlike the neutral analogues, the Ru atoms of the cationic complexes are 
coincident or nearly coincident with the porphyrin plane.  As depicted in Figure 3.9d, 
the HIm ligand in the cationic complex bisects the porphyrin’s nitrogen core at 
29.0(8)º, which is similar to the angles at which the imidazolate ligands in the neutral 
complexes bisected the mean plane.  The cationic 5(4)-MeHIm complex, however, 
bisects the nitrogen core of the porphyrin at 36.75(17)° which otherwise increases the 
distance between the methyl group of the 4-MeHIm ligand and the nitrogens of the 
porphyrin core and further relieves steric strain caused by the close proximity of the 
methyl group of the 4-MeHIm isomer and the porphyrin plane (Fig. 3.9d). 
 
Conclusion 
 We have prepared a series of ruthenium porphyrin complexes containing axial 
imidazolate, 5-methylimidazolate, imidazole, 1-methylimidazole, and an isomeric 
mixture of the 4-methylimidazole and 5-methylimidazole ligand trans to nitric oxide.  
The infrared and 1H NMR spectroscopic characteristics of these complexes are typical 
of diamagnetic {MNO}6  metalloporphyrin complexes with linear metal nitrosyl 
groups.  The aryl meso-substituted porphyrins displayed higher nitrosyl stretches in 
the IR than the electron rich octaethyl β-substituted porphyrins due to decreased 
metal-nitrosyl π back-bonding to NO.  
The addition of 4-methylimidazole to [(OEP)Ru(NO)]+ afforded an interesting 
isomeric mixture of [(OEP)Ru(NO)(5-MeHIm)]+ and [(OEP)Ru(NO)(4-MeHIm)]+ 
complexes.  We were able to determine that the sterically unstable 4-MeHIm isomer 
undergoes a first order dissociation of the 4-MeHIm ligand from the Ru center with 
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the rate constant, k = 1.44 x 10-5 s-1 and the half-life, t1/2 = 4.81 x 104 s.  Subsequently, 
the release of the 4-MeHIm ligand and subsequent binding of the tautomeric 5-
MeHIm ligand to form the more stable [(OEP)Ru(NO)(5-MeHIm)]+ isomer appears 
to have a more intricate mechanism preventing the determination of the rate-law 
using the methods employed in this work.   
Solid-state structures were obtained for the (OEP)Ru(NO)(Im), 
[(OEP)Ru(NO)(HIm)]SbF6, (OEP)Ru(NO)(5-MeIm) complexes.  Additionally, the 
crystal structure for an isomeric mixture of the [(OEP)Ru(NO)(5-MeHIm)]SbF6 and 
[(OEP)Ru(NO)(4-MeHIm)]SbF6 complexes was solved.  All solid-state structures 
display characteristics typical of linear metal-nitrosyl linkages.  The complexes 
containing an imidazolate ligand displayed Ru-NO and Ru-Nligand bond lengths and 
angles similar to their imidazole analogues.  The Ru-atoms in the imidazolate 
(OEP)Ru(NO)(Im) and (OEP)Ru(NO)(5-MeIm) complexes, however, show a larger 
displacement from the 24-atom porphyrin plane than their imidazole analogues and 
may reflect the greater degree of π-backbonding in the imidazolate complexes that 
was suggested by the IR studies.  
The structures reported here are the first such structures reported for nitrosyl-
ruthenium porphyrin imidazole/imidazolate complexes and the neutral imidazole and 
5-methylimidazole complexes compose two of only three structures containing a 
ruthenium-imidazolate linkage that can be found in the literature to date.  Of 
particular interest are the close structural similarities of these complexes to the 
previously reported [(OEP)Fe(1-MeIm)(NO)]ClO4 structure reported by Ellison et 
al.10  Where this putative iron-nitrosyl model of the biological heme prosthetic groups 
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showed poor stability requiring specially developed crystallization techniques in 
order to obtain the molecular structure, the related Group 8 ruthenium complexes 
have the advantage of relatively high stability in inert atmospheres and show similar 
structural features.  Hence, these derivatives provide an attractive alternative to iron 
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Chapter 4.  Fiber-optic infrared reflectance spectroelectrochemical 






Nitric oxide (NO), the biologically ubiquitous free radical, is a key signaling 
molecule in numerous biological events including vasodilation.  Many of these 
processes occur when NO interacts with the iron center of heme enzymes.1 Of these 
enzymes, cytochromes have an imidazole containing histidine (His) residue attached 
to the iron center and are generally considered to exhibit electron transfers closely 
associated with proton or hydrogen-atom exchanges.  Cytochromes play an important 
role in the terminal steps of the oxidative respiration chain.   
Cytochrome c oxidase (CcO), specifically, reduces molecular oxygen to water 
through a series of electron transfers which in-turn provides energy to pump protons 
across the mitochondrial membrane in eukaryotic cells.2,3 CcO is composed of two 
hemes (heme a and a3) a dimeric copper center (CuA) and a mononuclear CuB center.   
Reduction of dioxygen occurs at the heme-copper binuclear site, where heme a3 and 
CuB are in close proximity.   The structural features of various CcO enzymes have 
been extensively explored.2  The heme a3 contains an Fe center axially linked with a 
His, whereas the CuB site is linked to three His residues, one of which is covalently 
bound to a tyrosine (Tyr) residue.  The cross-linked His-Tyr unit has been suggested 
to play important roles in the reduction of oxygen by either the concerted or coupled 




hydrogen-atom transfer from the Tyr to the Fe bound dioxygen.    Among, the many 
factors that govern this process, it is believed that the protonation state of the 
covalently bound His may be important.4   
Evidence showing that NO reversibly binds to the iron center of CcO 
competitively with oxygen has been presented.  It is believed that the binding of NO 
to the heme center plays a role in oxygen sensing and the cells response to hypoxia.5 
Additionally, interaction of a NO molecule with the CuB site induces limited 
inhibition of the dioxygen reduction.6  The mechanism by which NO interacts with 
the heme-copper binuclear center is not well understood and is an active area of 
research.   
Our previous research explored the structure and chemistry of the heme 
related ruthenium-porphyrin model complexes containing trans axial linked nitric 
oxide and imidazole(ate) ligands (Chapter 3).  The importance detailed above of the 
electron/proton transfers in the native cytochrome c oxidase in the reduction of 
molecular oxygen and the inhibition of this process in the presence of nitric oxide 
under certain cell condition has led us to explore the electrochemical reactions of the 
(OEP)Ru(NO)(RIm), where OEP is the dianion of octaethylporphyrin and R is either 
a vacant Nimidazole position, or occupied by H or a methyl group.  We were interested 
in examining how the protonation state of an imidazole ligand affects the redox 
properties of metalloporphyrin complexes as well as detailing the possibility of 
proton or atomic-hydrogen transfers from the ruthenium-bound imidazole(ate) upon 




studies of a set of (OEP)Ru(NO)-containing complexes with an imidazolate, 
imidazole, or 1-methylimidazole ligand trans to the nitrosyl.    
 
 
Experimental Section   
   
Chemicals.  The compounds (OEP)Ru(NO)(Im), [(OEP)Ru(NO)(HIm)]BF4 
and  [(OEP)Ru(NO)(1-MeIm)]BF4 were prepared as previously reported in Chapter 3. 
Methylene chloride for use in the spectroelectrochemistry experiments was purified 
just prior to use by passing it though an Innovative Technologies Solvent Purification 
system.  Ferrocene (Cp2Fe; Cp = η5-cyclopentadienyl anion) was sublimed prior to 
use.  NBu4PF6 was recrystallized from hot ethanol and dried prior to use. 
Instrumentation.  Electrochemical measurements were recorded using a BAS 
CV50W instrument (Bioanalytical Systems, West Lafayette, IN, USA).  For all 
electrochemical experiments, a 3.0 mm diameter Pt disk electrode was used as the 
working electrode, a silver wire coated with silver chloride acted as the reference 
electrode, and a platinum wire served as the auxiliary electrode.  Experiments were 
performed at room temperature unless otherwise noted, and were performed under an 
atmosphere of pre-purified nitrogen in a solution of the analyte in CH2Cl2 containing 
0.5 - 1.0 M NBu4PF6 as supporting electrolyte.  Ferrocene served as an internal 
standard, and potentials are referenced to the Cp2Fe0/+ couple set at 0.00 V (+0.44 V 
vs. Ag/AgCl).7 Typical solvent system windows with our configuration were +1.2-1.5 





Infrared spectroscopic measurements were performed using a Bruker Vector 
22 FTIR spectrometer equipped with a mid-IR fiber-optic dip probe and liquid 
nitrogen cooled MCT detector (RemSpec Corporation, Sturbridge, MA, USA) as 
described previously.8 The same electrode configuration was used for both cyclic 
voltammetry and infrared spectroelectrochemical experiments.  The fiber-optic 
infrared reflectance spectroelectrochemical experiments were performed in a 
specially designed cell and in a manner that was previously reported.8 For the low-
temperature work, we jacketed the cell with a dry ice/acetone bath as described in our 
complementary studies on manganese nitrosyl porphyrins.9 
Extended Hückel Calculations.   Extended Hückel calculations, as 
implemented in the YAeHMOP suite of programs,10 were performed on the six-
coordinate ruthenium nitrosyl complexes (OEP)Ru(NO)(Im) and 
[(OEP)Ru(NO)(HIm)]+ using geometries obtained from the crystal structures 
included in Chapter 3 of this work.  Calculations on the theoretical five-coordinate 
complex [(OEP)Ru(NO)]+ were also performed using a geometry derived from the 
crystal structure of (OEP)Ru(NO)(Im) by removing the imidazolate ligand.  Initial 
images of the molecular orbitals were produced using the viewkel application 
distributed in the YAeHMOP suite.10  Adobe Photoshop® was used to add color to 
the figures. 
 
Results and Discussion 
Our previous studies of the ruthenium-nitrosyl porphyrin complexes 




structural/ spectroscopic characteristics of this class of compounds (Chapter 3).  We 
demonstrated that the neutral complexes could be prepared through the reaction of a 
ruthenium-nitrosyl porphyrin alkoxide with imidazole, while cationic complexes 
could be prepared through the reaction of a cationic ruthenium-nitrosyl porphyrin 
with imidazole (Eqs. 4.1 and 4.2, respectively). 
 
(por)Ru(NO)(O-i-C5H11) + HIm  (por)Ru(NO)(Im) + HO-i-C5H11         (4.1) 
[(por)Ru(NO)]+ + HIm  [(por)Ru(NO)(HIm)]+             (4.2) 
 
 Both the cationic Ru-HIm and neutral Ru-Im complexes exhibit linear metal-
nitrosyl linkages and have characteristic infrared nitrosyl stretches between 1845 and 
1855 cm-1 for the neutral complexes and 1866 to 1868 cm-1 for the cationic 
complexes (in CH2Cl2). 
 In the current studies, we compare the infrared (IR) spectroelectrochemistry of 
the imidazolate complex (OEP)Ru(NO)(Im) with that of the imidazole 
[(OEP)Ru(NO)(HIm)]+ complex and the structurally related [(OEP)Ru(NO)(1-
MeIm)]+ analogue.  Extended Hückel calculations were performed and the obtained 









Table 4.1.   Electrochemical data for the [(OEP)Ru(NO)(RIm)]n+ (R = nothing and n 
= 0; X = H or 1-Me and n = 1) compounds in CH2Cl2.a 
 Oxidation  Reduction 
Compound E°
/
1  Epc1 Epc2 E°/3 
(OEP)Ru(NO)(Im) 0.73 (203)  -0.83b -1.24b  
[(OEP)Ru(NO)(HIm)]+ 0.71  (90)    -1.09 (105) 
[(OEP)Ru(NO)(1-MeIm)]+ 0.72 (130)    -1.10 (224) 
 
a Potentials are in volts, and are referenced to the ferrocene-ferrocenium couple set at 0.00 V.  
Conditions:  0.5 - 1 mM analyte, 200 mV/s, 0.1 M NBu4PF6.  The numbers are in brackets represent 
the ΔE values (in mV) for the redox couples. 
b These peaks represent irreversible processes. 
 
 
Cyclic Voltammetry and Infrared Spectroelectrochemistry 
 The redox properties of the three compounds (OEP)Ru(NO)(RIm) were 
examined by cyclic voltammetry, and the electrochemical data are summarized in 
Table 4.1.  We will consider the neutral imidazolate followed by the cationic 
imidazole and then 1-methylimidazole complexes. 
Neutral Ru-Imidazolate Complex.  The response features of the cyclic 
voltammogram of (OEP)Ru(NO)(Im) are shown in Fig. 4.1c.  A major oxidation 
couple occurs at E°'1 = 0.73 V, which is partially reversible (ipa/ipc = 0.71, ΔE = 203 
mV).  The |Ep-Ep/2| value of 80 mV (at 200 mV s-1) and the linear plot of ipa vs. (scan 
rate)1/2 suggests a reversible diffusion controlled second oxidation followed by a 
chemical reaction.  Indeed, the appearance of two daughter peaks at -0.83 and -1.24 V 
upon the negative return scan is consistent with the proposed EC mechanism.  
Interestingly, in addition to E°'1 there was a reversible oxidation at 0.47 V that 




the complex showed no evidence of free imidazole or other impurities via 1H NMR 
spectroscopy, suggesting that this small pre-wave is not due to a 1H NMR active 
impurity.  Previous studies of metalloporphyrins containing N-bound imidazole 
linkages have shown the existence of an equilibrium between the complexes 
containing bound imidazole and free imidazole. 11 The absence of this pre-wave at 
low temperatures scans (dry ice/acetone bath) of the voltammogram suggest that an 
equilibrium is established between a five- and six-coordinate complex and is shifted 
to the six-coordinate complex at lower temperatures.12 Since the electrochemical 
response of the (OEP)Ru(NO)(Im) complex was maintained in the cyclic 
voltammogram at low temperatures minus the pre-wave, the complex responsible for 
the pre-wave does not seem to interfere with the electrochemical response of the 
imidazolate complex.  Hence, the identity of the minor component in the redox 






Figure 4.1.  Cyclic voltammogram of (a) [(OEP)Ru(NO)(1-MeIm)]+, (b) 
[(OEP)Ru(NO)(HIm)]+, and (c) (OEP)Ru(NO)(Im) in CH2Cl2 containing 0.1 mM 
NBu4PF6.  The insets are the low temperature cyclic voltammograms of the respective 
complexes.  Potentials are referenced to the Cp2Fe+/0 couple (at 0.00 V).  Scan rates 





 The IR difference spectrum which shows product formation after the second 
oxidation of (OEP)Ru(NO)(Im) is presented in Fig. 4.2c.  The electrogenerated 
product of the oxidation has a νNO band at 1870 cm-1, which is shifted by +23 cm-1 
from the starting compound.  Such a relatively small shift in νNO is attributed to an 
oxidation site that is somewhat remote from the RuNO fragment.  Indeed, evidence 
for a porphyrin-centered oxidation is provided by the appearance in the spectrum of a 
new band at 1527 cm-1 assigned to an OEP-containing π-radical cation.  Bands 
between 1520 and 1570 cm-1 have been previously reported as characteristic of OEP-
containing π-radical cations13 and were also present in the porphyrin-centered 
oxidations reported in our earlier study (Chapter 2) of the complexes 
(OEP)M(NO)(XEt) (where M = Os, Ru; X = O, S).14 The extra NO peaks that follow 
the oxidation product peak in the difference IR spectrum could arise due to the 
potential being held close to the solvent potential limit, giving rise to significant side 
reactions. 
It is interesting that the product of oxidation shows a νNO band that is similar 
to the band for the cationic  [(OEP)Ru(NO)(HIm)]+ complex (vide infra).  Indeed, the 
electrochemical and IR spectroelectrochemical data suggests that the net partially 
reversible first oxidation of (OEP)Ru(NO)(Im) can be described as consisting of a 
reversible oxidation process centered on the porphyrin followed by H-atom extraction 
by the imidazolate ligand from the solvent (Eqs 4.3 and 4.4). 
 
(OEP)Ru(NO)(Im)  [(OEP˙)Ru(NO)(Im)]+ + e-            (4.3) 




   
 
Figure 4.2.  Difference FTIR spectra showing the formation of products from the first 
oxidations of (a) [(OEP)Ru(NO)(1-MeIm)]+, (b) [(OEP)Ru(NO)(HIm)]+, and (c) 






Figure 4.3. Difference FTIR spectrum showing the formation of product from the 
reduction of (a) [(OEP)Ru(NO)(1-MeIm)]+ and (b) [(OEP)Ru(NO)(HIm)]+ in CH2Cl2 




Holding the potential at 620 mV, just prior to the major first oxidation, 
resulted in difference IR spectra that were devoid of νNO bands.  The relatively small 
amount of material responsible for the cyclic voltammogram response wave may 
have been insufficient for producing enough of the oxidized species on the electrode 
for detection with infrared spectroscopy under our conditions. 
Cationic Ru-Imidazole Complex.  The cyclic voltammogram of the cationic 
imidazole complex [(OEP)Ru(NO)(HIm)]+ is shown in Fig. 4.1b.  The redox behavior 
is characterized by two oxidations and a reduction.  Similar to the electrochemical 
response of the imidazolate complex, the initial oxidation at 0.52 V (ΔE = 65 mV) is 
relatively small, only ca. 1/3 the intensity of the other redox waves and is absent from 
the voltammogram at low temperatures (Fig. 4.1b inset).  The room-temperature 1H 
NMR spectrum of the imidazole complex in CDCl3 exhibits no peaks associated with 
the unbound imidazole ligand or any other impurities, suggesting that the response 
may be due to a 5-coordinate equilibrium product that does not contain the imidazole 
ligand. 
 A well-defined oxidation is evident at 0.71 V versus the ferrocene-ferricenium 
couple.  The ΔEp for this redox couple is 90 mV at 200 mV s-1.  The cathodic to 
anodic peak current ration (ipc/ipa) is 0.9 at 200 mV s-1, and approaches unity at higher 
scan rates, suggesting that the oxidation is chemically reversible.  The plot of ipa vs. 
(scan rate)1/2 is linear and indicative of diffusion-controlled reversible one-electron 
transfer process (Eq. 4.5) site of oxidation not specified). 
 





 A partially reversible reduction peak for [(OEP)Ru(NO)(HIm)]+ is observed at 
E°' = -1.09 V (ΔE = 105 mV).  The ipa/ipc for this redox couple was between 0.5 and 
0.6 at scan speeds between 50 mV s-1 and 1.0 V s-1, indicating high reactivity of the 
reduction product.  This is consistent with the observation of a daughter peak at 0.39 
V upon the return scan after the reduction.  The |Ep – Ep/2| value of 78 mV is similar to 
the value for the ferrocene/ferrocenium couple (68 mV) under the same conditions 
and suggests a fast reversible electron transfer followed by a chemical change. 
 The IR spectroelectrochemistry results obtained for the well-defined oxidation 
of [(OEP)Ru(NO)(HIm)]+ are shown in Fig. 4.2b and display a new νNO at 1895 cm-1 
(ΔνNO = 25 cm-1) and a small band at 1527 cm-1 in the IR difference spectrum.  
Similar to what was observed for the neutral imidazolate analogue, this minor shift of 
νNO with the appearance of the diagnostic OEP-containing π-radical cation band 
suggests, along with the electrochemical evidence, a reversible porphyrin centered 
electron transfer (Eq. 4.6) 
 
 [(OEP)Ru(NO)(HIm)]+  [(OEP˙)Ru(NO)(HIm)]2+ + e-           (4.6) 
 
Porphyrin centered oxidations have been observed for a number of 
(por)Ru(NO)-containing complexes15-17 including those reported by us for OEP 
porphyrins (Chapter 2).14,18 Similar to the oxidation of the imidazolate analogue, a 




potential being held close to the oxidation potential limit of the solvent, resulting in a 
number of labile species. 
 As is evident in Fig. 4.3b, a new νNO band was observed at 1847 cm-1 (ΔνNO = 
23 cm-1) when the potential was held slightly negative of the E°' for the reduction.  As 
previously discussed, the electrochemical data suggests that the reduction of the 
[(OEP)Ru(NO)(Im)]+ proceeds through an initial reversible electron transfer (and is 
likely centered on the porphyrin as evidenced by the small shift in the nitrosyl 
stretch), followed by an irreversible chemical change.  The similarity of the frequency 
of this nitrosyl band at 1847 cm-1 to the νNO of the neutral imidazolate 
(OEP)Ru(NO)(Im) complex (at 1847 cm-1) suggests that H-atom abstraction from 
neutral (OEP)Ru(NO)(HIm) to the solvent system to form the neutral complex 
(OEP)Ru(NO)(Im) (Eqs 4.7 and 4.8) could have occurred.  Similar types of radical 
hydrogen extractions have been observed when photo generated t-butoxyl radicals 
react with amine-boryl complexes to give the corresponding iminyl radical through 
H˙ extraction from the amine portion of the complex; additionally, a recent 
publication has shown that a covalently linked phenoxy-imidazole complex 
exchanges radical hydrogen between the O of a phenoxyl group and the N of the 
imidazole upon oxidation and reduction.19,20  The complimentary process, where by 
H˙ was extracted from the solvent by the bound imidazolate ligand in the 
(OEP)Ru(NO)(Im) complex to form the cationic analogue, was previously discussed. 
 
 [(OEP)Ru(NO)(HIm)]+ + e-  (OEP)Ru(NO)(HIm)            (4.7) 




 Comparison of the oxidation potentials of the imidazolate and the imidazole 
complexes shows a difference of 20 mV, suggesting that the state of protonation of 
the imidazole derivative has little effect on the oxidation potentials of ruthenium-
nitrosyl complexes.  However, it appears to have a significant effect on the reduction 
potentials of the complexes.  It is interesting that the reduction potential of the 
imidazolate complex (reduction of the imidazolate complex was not observed under 
our conditions) is presumably more negative than the reduction potential of the 
imidazole complex.  Similar observations were made for the protonation states of 
imidazole/imidazolate containing His residues attached to the ferric heme centers of 
Rieske clusters upon reduction.21 Hirst and co-workers demonstrated that the 
reduction potential is lowered when histidines attached to their ferric heme centers of 
Rieske clusters are deprotonated because the negatively charged “deprotonated” 
imidazolates contained in the His residue are easier to oxidize than the imidazoles in 
neutral His residues.  The authors propose that this is due to neutral imidazoles in 
ferric bound His being more electron withdrawing than the “deprotonated” analogue 
and favor reduction.  
[(OEP)Ru(NO)(1-MeIm)]+ compound.  The results obtained from the cyclic 
voltammetry of [(OEP)Ru(NO)(1-MeIm)]+ were quite similar to those of the cationic 
imidazole analogue, as can be seen in Fig. 4.1a  The redox behavior of this complex 
shows a well-defined reversible oxidation at E°' = 0.72 V (ipc/ipa = 1.0, ΔEp = 130 
mV).  Additionally, reduction of the 1-MeIm complex is evident at E°' = -1.10 V (ΔEp 
= 224 mV) and ipa/ipc = 0.6 at 200 mV s-1 and approaches unity at higher scan rates.  




couple of 75 mV under the same conditions.  An additional minor reduction peak at -
0.80 V was observed on forward and reverse scans.  The reduction wave showed 
strong similarities to the redox response of 1-methylimidazole and was attributed to 
the presence of the free ligand.  Further characterization of this reduction wave was 
not explored.  The electrochemical data suggests that the [(OEP)Ru(NO)(1-MeIm)]+ 
complex undergoes a fast electron transfer upon reduction followed by a chemical 
change.  The appearance of two daughter peaks at 0.39 V and 0.58 V after the 
reduction upon the forward scan of the potential further supports the proposed EC 
mechanism.  The electrochemical response of the [(OEP)Ru(NO)(1-MeIm)]+ complex 
is remarkably similar to the analogous [(OEP)Ru(NO)(HIm)]+ complex minus the 
pre-wave that plagued both the cationic imidazole and neutral imidazolate complexes 
(vide supra).  This is particularly of interest since the ca. 1% of the unbound 1-methyl 
imidazole ligand was evident in the 1H NMR despite exhaustive purification of the 
[(OEP)Ru(NO)(1-MeIm)]+ complex.   As noted in chapter 3, (OEP)Ru(NO) 
complexes containing imidazole and analogues of imidazole can form an equilibrium 
between the six-coordinate imidazole containing complexes and the five-coordinate 
imidazole free complexes (Eq. 4.9).  Equilibria between five- and six-coordinate 
complexes have also been observed in similar imidazole containing porphyrin 
complexes.11  
 





Absence of the pre-wave in the 1-methyl imidazole complex highlights the probable 
formation of the five-coordinate complexes in the imidazole and imidazolate 
complexes.  The excess unbound 1-MeIm ligand in solution drives the equilibrium to 
the formation of the six-coordinate [(OEP)Ru(NO)(1-MeIm)]+ complex leaving no 
five-coordinate complex in solution; hence, the cyclic voltammogram response 
displayed no pre-wave.  In previous electrochemical studies, excess imidazole was 
used to prepare a single [(por)Fe(Im)2]+ complex and prevent the formation of 
equilibrium products.22  
 As mentioned previously, the electrochemical responses of 
[(OEP)Ru(NO)(HIm)]+ and [(OEP)Ru(NO)(1-MeIm)]+ are very similar.  Structurally, 
the complexes differ only at the unbound N-position, which is protected by a methyl 
group in the 1-MeIm complex.  The lack of an N-H bond on the imidazole in the 
[(OEP)Ru(NO)(1-MeIm)]+ complex and the similarities of the redox responses 
displayed in the voltammagrams by the two complexes suggests that oxidation and 
reduction waves in the [(OEP)Ru(NO)(HIm)]+ are not due to the formation of 
hydrogen bonds between the N-H of the ligand and the electrolyte solution.  
 The IR spectroelectrochemical results for the oxidation of the 
[(OEP)Ru(NO)(1-MeIm)]+ can be seen in Fig. 4.2a, while those for the reduction can 
be seen in Fig. 4.3a.  A new νNO at 1895 results from holding the potential just past 
the oxidation response of the complex.  Similar to what was observed with the 
electrogenerated oxidation product of the cationic imidazole complex, a reversible 
porphyrin based electron transfer upon oxidation is evident by cyclic voltammetry 




electogenerated product (ΔνNO = 23 cm-1) with the formation of a small peak at 1527 
cm-1 (Eq. 4.10). 
 
 [(OEP)Ru(NO)(1-MeIm)]+  [(OEP˙)Ru(NO)(1-MeIm)]2+         (4.10) 
 
 The series of small peaks just subsequent to the νNO band in the difference IR that 
were noted earlier for both the imidazolate and imidazole complexes, were also 
visible in the spectrum for the 1-methyl imidazole complex. 
The electrogenerated product that resulted from the reduction of the 
[(OEP)Ru(NO)(1-MeIm)]+ complex displayed a νNO at 1820 cm-1 (ΔνNO = 52 cm-1) in 
the difference IR spectrum.  This shift of the NO stretching frequency is similar to the 
magnitude of what we previously reported for the reduction of the 
(OEP)Ru(NO)(SEt) complex and suggests a porphyrin based reduction.  Considered 
with the cyclic voltammetry data, the IR spectroelectrochemical indicates that the 
reduction of the [(OEP)Ru(NO)(1-MeIm)]+ complex proceeds via a reversible 
electron transfer based on the porphyrin ring followed by a chemical change which 
likely involves the loss of the 1-MeIm ligand (Eqs. 4.11 and 4.12) 
 
 [(OEP)Ru(NO)(1-MeIm)]+ + e-  (OEP˙)Ru(NO)(1-MeIm)         (4.11) 







Extended Hückel calculations 
 The net oxidation of the (OEP)Ru(NO)(Im) complex resulted in the neutral 
formation of the cationic [(OEP)Ru(NO)(HIm)]+ complex; similarly, reduction of the 
cationic (“protonated”) complex produced the neutral (“deprotonated”) complex.  
Extended Hückel calculations on both the “deprotonated” imidazolate and 
“protonated” imidazole complexes of (OEP)Ru(NO) and the corresponding 
theoretical five-coordinate nitrosyl complex were obtained in order to better 
understand the complimentary but opposite redox chemistry exhibited by these 
complexes. 
 The highest occupied molecular orbitals (HOMOs) of (OEP)Ru(NO)(Im), 
[(OEP)Ru(NO)(HIm)]+, and [(OEP)Ru(NO)]+ are shown in Fig. 4.4.  The HOMO of 
(OEP)Ru(NO)(Im) is porphyrin centered with all of the charge concentrated on the 
porphyrin ring.  The infrared spectroelectrochemical results for the oxidation of 
(OEP)Ru(NO)(Im), described earlier, reveal a net formation of a porphyrin-based π-
radical cation as the primary observable product.  The axial ligands display little 
effect by the oxidation of (OEP)Ru(NO)(Im), consistent with the HOMO of 
(OEP)Ru(NO)(Im) having no axial contributions.  The lowest unoccupied molecular 
orbital (LUMO) of (OEP)Ru(NO)(Im) (Fig. 4.5b) involves antibonding interactions 
between the metal dxz orbital and the π* orbital of NO.  In the reduction of 
(OEP)Ru(NO)(Im), however, the LUMO was not accessible due to the reduction 
potential falling outside the solvent limit. 
 The HOMO of [(OEP)Ru(NO)(HIm)]+ is shown in Fig. 4.4a.  Similar to the 




of the complex.  The similarities between the imidazolate and imidazole HOMOs are 
not surprising.  The two compounds vary only in the nitrogen atom of the imidazole 
ring in the cationic [(OEP)Ru(NO)(HIm)]+ complex is bound to a proton, making 
them isoelectronic.  The infrared spectroelectrochemical results, discussed previously, 
for the oxidation of [(OEP)Ru(NO)(HIm)]+ revealed a small change in the nitrosyl 
stretch in addition to a new peak that is associated with a porphyrin-based π-radical 
cation peak.  The observation of the porphyrin-based π radical cation peak with little 
affect on the axial ligands is consistent with the nature of  the HOMO of the 
[(OEP)Ru(NO)(HIm)]+ complex. 
 The LUMO of [(OEP)Ru(NO)(HIm)]+ (Fig. 4.5a) involves antibonding 
interactions between the metal dxz orbital and a π* orbital on the NO.  Thus, it would 
be expected that reduction of [(OEP)Ru(NO)(HIm)]+ would result in a weakening in 
the Ru-NO bond and increase in the antibonding character in the N-O bond.  The 
increased charge on the metal nitrosyl would lead to a bent metal-nitrosyl geometry.  
With the exception of a few organometallic ruthenium-nitrosyl porphyrin 
complexes,23,24, ruthenium-nitrosyl porphyrin complexes prefer to have linear metal-
nitrosyl linkages.14,15,25-33 Nan Xu, in our lab, is currently examining the 
spectroelectrochemistry of a series of novel organometallic ruthenium-nitrosyl 
porphyrins containing bent metal-nitrosyl linkages.  In order to relieve the strain 
placed on the molecule by the bending of the metal-NO fragment, the charge on the 
LUMO could be redistributed away from being mostly metal-nitrosyl based, thereby, 
allowing for a linear Ru-NO bond.  The electrochemical and spectroelectrochemical 




[(OEP)Ru(NO)(HIm)]+, discussed previously, suggested a reversible electron transfer 
followed by an irreversible chemical change involving a small shift of the νNO to a 
new nitrosyl stretch at 1847 cm-1 (ΔνNO = 23 cm-1), characteristic of the neutral 
(OEP)Ru(NO)(Im) complex.  This is consistent with the LUMO where the initial site 
of electron transfer is on the ruthenium-nitrosyl fragment followed by a 
rearrangement of the charge to relieve the bent metal-nitrosyl linkage, allowing for 
the extraction of H˙ from the imidazole ligand by the solvent to form the neutral 
analogue (OEP)Ru(NO)(Im) (Eqs. 4.13 and 4.14). 
 
 [(OEP)Ru(NO)(HIm)]+ + e-   (OEP)Ru(NO˙) (HIm)          (4.13) 
 (OEP)Ru(NO˙)(HIm)   (OEP)Ru(NO)(Im) + H˙solv           (4.14) 
 
 The (OEP)Os(NO)(SEt) complex, previously discussed in Chapter 2, showed 
nearly identical electrochemical and spectroelectrochemical responses to the 
ruthenium analogue (OEP)Ru(NO)(SEt).  The LUMO of the osmium complex also 
displayed antibonding character between metal dxz and the π* orbital on NO.  
Additionally, there was significant antibonding character between the metal dxz and 
the S-atom orbital.  The reduction of the (OEP)Os(NO)(SEt) complex resulted in an 
axial centered electron transfer followed by the loss of the NO fragment, likely due of 
the formation of an unfavorable bent metal-nitrosyl geometry. 
 As seen in Fig. 4.4b, the HOMO of the five-coordinate [(OEP)Ru(NO)]+ 
complex is porphyrin centered, similar to the HOMOs for the six-coordinate 




expected due to the lack of any charge contribution from the metal-nitrosyl or the 
imidazolate or imidazole ligands in the structurally related six-coordinate complexes.  
Though the six-coordinate complexes are in principle more electron-rich than the 
five-coordinate complexes, oxidation may be easier for the five-coordinate depending 
on interactions between the metal center of the five-coordinate complex and the 
solvent or the supporting electrolyte that composes the system used for the 
electrochemical and spectroelectrochemical studies.  The identity of the resulting 
species may explain the lower oxidation potentials observed for the five-coordinate 
complexes in the equilibrium that is established with the imidazolate and imidazole 
complexes of (OEP)Ru(NO)(Im) and [(OEP)Ru(NO)(HIm)]+. 
 Comparison of the oxidation potentials of (OEP)Ru(NO) imidazole(ate) 
complexes to those of the (OEP)Ru(NO) alkoxide/thiolate complexes (detailed in 
Chapter 2) show a ease of reduction that is 280 – 360 mV lower for the alkoxide and 
thiolate complexes as a group.  This is not surprising when considering the HOMOs 
of the alkoxide exhibited charge contribution from the O- and S-bound ligands.  The 
HOMOs of the imidazole/imidazolate complexes had no such features.  The increased 
bonding contribution from the alkoxide and thiolate ligands leads to relatively more 
electron donation to the (OEP)Ru(NO) fragment resulting in easier reduction when 




 We have shown that the complexes (OEP)Ru(NO)(Im) and 




respectively.  The redox behaviors and identities of the electrochemical products can 
be readily explained by extended Hückel calculations as well as by infrared 
spectroelectrochemistry analyses.   
Both the (OEP)Ru(NO)(Im) and the [(OEP)Ru(NO)(HIm)]+ complexes 
exhibit equilibria between their six-coordinate and five-coordinate ruthenium-nitrosyl 
porphyrin forms, which are apparent from the cyclic voltammagrams of the 
complexes.  Electrochemical oxidation of the (OEP)Ru(NO)(Im) complex in CH2Cl2 
displayed a partially reversible single electron transfer centered on the porphyrin 
followed by radical hydrogen extraction from the solvent by the nitrogen atom of the 
imidazolate ring to form the cationic [(OEP)Ru(NO)(HIm)]+ derivative.  The 
[(OEP)Ru(NO)(HIm)]+ complex, however, exhibits a porphyrin based reversible 
(diffusion controlled) single electron transfer upon oxidation.  The calculated 
HOMOs for both the (OEP)Ru(NO)(Im) complex and [(OEP)Ru(NO)(HIm)]+ 
complexes show charge distribution on the porphyrin, providing supporting evidence 








Figure 4.4.  Highest molecular orbitals of (a) [(OEP)Ru(NO)(HIm)]+ and 
(OEP)Ru(NO)(Im) (these complexes are isoelectronic and calculations result in 
identical HOMOs), and (b) model compound [(OEP)Ru(NO)]+ as determined by 
Extended Hückel calculations.  The eight ethyl groups on the porphyrin and the 







Figure 4.5.  Lowest molecular orbitals of (a) [(OEP)Ru(NO)(HIm)]+ and (b) 
(OEP)Ru(NO)(Im) as determined by Extended Hückel calculations.  The eight ethyl 
groups on the porphyrin and the hydrogens were included in the calculation but are 





 Reduction of the [(OEP)Ru(NO)(HIm)]+ complex proceeds through a partially 
reversible single electron transfer followed by a H˙ extraction from the nitrogen of the 
imidazole by the solvent system to form the neutral (OEP)Ru(NO)(Im) derivative.  
The calculated LUMO suggests that reduction occurs first on the metal-nitrosyl 
fragment of the [(OEP)Ru(NO)(HIm)]+ increasing the antibonding interaction 
between the metal dxz and the π* orbital on NO.  Presumably, the resulting 
unfavorable bent Ru-NO- like geometry is relieved by an electronic rearrangement 
that leads to the extraction of H• from the nitrogen of the imidazole by the solvent 
system.  The similarities in the electrochemical responses of the 
[(OEP)Ru(NO)(HIm)]+ and the [(OEP)Ru(NO)(1-MeIm)]+ suggest that the redox 
properties of the cationic [(OEP)Ru(NO)(HIm)]+ cannot be attributed to the formation 
of hydrogen bonding in solution.  This research suggests that conversion between the 
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Table 2.5.   Bond lengths [Å] for (OEP)Os(NO)(OEt). 
 
Os(1)-O(2)#1  1.849(7) 
Os(1)-O(2)  1.849(7) 
Os(1)-N(3)#1  1.880(7) 
Os(1)-N(3)  1.880(7) 
Os(1)-N(1)#1  2.059(4) 
Os(1)-N(1)  2.059(4) 
Os(1)-N(2)  2.066(4) 
Os(1)-N(2)#1  2.066(4) 
N(1)-C(4)  1.364(7) 
N(1)-C(1)  1.372(6) 
N(2)-C(6)  1.361(7) 
N(2)-C(9)  1.380(6) 
N(3)-O(1)  1.165(9) 
C(1)-C(10)#1  1.385(8) 
C(1)-C(2)  1.454(8) 
C(2)-C(3)  1.353(8) 
C(2)-C(11)  1.508(7) 
C(3)-C(4)  1.453(7) 
C(3)-C(13)  1.494(8) 
C(4)-C(5)  1.391(6) 
C(5)-C(6)  1.381(7) 
C(6)-C(7)  1.456(6) 
C(7)-C(8)  1.354(8) 
C(7)-C(15)  1.501(8) 
C(8)-C(9)  1.436(8) 
C(8)-C(17)  1.534(8) 
C(8)-C(17')  1.535(9) 
C(9)-C(10)  1.388(8) 
C(10)-C(1)#1  1.385(8) 
C(11)-C(12)  1.515(8) 
C(13)-C(14)  1.529(7) 
C(15)-C(16)  1.521(8) 
C(17)-C(18)  1.532(11) 
C(17')-C(18')  1.531(12) 
O(2)-C(19)  1.351(12) 























































































Table 2.7.  Bond lengths [Å] for (OEP)Os(NO)(SEt).0.5(CH2Cl2). 
 
Os(1)-N(3)  1.944(10) 
Os(1)-N(1)  2.048(3) 
Os(1)-N(1)#1  2.048(3) 
Os(1)-N(2)#1  2.054(2) 
Os(1)-N(2)  2.054(2) 
Os(1)-S(1)  2.227(2) 
S(1)-C(19)  1.768(10) 
N(1)-C(1)  1.366(4) 
N(1)-C(4)  1.369(4) 
N(2)-C(6)  1.363(4) 
N(2)-C(9)  1.369(4) 
N(3)-O(1)  1.136(11) 
C(1)-C(10)#1  1.389(4) 
C(1)-C(2)  1.443(5) 
C(2)-C(3)  1.365(4) 
C(2)-C(11)  1.497(4) 
C(3)-C(4)  1.440(5) 
C(3)-C(13)  1.486(5) 
C(4)-C(5)  1.385(4) 
C(5)-C(6)  1.379(5) 
C(5)-H(5)  0.9500 
C(6)-C(7)  1.446(4) 
C(7)-C(8)  1.362(5) 
C(7)-C(15)  1.491(4) 
C(8)-C(9)  1.451(4) 
C(8)-C(17)  1.493(4) 
C(9)-C(10)  1.378(5) 
C(10)-C(1)#1  1.389(4) 
C(10)-H(10)  0.9500 
C(11)-C(12)  1.517(4) 
C(11)-H(11A)  0.9900 
C(11)-H(11B)  0.9900 
C(12)-H(12A)  0.9800 
C(12)-H(12B)  0.9800 
C(12)-H(12C)  0.9800 
C(13)-C(14)  1.525(5) 
C(13)-H(13A)  0.9900 
C(13)-H(13B)  0.9900 
C(14)-H(14A)  0.9800 
C(14)-H(14B)  0.9800 
C(14)-H(14C)  0.9800 
C(15)-C(16)  1.525(5) 
C(15)-H(15A)  0.9900 
C(15)-H(15B)  0.9900 
C(16)-H(16A)  0.9800 
C(16)-H(16B)  0.9800 
C(16)-H(16C)  0.9800 
C(17)-C(18)  1.518(5) 
C(17)-H(17A)  0.9900 
C(17)-H(17B)  0.9900 
C(18)-H(18A)  0.9800 
C(18)-H(18B)  0.9800 
C(18)-H(18C)  0.9800 
C(19)-C(20)  1.559(16) 
C(19)-H(19A)  0.9900 
C(19)-H(19B)  0.9900 
C(20)-H(20A)  0.9800 




C(20)-H(20C)  0.9800 
Cl(1S)-C(1S)  1.719(3) 
C(1S)-Cl(2S)  1.720(3) 
C(1S)-H(1S1)  0.9900 
C(1S)-H(1S2)  0.9900 
Cl(1T)-C(1T)  1.721(3) 
C(1T)-Cl(2T)  1.720(3) 
C(1T)-H(1T1)  0.9900 













































































































































Table 3.4.   Bond lengths (Å) for (T(p-OMe)PP)Ru(NO)(O-i-C5H11). 
 
Ru(1)-N(5)  1.754(4) 
Ru(1)-O(2)  1.932(3) 
Ru(1)-N(2)  2.053(4) 
Ru(1)-N(4)  2.055(4) 
Ru(1)-N(1)  2.058(4) 
Ru(1)-N(3)  2.061(4) 
O(1)-N(5)  1.172(5) 
O(2)-C(49")  1.293(8) 
O(2)-C(49)  1.294(8) 
O(2)-C(49')  1.295(8) 
O(3)-C(24)  1.369(5) 
O(3)-C(27)  1.421(6) 
O(4)-C(31)  1.367(6) 
O(4)-C(34)  1.420(9) 
O(5)-C(38)  1.373(5) 
O(5)-C(41)  1.423(7) 
O(6)-C(45)  1.366(6) 
O(6)-C(48)  1.444(8) 
N(1)-C(4)  1.370(5) 
N(1)-C(1)  1.373(6) 
N(2)-C(6)  1.378(6) 
N(2)-C(9)  1.379(6) 
N(3)-C(11)  1.359(6) 
N(3)-C(14)  1.375(5) 
N(4)-C(16)  1.367(6) 
N(4)-C(19)  1.369(6) 
C(1)-C(20)  1.402(6) 
C(1)-C(2)  1.436(6) 
C(2)-C(3)  1.343(6) 
C(2)-H(2)  0.9500 
C(3)-C(4)  1.441(6) 
C(3)-H(3)  0.9500 
C(4)-C(5)  1.403(6) 
C(5)-C(6)  1.397(6) 
C(5)-C(21)  1.500(6) 
C(6)-C(7)  1.441(6) 
C(7)-C(8)  1.344(7) 
C(7)-H(7)  0.9500 
C(8)-C(9)  1.440(6) 
C(8)-H(8)  0.9500 
C(9)-C(10)  1.394(6) 
C(10)-C(11)  1.406(6) 
C(10)-C(28)  1.501(6) 
C(11)-C(12)  1.430(6) 
C(12)-C(13)  1.364(6) 
C(12)-H(12)  0.9500 
C(13)-C(14)  1.440(6) 
C(13)-H(13)  0.9500 
C(14)-C(15)  1.391(6) 
C(15)-C(16)  1.401(6) 
C(15)-C(35)  1.508(6) 
C(16)-C(17)  1.432(6) 
C(17)-C(18)  1.346(7) 
C(17)-H(17)  0.9500 
C(18)-C(19)  1.439(6) 
C(18)-H(18)  0.9500 
C(19)-C(20)  1.399(6) 
C(20)-C(42)  1.504(6) 
C(21)-C(26)  1.373(6) 




C(22)-C(23)  1.387(6) 
C(22)-H(22)  0.9500 
C(23)-C(24)  1.370(7) 
C(23)-H(23)  0.9500 
C(24)-C(25)  1.391(7) 
C(25)-C(26)  1.393(6) 
C(25)-H(25)  0.9500 
C(26)-H(26)  0.9500 
C(27)-H(27A)  0.9800 
C(27)-H(27B)  0.9800 
C(27)-H(27C)  0.9800 
C(28)-C(33)  1.356(7) 
C(28)-C(29)  1.393(7) 
C(29)-C(30)  1.384(7) 
C(29)-H(29)  0.9500 
C(30)-C(31)  1.377(8) 
C(30)-H(30)  0.9500 
C(31)-C(32)  1.369(7) 
C(32)-C(33)  1.395(6) 
C(32)-H(32)  0.9500 
C(33)-H(33)  0.9500 
C(34)-H(34A)  0.9800 
C(34)-H(34B)  0.9800 
C(34)-H(34C)  0.9800 
C(35)-C(36)  1.367(7) 
C(35)-C(40)  1.380(7) 
C(36)-C(37)  1.382(7) 
C(36)-H(36)  0.9500 
C(37)-C(38)  1.365(7) 
C(37)-H(37)  0.9500 
C(38)-C(39)  1.385(7) 
C(39)-C(40)  1.386(7) 
C(39)-H(39)  0.9500 
C(40)-H(40)  0.9500 
C(41)-H(41A)  0.9800 
C(41)-H(41B)  0.9800 
C(41)-H(41C)  0.9800 
C(42)-C(47)  1.383(7) 
C(42)-C(43)  1.385(7) 
C(43)-C(44)  1.393(7) 
C(43)-H(43)  0.9500 
C(44)-C(45)  1.370(8) 
C(44)-H(44)  0.9500 
C(45)-C(46)  1.376(8) 
C(46)-C(47)  1.386(7) 
C(46)-H(46)  0.9500 
C(47)-H(47)  0.9500 
C(48)-H(48A)  0.9800 
C(48)-H(48B)  0.9800 
C(48)-H(48C)  0.9800 
C(49)-C(50)  1.575(7) 
C(49)-H(49A)  0.9900 
C(49)-H(49B)  0.9900 
C(50)-C(51)  1.573(7) 
C(50)-H(50A)  0.9900 
C(50)-H(50B)  0.9900 
C(51)-C(53)  1.569(6) 
C(51)-C(52)  1.570(6) 
C(51)-H(51)  1.0000 
C(52)-H(52A)  0.9800 
C(52)-H(52B)  0.9800 




C(53)-H(53A)  0.9800 
C(53)-H(53B)  0.9800 
C(53)-H(53C)  0.9800 
C(49')-C(50')  1.567(7) 
C(49')-H(49C)  0.9900 
C(49')-H(49D)  0.9900 
C(50')-C(51')  1.568(7) 
C(50')-H(50C)  0.9900 
C(50')-H(50D)  0.9900 
C(51')-C(52')  1.569(7) 
C(51')-C(53')  1.573(7) 
C(51')-H(51')  1.0000 
C(52')-H(52D)  0.9800 
C(52')-H(52E)  0.9800 
C(52')-H(52F)  0.9800 
C(53')-H(53D)  0.9800 
C(53')-H(53E)  0.9800 
C(53')-H(53F)  0.9800 
C(49")-C(50")  1.570(7) 
C(49")-H(49E)  0.9900 
C(49")-H(49F)  0.9900 
C(50")-C(51")  1.573(7) 
C(50")-H(50E)  0.9900 
C(50")-H(50F)  0.9900 
C(51")-C(53")  1.569(7) 
C(51")-C(52")  1.571(7) 
C(51")-H(51")  1.0000 
C(52")-H(52G)  0.9800 
C(52")-H(52H)  0.9800 
C(52")-H(52I)  0.9800 
C(53")-H(53G)  0.9800 
C(53")-H(53H)  0.9800 

















































































































































































































































































































Table 3.6.  Bond lengths (Å) for (OEP)Ru(NO)(Im). 
 
Ru(1)-N(5)  1.748(3) 
Ru(1)-N(4)  2.046(2) 
Ru(1)-N(2)  2.049(2) 
Ru(1)-N(3)  2.054(2) 
Ru(1)-N(1)  2.058(3) 
Ru(1)-N(6)  2.063(3) 
O(1)-N(5)  1.148(4) 
N(1)-C(1)  1.364(4) 
N(1)-C(4)  1.372(4) 
N(2)-C(6)  1.367(4) 
N(2)-C(9)  1.369(4) 
N(3)-C(11)  1.369(4) 
N(3)-C(14)  1.370(4) 
N(4)-C(16)  1.372(4) 
N(4)-C(19)  1.373(4) 
N(6)-C(39)  1.348(4) 
N(6)-C(37)  1.379(4) 
N(7)-C(39)  1.322(4) 
N(7)-C(38)  1.372(4) 
C(1)-C(20)  1.381(4) 
C(1)-C(2)  1.453(4) 
C(2)-C(3)  1.361(5) 
C(2)-C(21)  1.495(4) 
C(3)-C(4)  1.449(4) 
C(3)-C(23)  1.502(4) 
C(4)-C(5)  1.387(4) 
C(5)-C(6)  1.388(4) 
C(6)-C(7)  1.438(4) 
C(7)-C(8)  1.360(5) 
C(7)-C(25)  1.499(4) 
C(8)-C(9)  1.448(4) 
C(8)-C(27)  1.500(4) 
C(9)-C(10)  1.383(4) 
C(10)-C(11)  1.388(4) 
C(11)-C(12)  1.448(4) 
C(12)-C(13)  1.362(4) 
C(12)-C(29)  1.502(4) 
C(13)-C(14)  1.449(4) 
C(13)-C(31)  1.501(4) 
C(14)-C(15)  1.383(4) 
C(15)-C(16)  1.380(4) 
C(16)-C(17)  1.451(4) 
C(17)-C(18)  1.359(5) 
C(17)-C(33)  1.494(4) 
C(18)-C(19)  1.455(4) 
C(18)-C(35)  1.486(7) 
C(18)-C(35')  1.530(13) 
C(19)-C(20)  1.380(5) 
C(21)-C(22)  1.521(5) 
C(23)-C(24)  1.521(5) 
C(25)-C(26)  1.522(4) 
C(27)-C(28)  1.524(5) 
C(29)-C(30)  1.528(5) 
C(31)-C(32)  1.516(5) 
C(33)-C(34)  1.524(5) 
C(35)-C(36)  1.535(9) 
C(35')-C(36')  1.539(13) 




N(8)-C(42)  1.338(5) 
N(8)-C(40)  1.344(5) 
N(9)-C(42)  1.287(7) 
N(9)-C(41)  1.374(9) 
C(40)-C(41)  1.350(8) 
Cl(1)-C(43)  1.743(6) 























































































































Table 3.8.  Bond lengths (Å) for [(OEP)Ru(NO)(HIm)]SbF6. 
 
Ru(1)-N(7)  1.695(9) 
Ru(1)-N(2)  2.007(7) 
Ru(1)-N(3)  2.033(7) 
Ru(1)-N(4)  2.037(7) 
Ru(1)-N(1)  2.047(7) 
Ru(1)-N(5)  2.069(8) 
O(1)-N(7)  1.131(12) 
N(1)-C(4)  1.368(12) 
N(1)-C(1)  1.396(11) 
N(2)-C(6)  1.394(12) 
N(2)-C(9)  1.420(10) 
N(3)-C(14)  1.355(12) 
N(3)-C(11)  1.393(9) 
N(4)-C(16)  1.363(12) 
N(4)-C(19)  1.387(10) 
N(5)-C(39)  1.274(12) 
N(5)-C(37)  1.368(13) 
N(6)-C(38)  1.297(14) 
N(6)-C(39)  1.337(15) 
C(1)-C(20)  1.358(13) 
C(1)-C(2)  1.379(14) 
C(2)-C(3)  1.329(9) 
C(2)-C(21)  1.523(3) 
C(3)-C(4)  1.391(11) 
C(3)-C(23)  1.523(3) 
C(4)-C(5)  1.383(13) 
C(5)-C(6)  1.381(13) 
C(6)-C(7)  1.426(9) 
C(7)-C(8)  1.313(7) 
C(7)-C(25)  1.520(3) 
C(8)-C(9)  1.440(11) 
C(8)-C(27)  1.513(10) 
C(9)-C(10)  1.412(13) 
C(10)-C(11)  1.354(12) 
C(11)-C(12)  1.446(12) 
C(12)-C(13)  1.371(12) 
C(12)-C(29)  1.493(11) 
C(13)-C(14)  1.468(13) 
C(13)-C(31)  1.485(15) 
C(14)-C(15)  1.362(12) 
C(15)-C(16)  1.381(12) 
C(16)-C(17)  1.434(11) 
C(17)-C(18)  1.384(13) 
C(17)-C(33)  1.493(14) 
C(18)-C(19)  1.447(13) 
C(18)-C(35)  1.499(12) 
C(19)-C(20)  1.364(13) 
C(21)-C(22)  1.517(4) 
C(23)-C(24)  1.520(3) 
C(25)-C(26)  1.519(3) 
C(27)-C(28)  1.495(11) 
C(29)-C(30)  1.471(13) 
C(31)-C(32)  1.465(17) 
C(33)-C(34)  1.514(16) 
C(35)-C(36)  1.458(15) 
C(37)-C(38)  1.319(14) 
Sb(1)-F(6)  1.789(8) 
Sb(1)-F(4)  1.803(7) 
 
 190 
Sb(1)-F(5)  1.804(8) 
Sb(1)-F(2)  1.803(7) 
Sb(1)-F(1)  1.815(7) 




























































































































Table 3.10.  Bond lengths (Å) for (OEP)Ru(NO)(5-MeIm). 
 
Ru(1)-N(7)  1.740(4) 
Ru(1)-N(4)  2.042(4) 
Ru(1)-N(3)  2.051(4) 
Ru(1)-N(2)  2.054(4) 
Ru(1)-N(1)  2.057(4) 
Ru(1)-N(5)  2.059(4) 
O(1)-N(7)  1.145(5) 
N(1)-C(4)  1.365(6) 
N(1)-C(1)  1.379(7) 
N(2)-C(9)  1.372(7) 
N(2)-C(6)  1.375(6) 
N(3)-C(14)  1.379(6) 
N(3)-C(11)  1.383(6) 
N(4)-C(19)  1.378(7) 
N(4)-C(16)  1.389(6) 
N(5)-C(37)  1.359(6) 
N(5)-C(39)  1.366(6) 
N(6)-C(37)  1.332(6) 
N(6)-C(38)  1.383(7) 
C(1)-C(20)  1.385(7) 
C(1)-C(2)  1.459(7) 
C(2)-C(3)  1.363(7) 
C(2)-C(21)  1.505(7) 
C(3)-C(4)  1.452(7) 
C(3)-C(23)  1.512(7) 
C(4)-C(5)  1.396(7) 
C(5)-C(6)  1.385(7) 
C(5)-H(5A)  0.9500 
C(6)-C(7)  1.451(7) 
C(7)-C(8)  1.369(7) 
C(7)-C(25)  1.497(7) 
C(8)-C(9)  1.449(7) 
C(8)-C(27)  1.491(7) 
C(9)-C(10)  1.396(7) 
C(10)-C(11)  1.379(7) 
C(10)-H(10A)  0.9500 
C(11)-C(12)  1.440(7) 
C(12)-C(13)  1.360(7) 
C(12)-C(29)  1.506(7) 
C(13)-C(14)  1.450(7) 
C(13)-C(31)  1.494(7) 
C(14)-C(15)  1.384(7) 
C(15)-C(16)  1.392(7) 
C(15)-H(15A)  0.9500 
C(16)-C(17)  1.438(7) 
C(17)-C(18)  1.377(7) 
C(17)-C(33)  1.493(7) 
C(18)-C(19)  1.450(7) 
C(18)-C(35)  1.486(7) 
C(19)-C(20)  1.397(7) 
C(20)-H(20A)  0.9500 
C(21)-C(22)  1.523(8) 
C(21)-H(21A)  0.9900 
C(21)-H(21B)  0.9900 
C(22)-H(22A)  0.9800 
C(22)-H(22B)  0.9800 
C(22)-H(22C)  0.9800 
C(23)-C(24)  1.535(7) 
 
 194 
C(23)-H(23A)  0.9900 
C(23)-H(23B)  0.9900 
C(24)-H(24A)  0.9800 
C(24)-H(24B)  0.9800 
C(24)-H(24C)  0.9800 
C(25)-C(26)  1.511(7) 
C(25)-H(25A)  0.9900 
C(25)-H(25B)  0.9900 
C(26)-H(26A)  0.9800 
C(26)-H(26B)  0.9800 
C(26)-H(26C)  0.9800 
C(27)-C(28)  1.527(7) 
C(27)-H(27A)  0.9900 
C(27)-H(27B)  0.9900 
C(28)-H(28A)  0.9800 
C(28)-H(28B)  0.9800 
C(28)-H(28C)  0.9800 
C(29)-C(30)  1.523(7) 
C(29)-H(29A)  0.9900 
C(29)-H(29B)  0.9900 
C(30)-H(30A)  0.9800 
C(30)-H(30B)  0.9800 
C(30)-H(30C)  0.9800 
C(31)-C(32)  1.523(7) 
C(31)-H(31A)  0.9900 
C(31)-H(31B)  0.9900 
C(32)-H(32A)  0.9800 
C(32)-H(32B)  0.9800 
C(32)-H(32C)  0.9800 
C(33)-C(34)  1.543(7) 
C(33)-H(33A)  0.9900 
C(33)-H(33B)  0.9900 
C(34)-H(34A)  0.9800 
C(34)-H(34B)  0.9800 
C(34)-H(34C)  0.9800 
C(35)-C(36)  1.519(7) 
C(35)-H(35A)  0.9900 
C(35)-H(35B)  0.9900 
C(36)-H(36A)  0.9800 
C(36)-H(36B)  0.9800 
C(36)-H(36C)  0.9800 
C(37)-H(37A)  0.9500 
C(38)-C(39)  1.353(7) 
C(38)-C(40)  1.486(8) 
C(39)-H(39A)  0.9500 
C(40)-H(40A)  0.9800 
C(40)-H(40B)  0.9800 
C(40)-H(40C)  0.9800 
N(8)-C(43)  1.329(8) 
N(8)-C(41)  1.384(7) 
N(8)-H(8N)  0.8800 
N(9)-C(43)  1.299(8) 
N(9)-C(42)  1.366(9) 
C(41)-C(42)  1.385(9) 
C(41)-H(41A)  0.9500 
C(42)-C(44)  1.467(9) 
C(44)-H(44A)  0.9800 
C(44)-H(44B)  0.9800 
C(44)-H(44C)  0.9800 
C(43)-H(43A)  0.9500 
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Table 3.12.   Bond lengths (Å) for [(OEP)Ru(NO)(5(4)-MeHIm)]SbF6. 
 
Ru(1)-N(5)  1.7305(17) 
Ru(1)-N(3)  2.0542(17) 
Ru(1)-N(1)  2.0549(17) 
Ru(1)-N(2)  2.0568(15) 
Ru(1)-N(4)  2.0580(15) 
Ru(1)-N(6)  2.1036(17) 
O(1)-N(5)  1.144(2) 
N(1)-C(4)  1.373(3) 
N(1)-C(1)  1.377(2) 
N(2)-C(9)  1.370(2) 
N(2)-C(6)  1.375(3) 
N(3)-C(11)  1.375(2) 
N(3)-C(14)  1.375(3) 
N(4)-C(19)  1.372(2) 
N(4)-C(16)  1.376(3) 
C(1)-C(20)  1.389(3) 
C(1)-C(2)  1.446(3) 
C(2)-C(3)  1.367(3) 
C(2)-C(21)  1.500(3) 
C(3)-C(4)  1.446(3) 
C(3)-C(23)  1.499(3) 
C(4)-C(5)  1.388(3) 
C(5)-C(6)  1.388(3) 
C(5)-H(5A)  0.9500 
C(6)-C(7)  1.445(2) 
C(7)-C(8)  1.363(3) 
C(7)-C(25)  1.504(3) 
C(8)-C(9)  1.456(3) 
C(8)-C(27)  1.495(3) 
C(9)-C(10)  1.390(3) 
C(10)-C(11)  1.401(3) 
C(10)-H(10A)  0.9500 
C(11)-C(12)  1.438(3) 
C(12)-C(13)  1.373(3) 
C(12)-C(29)  1.502(3) 
C(13)-C(14)  1.443(3) 
C(13)-C(31)  1.499(3) 
C(14)-C(15)  1.393(3) 
C(15)-C(16)  1.387(3) 
C(15)-H(15A)  0.9500 
C(16)-C(17)  1.450(3) 
C(17)-C(18)  1.363(3) 
C(17)-C(33)  1.501(3) 
C(18)-C(19)  1.451(3) 
C(18)-C(35)  1.501(3) 
C(19)-C(20)  1.387(3) 
C(20)-H(20A)  0.9500 
C(21)-C(22)  1.502(3) 
C(21)-H(21A)  0.9900 
C(21)-H(21B)  0.9900 
C(22)-H(22A)  0.9800 
C(22)-H(22B)  0.9800 
C(22)-H(22C)  0.9800 
C(23)-C(24)  1.539(3) 
C(23)-H(23A)  0.9900 
C(23)-H(23B)  0.9900 
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C(24)-H(24A)  0.9800 
C(24)-H(24B)  0.9800 
C(24)-H(24C)  0.9800 
C(25)-C(26)  1.526(4) 
C(25)-H(25A)  0.9900 
C(25)-H(25B)  0.9900 
C(26)-H(26A)  0.9800 
C(26)-H(26B)  0.9800 
C(26)-H(26C)  0.9800 
C(27)-C(28)  1.533(3) 
C(27)-H(27A)  0.9900 
C(27)-H(27B)  0.9900 
C(28)-H(28A)  0.9800 
C(28)-H(28B)  0.9800 
C(28)-H(28C)  0.9800 
C(29)-C(30')  1.494(3) 
C(29)-C(30)  1.494(3) 
C(29)-H(29A)  0.9900 
C(29)-H(29B)  0.9900 
C(29)-H(29C)  0.9900 
C(29)-H(29D)  0.9900 
C(30)-H(30A)  0.9800 
C(30)-H(30B)  0.9800 
C(30)-H(30C)  0.9800 
C(30')-H(30D)  0.9800 
C(30')-H(30E)  0.9800 
C(30')-H(30F)  0.9800 
C(31)-C(32)  1.525(4) 
C(31)-H(31A)  0.9900 
C(31)-H(31B)  0.9900 
C(32)-H(32A)  0.9800 
C(32)-H(32B)  0.9800 
C(32)-H(32C)  0.9800 
C(33)-C(34)  1.522(4) 
C(33)-H(33A)  0.9900 
C(33)-H(33B)  0.9900 
C(34)-H(34A)  0.9800 
C(34)-H(34B)  0.9800 
C(34)-H(34C)  0.9800 
C(35)-C(36)  1.536(3) 
C(35)-H(35A)  0.9900 
C(35)-H(35B)  0.9900 
C(36)-H(36A)  0.9800 
C(36)-H(36B)  0.9800 
C(36)-H(36C)  0.9800 
N(6)-C(37)  1.320(3) 
N(6)-C(39)  1.367(3) 
N(7)-C(37)  1.335(3) 
N(7)-C(38)  1.379(4) 
N(7)-H(7A)  0.8800 
C(37)-H(37A)  0.9500 
C(38)-C(39)  1.350(3) 
C(38)-C(40)  1.489(4) 
C(38)-H(38A)  0.9500 
C(39)-C(40')  1.478(4) 
C(39)-H(39A)  0.9500 
C(40)-H(40A)  0.9800 
C(40)-H(40B)  0.9800 
C(40)-H(40C)  0.9800 
C(40')-H(40D)  0.9800 
C(40')-H(40E)  0.9800 
C(40')-H(40F)  0.9800 
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Sb(1)-F(2)  1.8473(16) 
Sb(1)-F(3)  1.8525(18) 
Sb(1)-F(6)  1.8639(15) 
Sb(1)-F(4)  1.8678(19) 
Sb(1)-F(1)  1.8725(17) 



































































































































































































































































F(1)-Sb(1)-F(5) 88.28(7)  
 
